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ABSTRACT

Understanding how metabolites contribute to anaplerosis, antioxidant effects, and
hormetic pathways during aging is fundamental to creating supplements and dietary habits that
may decrease age-associated disease and decline, thus improving the quality of life in old age. In
order to uncover metabolic pathways that delay aging, the effects of large sets of metabolites
associated with mitochondrial function on lifespan were investigated.
Malate, the tricarboxylic acid (TCA) cycle metabolite, increased lifespan and
thermotolerance in C. elegans. Addition of fumarate and succinate also extended lifespan and all
three metabolites activated nuclear translocation of the cytoprotective DAF-16/FOXO
transcription factor and protected from paraquat-induced oxidative stress. The increased
longevity provided by malate addition did not occur in fumarase (fum-1), glyoxylate shunt (gei7), succinate dehydrogenase flavoprotein (sdha-2), or soluble fumarate reductaseF48E8.3 RNAi
knockdown worms. Therefore, to increase lifespan, malate must be first converted to fumarate,
then fumarate must be reduced to succinate by soluble fumarate reductase and the mitochondrial
electron transport chain complex II. Lifespan extension induced by malate depended upon the
longevity regulators DAF-16 and SIR-2.1. Malate supplementation did not extend the lifespan of
long-lived eat-2 mutant worms, a model of dietary restriction. Malate and fumarate addition
increased oxygen consumption, but decreased ATP levels and mitochondrial membrane potential
suggesting a mild uncoupling of oxidative phosphorylation.

xiv

Each of the twenty amino acids was individually supplemented to C. elegans and the
effects on lifespan were determined. All amino acids except phenylalanine were found to extend
lifespan at least to a small extent at one or more of the 3 concentrations tested with serine,
histidine, and proline showing the largest effects. In most cases, amino acid supplementation did
not extend lifespan in eat-2 worms, a model of dietary restriction or in daf-16, sir-2.1, rsks-1 (S6
kinase), or aak-2 (AMPK) longevity pathway mutants or in worms fed RNAi to skn-1, the C.
elegans Nrf2 homolog. Serine and tryptophan addition further protected worms from
Alzheimer’s amyloid-beta toxicity. Tryptophan and its catabolites nicotinic acid, picolinic acid,
and NAD further induced a broad heat shock response. These results indicate that dietary amino
acid imbalance and amino acid catabolism affect organismal longevity.
The ketone body beta-hydroxybutyrate (βHB) is a histone deacetylase (HDAC) inhibitor
and has been shown to be protective in many disease models, but its effects on aging are not well
studied. Therefore we determined the effect of βHB supplementation on the lifespan of C.
elegans. βHB supplementation extended mean lifespan by approximately 20%. RNAi
knockdown of HDACs hda-2 or hda-3 also increased lifespan and further prevented βHBmediated lifespan extension. βHB-mediated lifespan extension required the DAF-16/FOXO and
SKN-1/Nrf longevity pathways, the sirtuin SIR-2.1, and the AMP kinase subunit AAK-2. βHB
did not extend lifespan in a genetic model of dietary restriction indicating that βHB is likely
functioning through a similar mechanism. βHB addition also upregulated ΒHB dehydrogenase
activity and increased oxygen consumption in the worms. RNAi knockdown of F55E10.6, a
short chain dehydrogenase and SKN-1 target gene, prevented the increased lifespan and βHB
dehydrogenase activity induced by βHB addition, suggesting that F55E10.6 functions as an
inducible βHB dehydrogenase. Furthermore, βHB supplementation delayed Alzheimer's

xv

amyloid-beta toxicity and decreased Parkinson's alpha-synuclein aggregation. The results
indicate that D-βHB extends lifespan through inhibiting HDACs and through the activation of
conserved stress response pathways.
Aging is a progressive disease caused by the time dependent decline of an organism and
is the primary risk factor for many human ailments, including heart disease, cancer, and
Alzheimer’s disease. Uncovering metabolic pathways and metabolites that delay the onset of
age-related decline was the primary drive of this investigation.
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CHAPTER 1
INTRODUCTION AND BACKGROUND
Age-related decline affects nearly every biological system in virtually all species,
including humans. Although many theories overlap in the ever evolving biology of aging field, it
is apparent that mitochondria are central to life and death. Typically as we age, the function of
mitochondria declines in a tissue specific manner and results in a loss of energy production.
Understanding how metabolites taken in and broken down in our diet contribute to anaplerosis
(the re-filling of metabolites in metabolic pathways), antioxidant effects, and hormetic
(beneficial at one dose, but detrimental at a higher dose) pathways during aging is fundamental
to creating supplements and dietary habits that may decrease age-associated disease and decline,
thus improving the quality of life in old age. In order to discover metabolic pathways that delay
aging, the effects of large sets of metabolites on lifespan were investigated.
1.1 Mitochondrial dysfunction
Mitochondria are responsible for the production of ATP through the electron transport
chain (ETC) via oxidative phosphorylation (OXPHOS) located within the inner mitochondrial
membrane. Because of their importance in cellular physiology, defects in mitochondria are
linked to many human diseases and play a central role in aging. Particularly, mitochondrial
dysfunction contributes to age-related decline and is itself a consequence of aging. Mitochondria
are the major source and the main target of reactive oxygen species and regulate stress response,
calcium homeostasis, and apoptosis [1].
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Since mitochondria are crucial for biological processes, mitochondrial dysfunction has
been postulated to lead to premature aging [2]. Conversely, slight inhibition of mitochondrial
respiration extends the lifespan of yeast, C. elegans, Drosophila, and mice [3-6]. Electrons
passing through the mitochondrial ETC leak out and combine with molecular oxygen to form
reactive oxygen species (ROS) [7]. Continuous damage to cellular macromolecules via ROS
results in the decline of mitochondrial function, and coincides with some age-related disorders
[8]. The antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase quench
oxidants, and are considered oxidant scavengers [9].Glutathione peroxidases rely on the reduced
form of glutathione, a 3-amino acid peptide, to convert peroxides to water, while simultaneously
oxidizing glutathione. However, levels of small molecule antioxidants and oxidant scavenger
enzymes gradually decrease as organisms age, resulting in increased levels of oxidation,
accumulation of damaged proteins, DNA, and lipids [10], and decreased mitochondrial function
[11, 12]. This decrease in antioxidants as a consequence of aging is of great concern and a
current target for anti-aging therapies.
1.2 Mitochondrial disease
ROS are responsible for damaging proteins, DNA, and lipids such as cardiolipin, which is
localized in the mitochondrial inner membrane and makes up about 20% of the membrane’s
mass. Cardiolipin (CL) is considered the glue by which the respiratory complexes are held
together and is necessary for preserving the mitochondrial membrane potential [13]. Absence of
CL leads to defects in protein import, translocation of cholesterol from outer to the inner
membrane [14], and deficiency in major mitochondrial processes [15].
One important process that CL regulates is the release of cytochrome c from
mitochondria, which triggers apoptosis [16]. Recent evidence establishes a relationship between
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the oxidation and depletion of CL to a decrease of cytochrome c oxidase activity and
mitochondrial dysfunction in brain aging, which was alleviated by treatment with the natural
antioxidant hormone melatonin. A rise in mitochondrial DNA oxidative damage was also
observed in brains derived from Alzheimer’s disease patients, likely contributing to
neurodegenerative decline [17, 18]. Although much research links mitochondrial dysfunction and
Alzheimer’s disease (AD), the mechanism is not entirely clear. There is substantial evidence
demonstrating progressive accumulation of mitochondrial amyloid-beta, a 40-42 amino acid
peptide that forms extracellular plaques in Alzheimer’s brains [19], and these levels correspond
with the degree of mitochondrial dysfunction [20]. Evidence also suggests that enhanced
mitochondrial γ-secretase complex disrupts communication between the mitochondria and the
endoplasmic reticulum in models of AD [21]. Huntington’s disease is characterized by a
mutation in the Huntington gene (Htt), leading to protein aggregation, a reduction in
mitochondrial membrane potential, and neurotoxicity resulting in striatal atrophy [22]. Mutated
Htt weakens the mitochondrial outer membrane, increasing the sensitivity of the mitochondrial
permeability transition pore to apoptotic stimuli such as Ca2+ and ROS, resulting in cytochrome
c release and caspase activation [23]. Mitochondrial fission is enhanced in Huntington's disease
leading to fragmented mitochondria and the degree of fragmentation parallels disease severity
[24]. Dopamine treatment increases the vulnerability of striatal neurons to mutant Htt by downregulating mitochondrial complex II activity [25]. Parkinson’s disease is characterized by
intracellular α-synuclein-containing Lewy body formation [26], α-synuclein binds to the
mitochondrial membrane causing a decrease in complex I activity paralleling an increase in ROS
production [27]. Amyotrophic lateral sclerosis (ALS), another neurodegenerative disease
commonly referred to as Lou Gehrig's disease, can be caused by mutations in cytoplasic
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superoxide dismutase 1, which translocates to mitochondria causing mitochondrial dysfunction
[28]. Recent studies using ALS disease models suggest that disruption of the axonal transport of
mitochondria along microtubules compromises axonal function [29]. Equally significant to note
is that mitochondrial dysfunction is also associated with type 2 diabetes [30], cancer [31, 32],
systemic lupus [33], epilepsy, autism, and developmental delay [34]. Interestingly, recent
studies using young and aged rats subjected to heterochronic parabiosis (connection of their
circulatory systems) indicate an increase in neurogenesis in the aged rats, and that the decline of
cognitive abilities in the aged subjects can be reversed by factors in the plasma from the young
individual [35, 36]. In a similar study, the protein GDF11 was identified as a blood factor in mice
that can induce vascular restoration and increase neurogenesis suggesting a restored capacity of
autophagy/mitophagy and mitochondrial biogenesis in aged rodents [37].

Figure 1.1: Mitochondrial dysfunction underlies multiple age-induced
diseases. Diseases in red indicate strong experimental evidence to
support malfunctioning mitochondria in disease pathology. Diseases in
green exhibit mitochondrial dysfunction as well.

1.3 Calorie restriction
Calorie restriction, a 20-40% lowering of caloric intake, is the most effective method
known to extend lifespan in almost every species in which it has been tested, including mammals
[38]. Numerous studies recognize calorie restriction (CR) as a successful method to alleviate
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age-related decline, combat disease, and increase lifespan in model organisms [39]. CR-mediated
lifespan extension suggests a possible conservation of longevity-regulating pathways among
species [40]. Researchers have yet to completely unravel how CR extends lifespan, but research
spanning the past few decades illustrates a hopeful glimpse at the power of dietary alterations.
Some researchers initially hypothesized that CR would decrease overall metabolism. Aging and
longevity have been shown to positively correlate with energy metabolism in some
mitochondrial electron transport chain mutants. For example, a reduction in mitochondrial
energy metabolism and respiration has been shown to increase lifespan in clk-1 and isp-1
mutants in C. elegans [41]. However, more recent evidence has suggested that such a simple
correlation does not always hold as calorie restriction has been shown to not alter or even
increase mitochondrial electron transport chain function. Increased resistance to heat and
oxidative stress are strong indicators of health and longevity and, as expected, a decline in heat
tolerance and an increase in oxyradical damage are both markers of aging [42, 43]. Calorie
restriction has been shown to be protective against oxidative and heat stress[43] and the greatest
increases in C. elegans lifespan have been produced by culturing the worms in a defined axenic
media as a type of dietary restriction, which lacks the normal bacterial food source [44].
Currently, there is a considerable amount of interest in finding pharmacological mimetics
that act on the same pathways as CR, but compounds acting identical to CR will likely be
impossible to identify due to the multiple distinct and overlapping pathways affected by a low
calorie regimen. CR mediates an increase in antioxidant response pathways, genes responsible
for stress resistance and cellular repair, while also down-regulating inflammatory pathways [45].
Primary fibroblasts cultured with human CR sera induced upregulation of Nrf2, GSTK1, GSTT1,
IDH2, GPX1 (glutathione peroxidase 1), and SOD2 (superoxide dismutase 2) [46], emphasizing
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the importance of circulating factors in promoting health and longevity. Nrf2 is a transcription
factor that induces gene expression protecting from oxidants and xenobiotics. GSTK1 and
GSTT1 are glutathione-S-transferases which attach reduced glutathione to xenobiotic substrates
for detoxification. IDH2 is a subunit of a citric acid cycle isocitrate dehydrogenase complex that
reduces NADP to NADPH, an essential cofactor for the reduction of oxidized glutathione by a
glutathione reductase. A wide range of evidence supports the benefits of CR, but for the most
part the mechanisms which mediate these benefits have remained elusive.
The hypothesis that CR reduces damage mediated by ROS is supported by research
demonstrating an increase in oxidized lipids, proteins, and DNA in the nuclear and mitochondrial
genome with age that is decreased by the CR diet. CR has also been shown to delay the decline
in superoxide dismutase (SOD) activity and other cellular antioxidant defenses with age [47,
48]. In support of this hypothesis, age-related decline in antioxidant defenses is linked to
increased rates of stress-induced apoptosis, which is markedly reduced by CR [49]. CR animals
exhibit lower levels of oxidatively damaged DNA and reduced lipid peroxidation [50, 51].
Interestingly, data suggests that CR is responsible for both a decrease in ROS production and
also an increase ROS defenses and repair [52]. However an increase in SOD and cellular ROS
defenses may not play as large of a role in CR increased longevity as originally theorized,
because mice lacking superoxide dismutase show increased oxidative damage, but they do not
display signs of premature aging [53]. Pinning down the exact mechanisms through which CR
increases longevity has been quite challenging, but there are a few pathways that have been
identified that are well established as conserved mediators of longevity.
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1.4 Calorie restriction and sirtuins
Studies indicate that CR enhances the intracellular NAD+/NADH ratio of yeast by upregulating respiration resulting in decreased NADH levels [54]. Cellular increases in metabolic
redox reactions impacting NAD+/NADH ratios are important to numerous biological processes
including apoptosis[55], differentiation [56], and metabolism of fats and carbohydrates [57].
In mammals, disruption of mitochondrial metabolism and NADH shuttles have been associated
with age-related diseases such as diabetes [58]. Glucose metabolism controls the secretion of
insulin from mouse pancreatic β-cells and reduction of NAD+ to NADH is responsible for
glucose signaling in β-cells [59]. NAD+ is also an essential pyridine nucleotide that functions in
the vital processes of DNA repair and transcription [60]. Further studies in yeast indicate that
deleting NADH shuttle components abolishes CR-mediated lifespan extension whereas overexpressing NADH shuttle components extends lifespan [61]. Further studies in yeast showed that
decreased NADH levels are associated with CR-induced activation of sirtuins, an event
necessary for lifespan extension.
Sir2, the sirtuin or silent information regulator in Saccharomyces cerevisiae, is highly
conserved from prokaryotes to humans [62], and catalyzes the formation of silent
heterochromatin. Sirtuins are NAD+-dependent protein deacetylases that regulate lifespan in
lower organisms and also play a role in mammalian cellular fate [63], and overexpression of
sirtuins has been shown to extend the lifespan of some model organisms [64, 65]. By coupling
NAD+ cleavage to modifications of target proteins, sirtuins operate as a possible molecular link
between the cellular energy state and the mechanism of lifespan regulation.
The Caenorhabditis elegans Sir2 homolog (SIR-2.1) is required for stress resistance,
genomic stability, and lifespan extension [66] and increased longevity is seen when sir-2.1
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expression is increased [67]. Sir2 overexpression in Drosophila extends lifespan, however when
combined with CR, over-expression did not produce an additive affect [68]. The human homolog
of Sir2p, SIRT1,

mediates stress resistance, apoptosis, and inflammatory responses by

deacetylating transcription factors such as FOXOs [55, 69], nuclear factor Kappa β [70], and p53
[71, 72], giving cells time to repair endogenous damage. Additionally, SIRT1 knock-out mice fed
a CR diet did not exhibit the typical lengthened lifespan [73]. SIRT1 overexpression not only
extends lifespan and improves healthy aging, but it also reduces tumor formation [74] and
regulates insulin secretion [75]. Similarly, resveratrol activates SIRT1 and also improves the
health in mice fed a high calorie diet [76].
There are three mitochondrial sirtuins specific to mammals: SIRT3, SIRT4, and SIRT5.
SIRT3, a mitochondrial specific sirtuin, is critical for maintaining mitochondrial homeostasis and
cellular ROS levels. SIRT3 is responsible for activating isocitrate dehydrogenase by
deacetylation during CR resulting in a decrease in oxidative stress and a protection from agerelated hearing loss in mice [77]. CR increases activity of SIRT3 and SIRT5 aiding in the
metabolic shift from glycolysis to fatty acid oxidation [78, 79] and acetate metabolism [80].
SIRT4 deacetylates glutamate dehydrogenase. SIRT4 expression decreases during CR, removing
the break from glutamate dehydrogenase, which allows for the catabolism of glutamine and
glutamate into the TCA cycle, providing energy during CR [81]. Recently SIRT1 has emerged
as an important regulator of hypothalamus function, which regulates global metabolism and
aging in mammals [82]. Histone deacetylases regulate pro- and anti-inflammatory gene
expression[83] and pro-inflammatory cyclooxygenase-2 (COX-2) gene expression is suppressed
by SIRT1 [84]. Increased SIRT1 activity during CR also reduces inflammation by suppressing
the expression of pro-inflammatory genes such as NF-ĸβ, AP1, and iNOS [85]. SIRT1 is
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responsible for deacetylating glycolytic enzymes resulting in the reduction of glycolytic
metabolism [86] and repression of HIF-1α [87]. Piceatannol, a structural homolog of resveratrol
[88], asserts a stronger effect than resveratrol [89] and acts as an anti-inflammatory compound
that decreases the intracellular accumulation of ROS in PC12 cells engineered to produce high
levels of Aβ, while preventing Aβ-induced apoptosis [89]. Identifying CR mimetics are highly
sought after, but sirtuin activating compounds (STACs) are not the only high rollers in drug
discovery.
1.5 Altering epigenetics to increase longevity
There are several compounds that have been shown to extend lifespan through epigenetic
modifications DNA methylation status regulates gene expression, maintenance of DNA, and
aging [90]. DNA methyltransferases (DNMT) play a crucial role in controlling age-related
diseases and DNMT inhibitors have been used in the treatment of cancer [91]. The green tea
polyphenol (-)-epigallocatechin-3-gallate (EGCG) reduces DNA hypermethylation induced by
cancer-causing agents [92] and several studies reveal that CR decreases DNA methylation and
increases genomic stability during aging [93]. Another epigenetic modification of interest is
histone modification. Histone modifications include acetylation, methylation, ubiquitination, and
ADP ribosylation. Of these, histone acetylation status is the most common modification
associated with gene activation.
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are enzymes that
alter histone acetylation. There are four classes of HDACs: class I, II, III (which includes all
seven mammalian sirtuins), and IV. HAT modifications depend on nuclear acetyl-CoA
concentrations, whereas class III HDAC activity is dependent upon NAD+ concentrations. In
contrast, class I, II, and IV HDACs are zinc-dependent enzymes.
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Calorie restriction increases activity of SIRT1, while SIRT1 inactivation abrogates
lifespan extension by CR [94]. An increase in HDAC activity during CR suggests the possibility
that HDAC inhibitors may be beneficial in the treatment of aging and age-related diseases.
HDAC inhibitors such as valproic acid and phenylbutyrate exhibit strong antitumor activity, yet
have fairly low toxicity [95]. Curcumin effects histone acetylation status by inhibiting p300/CBP
HAT [96] and has also been shown to have anti-cancer properties [97]. As previously referenced,
the red grape polyphenol resveratrol is a potent SIRT1 activator and increases the mean lifespan
of mice [76]. Butyrate is a short-chain fatty acid (SCFA) that is the end result of bacterial acetylCoA fermentation. Butyrate inhibits class I and class II HDACs and increases both C. elegans
[98] and Drosophila [99] lifespans. The ketone D-beta-hydroxybutyrate is structurally very
similar to butyrate and is synthesized in the liver from fatty acid oxidation of acetyl-CoA under
fasting or ketogenic diet conditions. Beta-hydroxybutyrate has also been shown to be an
endogenous HDAC I inhibitor [100] and so therefore may have many uses in the treatment of
age-related diseases (Section 1.9). Much more work is needed to fully understand and utilize the
benefits of drug induced epigenetic modifications. One exciting possibility is that these
modifications are part of a larger phenomenon called hormesis and that epigenetic modifications
may be involved with hormetic responses [101].
1.6 Hormesis
Recent studies challenge the theory that mitochondrial reactive oxygen species (ROS)
have only a deleterious outcome on cell function and organismal aging. It is becoming clearer
that mitochondrial ROS perform vital roles in activating cell survival and disease resistance
signaling pathways. ROS may actually act as double-edged swords. This concept is supported by
hormesis, a proposed process by which mild stress activates biological stress responses, thereby
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improving the health and increasing the lifespan of an organism [102]. Activation of hormetic
pathways overcome immediate stresses and may actually repair prior damage in organisms [103]
by inducing the expression of genes that encode antioxidant enzymes and cytoprotective proteins
(Figure 2) [104]. Proposed examples include exercise, which temporarily produces substantially
higher than normal levels of damaging ROS [105], and calorie restriction, which represent a
metabolic stress for organisms [106].Other hormetic response activators include low levels of
ionizing radiation, which reduces the incidence of cancer [107], consumption of plant
phytochemicals, which protect the plant from herbivores and pests, while producing a beneficial
health response in humans [108], and exposure to mild heat, responsible for induction of gene
expression leading to transcription and translation of heat shock proteins [109, 110]. Ischemic
preconditioning also induces the expression of genes encoding protective proteins including
heat-shock proteins (HSP) [111]. HSPs are key defense responses that enable proper refolding of
damaged protein structure induced by heat, alcohol, heavy metals, age, disease, or oxidative
stress, avoiding inactivation of proteins and irregular protein aggregates [112]. The C. elegans
heat-shock factor (HSF-1) is a transcription factor that regulates response to heat and oxidative
stress and serves as a molecular chaperone to slow the rate of aging [113]. More examples of
hormetic response pathways include the sirtuin/FOXO pathway [114], the NF-κB pathway [115],
the cAMP-response-element-binding protein (CREB) pathway, the AMP kinase pathway [116],
the Nrf2–ARE pathway [108], and the DAF-16/Ins/IGF-1 signaling pathway [117]. SKN-1/Nrf is
involved with multiple roles in development and cellular homeostasis. The DAF-16/FOXO
family of Forkhead transcription factors act as sensors of the insulin signaling pathway and
activate protective genes that increase stress resistance and longevity [118-120].
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Many flavonoids, such as EGCG from green tea, and other plant-derived polyphenols
may promote healthy aging through hormesis. EGCG has been shown to upregulate
hemeoxygenase-1 (HO-1) expression in endothelial cells by activation of the Nrf2/ARE pathway,
triggering resistance against H2O2 induced apoptosis [121]. Likewise, FOXO transcription
factors are activated by the polyphenol resveratrol, up-regulating genes involved in energy
metabolism and antioxidant pathways [122]. The C. elegans transcription factor SKN-1, an
ortholog of Nrf2, was shown to mediate the protective responses to oxidative stress and
increased lifespan induced by low doses of the plant-derived toxin, plumbagin [123]. As more
evidence is published, the concept of hormesis is gaining acceptance as a major regulator of
lifespan.
1.7 Hormesis hypothesis of CR
The hormesis hypothesis of CR [124] proposes that food restriction introduces mild stress
to an organism and initiates upregulation of cellular defenses, while also altering metabolism,
resulting in increased longevity. The hormesis hypothesis of CR was recently altered to include
xenohormesis, which refers to the idea that organisms recognize and react to chemical signals
produced by other organisms undergoing stress, such as CR.These chemicals can be ingested
through food, as in the case of polyphenols [125], and can lead to the activation of internal
defense mechanisms [126].The hormesis hypothesis of CR unites much of the unrelated
observations originating from different species and laboratories. CR prompts an upregulation of
longevity genes that protect an organism and delays reproduction, which are keys to surviving
through a shortage of food or specific nutrients.
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Figure 1.2: A low dose of a stressor may initiate hormetic response pathways that increase
lifespan and healthspan of an organism. Too much of the stressor overrides this stress response
and is deleterious to the health of the organism.

1.8 Mitohormesis
Mitohormesis is a term used to describe reactive oxygen species (ROS)-induced stress
responses within mitochondria [127]. Research strongly suggests that transient endogenous free
radical production, caused by glucose restriction, extends the lifespan of C. elegans in an aak-2
(AMPK homolog)-dependent manner. Interestingly, this increase in lifespan is abrogated by
antioxidants, suggesting that toxic radicals may mitohormetically extend lifespan and promote
overall health [128].This phenomenon has also been observed in insulin-secreting cells following
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exposure to sub-lethal levels of H2O2 [129]. The mitohormetic protective response is also
activated by statins, which generate ROS and lead to an increase in peroxisome proliferatoractivated receptor gamma coactivator 1α (PGC-1α) and other mitochondrial-associated genes
[130, 131]. Low-dose arsenite has been shown to stimulate resistance against thermal and
chemical stressors, while extending the lifespan of C. elegans [132] and recent evidence
indicates that lipoxidative stress induced by EPA/DHA treatment may contribute to the
therapeutic effects observed [133].
Mutations in mitochondrial ETC genes, encoding proteins such as ISP-1 (of complex III)
and NUO-6 (of complex I) result in lifespan increases in C. elegans. These mutations lead to an
increase in superoxide production, although a rise in overall ROS was not detected [134].
Longevity was abolished upon use of antioxidants, again supporting the idea that gradual
increases in ROS and minor mitochondrial damage activate mitohormesis [134]. Additionally,
oxidative stress-induced hormesis by a transient hypoxia treatment is associated with a reduction
of mitochondrial superoxide production through activation of the Ins/IGF-1 signaling pathway
[135]. Interestingly, lifespan extension by TCA metabolites may be due to activation of hormetic
stress response pathways in conjunction with anaplerosis. The addition of malate to C. elegans
media leads to lifespan extension and a dramatic increase in NAD+ [136], which may lead to
SIRT1-mediated deacetylation and activation of PGC-1α in mammals [137]; PGC-1α
upregulates antioxidant and mitochondrial metabolic protective genes in response to CR and
exercise [137].
1.9 TCA cycle metabolites
The TCA cycle is a central pathway for the metabolism of sugars, lipids, and amino acids.
Although many factors contribute to aging, dysregulation in metabolism has been indicated as a
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contributing factor of sarcopenia, the loss of muscle mass, in the elderly [138]. The aging process
in C. elegans is associated with a disruption in metabolism that could partially be corrected by
metabolite supplementation. For instance, the long-lived dauer life cycle stage is accompanied
by a metabolic shift toward anaplerosis of the TCA cycle [139]. Metabolomics data from our lab
identifies a change in certain C. elegans metabolite concentrations with age, including the TCA
cycle metabolites citrate, which was upregulated in aged worms, and fumarate and malate, which
were downregulated in older worms. Consistent with these findings, we also established that
supplementation of fumarate and malate to C. elegans diet extends lifespan through the DAF-16
and SIR-2.1 pathways [136]. Fumarate reduction, glyoxylate shunt activity, and mild
mitochondrial uncoupling may also contribute to the lifespan extension induced by malate and
fumarate by increasing the amount of oxidized NAD and FAD cofactors [136]. Addition of the
TCA cycle intermediate oxaloacetate has been shown to extend lifespan in C. elegans through an
aak-2/AMP kinase and daf-16/FOXO-dependent mechanism [140] and protect against seizures
induced by kainic acid in rodents [141].
The TCA cycle intermediate alpha-ketoglutarate is the entry point in the citric acid cycle
for glutamate and glutamine. Alpha-ketoglutarate can cross the blood-brain barrier and then be
converted to glutamate, a precursor of the antioxidant glutathione. By inhibiting ATP synthase
and target of rapamycin (TOR) kinase, alpha-ketoglutarate dramatically extended the lifespan of
C. elegans. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes a
mitochondrial complex 1 deficit similar to that observed in Parkinson’s disease. Alphaketoglutarate was found to protect against cell death induced by MPTP [142] and seizure
induction by kainic acid [141]. A high dose of arginine alpha-ketoglutarate is found in the
Deanna Protocol, which combines a ketogenic diet with natural supplements, and has been
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shown to postpone disease progression in an Amyotrophic Lateral Sclerosis (ALS) mouse model
[143].
Remarkably, mice overexpressing wild-type frataxin showed an increase in mitochondrial
metabolism prompting mitohormesis. This increase in mitochondrial energy metabolism
improved survival and protection from doxorubicin-induced cardiac myopathy [144]. Reducing
the metabolic requirements of the mitochondria through decreased substrate metabolism is
thought to lead to a decrease in cellular damage and ROS production, and CR, which prevents
aging-related mitochondrial dysfunction, also increases lifespan. The prevention of aging-related
mitochondrial energy deficits or redox imbalance are possible mechanisms of TCA cycle
metabolite-induced lifespan extension. Mitochondrial electron transport chain function declines
by over 2-fold during aging with a 5-fold decline in cellular ATP levels [145]. Given the role of
specific metabolites as activators of hormesis, TCA cycle metabolites may also act in a similar
manner.
1.10 Amino Acids, disease, and aging
Of all of the classes of metabolites in the cell, current knowledge suggests that cellular
levels of amino acids may affect longevity the most, at least in short-lived model systems.
Amino acids are degraded into mitochondrial TCA cycle intermediates [146], many of which
have been shown to extend lifespan in C. elegans including oxaloacetate [147], malate, and
fumarate [136], as well as related metabolites pyruvate [148] and acetate [149], which can be
directly converted into the TCA cycle metabolite acetyl-CoA. Amino acids are likely signaling
through distinct pathways to affect lifespan. Therefore consuming an optimized ratio of amino
acids in the diet is hypothesized to be one possible way for increasing lifespan. Metabolomics
analysis of worms has found that many amino acids, including glutamine, valine, and isoleucine
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were increased in long-lived daf-2 insulin receptor mutant worms, while glutamate levels
declined [150]. Valine and isoleucine levels returned to wild-type levels in daf-2; daf-16 double
mutants as did lifespan. These results suggest that increased valine and isoleucine levels may
mediate lifespan extension in daf-2 mutants in a daf-16 dependent manner. Amino acids were
once commonly thought of as only nutrients and not signaling molecules, but this idea is not only
incorrect, it undermines how functionally diverse these compounds really are.
1.10.1 Alanine
Alanine is a non-essential amino acid and also one of 13 exclusively glucogenic amino
acids, meaning it is readily converted to glucose within the liver [151]. Alanine is crucial for
regulating nitrogen and glucose levels in the body. Following entry into the liver alanine is
converted to pyruvate, which participates in gluconeogenesis to supply energy to the TCA cycle.
In a fasted state skeletal muscles release profuse amounts of alanine and glutamine into the
circulating blood [152]. Additionally, alanine was shown to strengthen the immune system and
increase aerobic and anaerobic endurance in long distance runners [153]. More recent studies
indicate that alanine assists in the secretion of glucose [154] and supplementation may enhance
protection from cardiovascular diseases [155].
1.10.2 Arginine
Arginine is a semi-essential amino acid that plays important roles in nitric acid synthesis,
[156] growth hormone secretion [157], and in the removal of excess nitrogenous waste through
the urea cycle [158]. Arginine is found in large concentrations in the skin and muscles and is
responsible for stimulating the immune system to aid in rapid wound healing [159]. Arginine
was also shown to stimulate repair in aged coronary endothelial tissue in humans [160] and also
improved depressed macrophage function following trauma-induced hemorrhage in rats [161].
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1.10.3 Asparagine
Asparagine is a non-essential amino acid that is important for regulating metabolism and
maintaining central nervous system equilibrium. Interestingly, depletion of asparagine by
asparaginase resulted in increased survival among lymphoblastic leukemia patients [162], which
may be in part due to cell cycle inhibition created by asparagine deprivation [163]. There
remains a large gap of knowledge on the effects of asparagine when taken as a supplement.
1.10.4 Aspartic Acid
The non-essential amino acid, aspartic acid, participates in a range of important cellular
functions, such as lowering blood ammonia by way of the ornithine cycle and it is often
prescribed for fatigue [164]. Aspartic acid is important for generating cellular energy through the
TCA cycle by transporting NADH equivalents into the mitochondria, and within the brain
aspartic acid acts as a neurotransmitter [165] to regulate synaptic plasticity [166]. Nevertheless
increased amounts of aspartic acid may contribute to cognitive impairment by increasing damage
to hippocampal neurons [167].
1.10.5 Cysteine
Cysteine is a non-essential amino acid that promotes the production of T4 lymphocytes,
which are necessary for immune system activation [168]. An increase in oxidative stress
associated with aging results from the decline of antioxidants, such as reduced glutathione [169],
which is synthesized from cysteine, glycine, and glutamate. Although these three amino acids
parallel the decline of glutathione with age, supplementation with cysteine and glycine resulted
in an increase in plasma glutathione levels matching that of young controls. This elevation of
amino acids corresponded with a marked decrease in oxidative damage to tissues [170],
emphasizing the importance of amino acid supplementation in alleviating age-related decline.

18

1.10.6 Glutamine
Glutamine is the most abundant essential amino acid in the body and exists as a
prominent source of cellular energy as well as an important anaplerotic donator of carbon to the
TCA cycle [171]. Glutamine inhibits fatty acid oxidation, reduces blood plasma glucose, and
attenuates weight gain in mice prone to obesity [172]. Following prolonged exercise, an
increased T-helper cell/T-suppressor cell ratio was seen corresponding to a decrease in infections
in athletes supplementing with glutamine [173] and long-term supplementation may be
beneficial for maintaining intestinal immunity in the elderly [174]. Glutamine regulates genes
involved with cellular proliferation and survival, as well as genes involved with inflammation,
such as NFҠβ [175]. Additionally, glutamine is synthesized from glutamate through glutamine
synthetase, which is found in much higher concentrations in the brain [176] and is crucial for
both brain development and protection [177]. Glutamine synthetase is increased in AD patients
[178] and supplementation with glutamine was shown to be neuroprotective in the disease [179].
1.10.7 Glutamate
Glutamate is a non-essential amino acid often used to enhance the flavor of foods. This
amino acid acts as the main player in learning, cognition, and memory and is the most excitatory
transmitter in the brain. Glutamate is required for synaptic transmission, but at high levels
glutamate induces neuronal excitotoxicity, contributing to neuronal injury in neurodegenerative
disorders and diseases including AD [180] ALS [181], mental illness, and brain damage[182], as
well as causing myelin damage [183].The crucial balance between low extracellular
concentrations and high intracellular concentrations of glutamate are kept in check by glutamate
transporters. Much research focuses on finding compounds that can reduce glutamate induced
excitotoxicity. Oxaloacetate injection was shown to reduce glutamate levels in rats [184] and in a
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separate study it protected the brain following ischemic stroke through the stimulation of
oxaloacetate transaminase, responsible for clearing glutamate from the blood [185]. Dopamine,
through regulation of calcium hemostasis, was shown to inhibit glutamate excitotoxicity and
prevent neuronal death [186]. Although dietary monosodium glutamate (MSG) has gained a bad
reputation, it still is not known if the small amount used in food is actually harmful. If so, it is
possible that the sodium may be more harmful than the glutamate.
1.10.8 Glycine
Glycine is the smallest of the amino acids and is considered conditionally essential,
meaning that there are situations when synthesis of it is limited in the body. One group found
that dietary glycine supplementation mimicked lifespan extension by dietary methionine
restriction in rats through the clearance of hepatic methionine [187]. Glycine and cysteine
supplementation increases glutathione synthesis resulting in a decrease in oxidative stress [188],
an increase in insulin sensitivity [189], and may protect tissues from the side effects of
radiotherapy [190]. A recent study showed that mitohormesis promoted skeletal muscle cell
survival by triggering the serine/1-carbon/glycine pathway to increase protein turnover and
amino acid metabolism [191].
1.10.9 Histidine
Histidine is an essential amino acid that acts as a potent anti-glycating agent, free radical
scavenger [192], and a powerful metal chelator in plants [193] and mammals [194]. Histidine
supplementation is associated with increased insulin secretion and glycemic control, increased
glutathione peroxidase activity in diabetic mice, and decreased pro-inflammatory cytokine levels
[195]. Histidine has also shown efficacy in treating chronic alcoholic liver injury by increasing
glutathione levels and by enhancing catalase activity [196]. In mammals cysteine, histidine, and
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glycine addition inhibited NF-κB activation and the expression of E-selectin, which is expressed
only on endothelial cells activated by cytokines, suggesting that these amino acids may
demonstrate anti-inflammatory effects during endothelial inflammation [197]. Histidine also acts
as an antioxidant and scavenger of singlet oxygen and hydroxyl radicals [198] and
supplementation was beneficial in treating chronic kidney failure in elderly patients [199].
Although histidine administration shows promise in many areas of health, its supplementation to
the diet showed no effect on the mean lifespan of Drosophila [200], nor have studies, except my
recent study in C. elegans, focused on its ability to affect lifespan in other model organisms.
1.10.10 Isoleucine
Isoleucine, another essential amino acid, is part of the branched-chain amino acid
(BCAA) family and is best known for its ability to repair injured muscle tissue and stimulate
muscle synthesis [201]. Isoleucine stabilizes energy levels by stimulating glucose uptake into
skeletal muscle cells, a process mediated by phosphatidylinositol 3-kinase [202]. High blood
levels of isoleucine have been associated with hypoglycemia in rats [203], but little research
involving life span or health span exists.
1.10.11 Leucine
Like isoleucine, leucine is an essential branch-chained amino acid that works with
isoleucine and valine to repair muscle tissue. A diet high in the BCAAs leucine, isoleucine, and
valine is associated with longevity and protection from disease [150]. Leucine, isoleucine, valine,
and threonine have all been shown to extend chronological longevity in yeast [204]. Leucine is
an exclusively ketogenic amino acid, so it is broken down into acetyl-CoA and potentially ketone
bodies if glucose levels are low. It is the major amino acid regulating the rate of protein synthesis
by the ribosome. The enhancement of mitochondrial biogenesis, cell growth, and differentiation
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driven by leucine occurs through the protein kinase mTOR (mammalian target of rapamycin)
[205], which stimulates cell growth and division. mTOR also increases PGC-1α levels in some
tissues to stimulate mitochondrial function to match the energy supply with the demand [206].
Administration of leucine prevents muscle degeneration in vitro [207] and may increase overall
muscle anabolism in humans [208, 209]. Leucine promotes fatty acid oxidation, stimulates
mitochondrial biogenesis, increases NAD+ levels, upregulates SIRT1 activity, and promotes
AMPK signaling in skeletal myotube cells [210]. Although leucine is commonly used by body
builders for growth, there is little evidence to support the long-term use of leucine
supplementation for the amelioration of sarcopenia in the elderly [211].
1.10.12 Lysine
Lysine, the other fully ketogenic amino acid, is an essential amino acid with the capacity
to interrupt replicating viruses and is often used for the treatment of Herpes simplex virus
infections [212]. Lysine inhibits Herpes viral growth by blocking and preventing arginine
absorption necessary for replication [213]. Another vital job of lysine is the regulation of neural
plasticity in the prefrontal cortex and the release of noradrenaline from the hypothalamus [214].
Supplementation with lysine not only improves symptoms of schizophrenia, but increases
problem solving speed and capacity in patients [215].
1.10.13 Methionine
Methionine is an essential amino acid. Reducing its dietary levels in rodents has been
shown to partially mimic CR and induce lifespan extension. Methionine restriction can also
occur when people adhere to a strict ketogenic diet due to the low protein intake prescribed to
this diet, and the addition of methionine to the diet of ketogenic fed mice resulted in reversal of
weight loss [216]. A diet deficient in methionine is associated with many positive effects such as
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enhanced fatty acid oxidation, increased energy, decreased ROS production, reduced oxidative
damage [217]. Most notably, methionine restriction extended lifespan in mice by nearly 7%
[218], rats by 44% [219], and drosophila by 36% [220]. Similar to CR, methionine restriction
produced a lifelong reduction in fatty body mass [221]. Unexpectedly, glycine supplementation
mimics the effects of methionine restriction though the clearance of hepatic methionine [222].
Remarkably, when fruit flies were placed on a protein-deficient diet that extended lifespan, the
addition of methionine could restore fecundity without decreasing lifespan, suggesting that it
may be possible to design a modified amino acid diet that offers the positive effects of dietary
restriction without the negative effects [223].
1.10.14 Phenylalanine
Phenylalanine is an essential amino acid that is converted to tyrosine by phenylalanine
hydroxylase. Phenylalanine is necessary for proper central nervous system and memory function
and was protective against acetylcholine reduction generated by hydroxide radicals [224], which
may be beneficial for treating AD related acetylcholine deficiency. Many foods such as meat and
most cheese products contain normal and safe amounts of phenylalanine. However, increased
phenylalanine has not been associated with benefits; on the contrary, elevated serum
phenylalanine has been linked to inflammatory disease [225] and was recently shown to be
raised in AD [226].
1.10.15 Proline
Proline is a non-essential amino acid that is broken down into glutamate and, along with
glycine, is one of the main components of mammalian collagen. Dietary proline supplementation
stimulates the immune system [227]. The topical application of proline to cutaneous wounds led
to a rapid acceleration of healing in rats [228]. Further, proline was shown to extend the lifespan
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of C. elegans by transiently increasing ROS levels, which then stimulated mitohormetic
pathways to upregulate superoxide dismutase and catalase [229].
1.10.16 Serine
Serine is a non-essential amino acid that is required for sphingolipid synthesis as well as
neuronal survival [230].L-serine is synthesized from 3-phosphoglycerate dehydrogenase,
whereas non-proteogenic D-serine is derived from L-serine through serine racemase [231].
Unlike

L-serine, the

D isoform

inhibits

sphingolipid

synthesis

[232].Deficient 3-

phosphoglycerate dehydrogenase leads to a decline in L-serine levels in plasma and
cerebrospinal fluids resulting in serine deficiency syndrome, which is characterized by seizures,
congenital microcephaly, and retardation [233].
1.10.17 Threonine
Threonine is an essential amino acid necessary for glycine and serine production,
regulation of the G1/S phase transition, and proliferation of embryonic cells [234, 235].
Threonine supplementation in laying chickens led to an increase in egg production and improved
immune response [236], whereas threonine deficiency was associated with depression and
neurological dysfunction in kittens [237]. To date, few if any, studies focus on the efficacy of
threonine for the alleviation of age-related decline.
1.10.18 Tryptophan
Tryptophan is an essential amino acid that was long touted as the reason for After Turkey
Fatigue Syndrome, the exhaustion that many people feel after eating a large Thanksgiving dinner.
Scientists realize that this fatigue syndrome is due to gluttony and not so much the trivial
amounts of tryptophan in turkey, which coincidentally is no more than the amounts found in
most meats. In any case, tryptophan is a vital precursor of many metabolites, including melatonin

24

and serotonin, which regulate immunity, inflammation, and circadian cycles. Increased
tryptophan boosts neurotransmission and improves memory tests in aged rats [238], while
tryptophan enriched cereals improved the sleep/wake cycle in elderly humans [239]. Serotonin
production is dependent upon tryptophan levels [240] and tryptophan depletion results in
increased aggression in conjunction with a decrease in pain tolerance in humans [241]. As
expected, increased tryptophan reduced aggression in pigs [242], alleviated depression and
aggression in people [243, 244], acted as a powerful sleep aid [245], and blocking tryptophan
catabolism decreased aging and aging-related proteotoxicity in C. elegans [246].
1.10.19 Tyrosine
Tyrosine, a non-essential amino acid, is produced from phenylalanine. Tyrosine
supplementation may ameliorate cognitive decline induced by stress and fatigue through the
sparing of norepinephrine [247]. Supplementation with tyrosine in both hypertensive rats and
humans led to a decrease in blood pressure [248], alleviated symptoms of nemaline myopathy
[249], and enhanced dopaminergic neurotransmission in Parkinson’s disease patients [250].
1.10.20 Valine
Valine is an essential BCAA that together with leucine and isoleucine are broken down to
provide the body with energy. BCAA supplementation improves the quality of life and prognosis
in patients suffering from hepatitis [251] and may contribute to lower obesity rates in middleaged adults [252]. BCAA supplementation promotes survival and mitochondrial biogenesis in
mice [253], whereas valine supplementation alone was protective against paraquat-induced
toxicity in rats [254]. Like isoleucine, little research has been dedicated to this amino acid
outside of overall BCAA activity. Elucidating metabolic byproducts and signaling pathways
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through which amino acids extend healthy lifespan is not only important for delaying aging
itself, but for improving the quality of life for aged individuals.
1.11 Beta-hydroxybutyrate
CR in animals is defined as a daily reduction of food intake. Intermittent fasting (IF) is
associated with many of the same benefits as CR, yet IF leads to a greater increase in blood
levels of the ketone body β-hydroxybutyrate

[255], which is produced by the liver when

the body is in ketosis. Ketone bodies work to provide energy to the body, most importantly, the
nervous system, during ketosis. Through a complex II-dependent mechanism leading to
improved mitochondrial respiration and ATP production, mice treated with β-hydroxybutyrate
showed partial protection from neurodegeneration and motor deficiency induced by MPTP [256].
Parkinson’s disease patients treated with a ketogenic diet for one month improved their Unified
Parkinson’s Disease Rating Scale scores by a mean of 43% [257]. β-hydroxybutyrate inhibited
the growth of malignant cancer [258] and evidence suggests that a low carbohydrate, high ketone
diet can halt the growth of cancer completely [259]. Oral ingestion of medium chain triglycerides
MCTs increased

HB levels and improved cognitive function in patients with AD [260].

and acetoacetate have been reported to inhibit mitochondrial production of ROS in mouse
neocortical neurons following glutamate excitotoxicity, by increasing the NAD+/NADH ratio
and improving mitochondrial respiration [261]. Butyrate is a short-chain fatty acid that that
inhibits class I and class II HDACs and increases both C. elegans [98] and Drosophila [99]
lifespans.

HB is structurally similar to butyrate and has been shown to be an endogenous class

I HDAC inhibitor [100]. In addition, people on a ketogenic diet show increased rates of oxidative
metabolism and antioxidant defense due to a rise in fatty acid beta-oxidation [262]. A ketogenic
diet, which stimulates the downstream targets of the PGC-1α pathway, protected mice from
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neurodegeneration by increasing mitochondrial uncoupling protein levels [263]. The ketogenic
diet also delayed progression of motor decline and neuron loss in a murine model of ALS [264].
Although, much more work is needed in the study of the protective effects of ketones and a low
carbohydrate diet, there is some evidence that a high fat, medium to low protein, and very low
carbohydrate diet is one possible way to delay aging-related disorders.
1.12 C. elegans as a model to study nutritional effects on lifespan
C. elegans nematode worms are a well-studied model organism often used in biomedical
research as a model for human aging and disease and share almost all central metabolic pathways
with humans. After reproduction, the worm gradually ages and dies in a similar pattern as
humans [265]. Mutations in many mitochondrial-localized proteins in C. elegans have been
shown to alter lifespan, either increasing or decreasing the rate of aging. These mutations directly
impact overall energy metabolism by affecting the ETC complexes. The metabolic pathways
studied in these chapters are also present in mammals, so the information gained using C.
elegans may be applicable to human health and disease. In order to study the effect of
metabolites on mitochondrial energy metabolism and the reliance on common longevity
pathways, we selected the well-characterized mutant strains of C. elegans, daf-16(mgDf50), daf2(e1370), age-1(hx546), aak-2(ok524), sir-2.1(ok434), eat-2(ad1116), gcn-2, and rsks-1 mutants,
and skn-1/Nrf and CREB binding protein-1 (cbp-1) RNAi worms.
Through the use of six different stress response reporter strains of worms, potential stress
responses to dietary supplementation with metabolites were monitored. These reporter strains use
GFP driven by stress response promoters. We monitored expression of hsp-70::GFP (HSF-1
target), hsp-16.2::GFP (HSF-1 target), hsp-6::GFP (mitochondrial unfolded protein response),
hsp-4::GFP (ER unfolded protein response), sod-3::GFP (DAF-16/FOXO reporter), and gst-
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4::GFP (SKN-1/Nrf reporter). All C. elegans strains were acquired from The University of
Minnesota’s Caenorhabditis Genetics Center.
Amyloid-β (Aβ) toxicity is responsible for neuronal degeneration seen in AD. The
transgenic CL4176 (smg-1(cc546ts) I; dvIs27 [myo-3/ Aβ minigene + rol-6(su1006) marker
gene] is a commonly used C. elegans model that employs a temperature-sensitive mutation in the
mRNA system to initiate muscle expression of the Aβ1–42 transgene, resulting in paralysis of the
body wall muscle upon temperature upshift from 16 to 25 °C. In conjunction with the CL4176
strain, the CL2006 strain constitutively produces Aβ3–42 in the body-wall muscles, resulting in a
decreased lifespan and paralysis. The CL2006, CL4176, and CL802 (control) strains all contain
the dominant mutant roller phenotype [rol-6 (su1066)] as morphological marker. Parkinson’s
disease is a neurodegenerative disease associated with the aggregation of alpha-synuclein and
death of dopaminergic neurons leading to cognitive and motor decline in patients. The use of
transgenic models of C. elegans expressing human alpha-synuclein is rapid and economical for
exploring the anti-Parkinson’s disease effects of compounds. The NL5901 (Punc-54::alpha
synuclein::YFP+unc-119), strain is commonly used for drug screens to visualize alpha-synuclein
aggregation. Identifying compounds that suppress Aβ-induced paralysis, polyglutamine
paralysis, and alpha-synuclein aggregation could lead to the identification of compounds for the
prevention and treatment of AD, Parkinson’s disease, and ALS.
1.13 Hypothesis and objectives
C. elegans share almost all metabolic pathways with humans. Therefore, we hypothesize
that C. elegans, both wild-type models and models displaying age-related decline related to
humans, are promising candidates for screening dietary metabolites. A wide range of metabolites
have been found to have altered concentrations in older C. elegans, which may be indicative of
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an age-related change in metabolic homeostasis. We therefore proposed the following
hypotheses: First, we hypothesized that alterations in metabolite concentrations may represent
homeostatic dysregulation. In accordance with this hypothesis, we expected that systematically
supplementing the diet of C. elegans with metabolites shown to have lower concentrations in
older age would compensate for this dysregulation to increase lifespan. Second, we postulated
that small changes in many dietary metabolites would result in minor dietary stress, resulting in a
hormetic effect. As such, we hypothesized that supplementing the diet of C. elegans with
metabolites would result in an increase in lifespan and stress resistance, with an accompanying
increase in stress signaling and resistance to disease. We have determined that the TCA cycle
metabolites fumarate, malate, and oxaloacetate extended lifespan in C. elegans, while all of the
amino acids except phenylalanine and aspartate extended lifespan at least to a small extent at one
or more of the 3 concentrations tested with serine and proline showing the largest effects.
Although much is known about the effects of βHB on neurodegenerative and other agingassociated diseases, not much is known about its effects on aging. Moreover, the mechanisms
through which βHB are protective are not entirely clear. We hypothesized that βHB would
increase the lifespan of C. elegans and we determined the cytoprotective signaling pathways
required for this effect.
The major aim of this study was to understand the mechanisms by which natural
metabolites influence the lifespan of C. elegans.
Specific Aim1 (Chapter 3): Determine the signaling pathways through which TCA cycle
metabolites increase lifespan and stress tolerance in C. elegans.
Aim 1.1: Determine the metabolic pathways through which addition of TCA cycle metabolites to
the culture medium extend lifespan.
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Aim 1.2: Determine the enzymes and signaling pathways through which TCA cycle metabolites
extend lifespan through RNAi knockdown and mutant strains.
Aim 1.3: Determine the effects of TCA cycle metabolites on C. elegans models of
neurodegenerative disease.
Specific Aim2 (Chapter 4): Determine the metabolic pathways through which the twenty amino
acids increase lifespan and stress tolerance in C. elegans.
Aim 2.1: Outline the signaling pathways through which individual addition of each of the twenty
amino acids to the culture medium at varying concentrations extend lifespan.
Aim 2.2: Determine the enzymes and signaling pathways through which amino acids extend
lifespan through RNAi knockdown and mutant strains.
Aim 2.3: Determine the effects of the top performing amino acids on C. elegans models of
neurodegenerative and diabetic disease.
Specific Aim3 (Chapter 5): Determine the signaling pathways through which βHB increases
lifespan and stress tolerance in C. elegans.
Aim 3.1: Determine the metabolic pathways through which addition of βHB to the culture
medium extend lifespan.
Aim 3.2: Determine the enzymes and signaling pathways through which βHB extends lifespan
through RNAi knockdown, enzyme activity assays, and mutant strains.
Aim 3.3: Determine the effects of βHB on C. elegans models of diabetic and neurodegenerative
disease.
1.14 Impact and significance
The overall goal of this study was to obtain a better understanding of the role of
metabolites in the control of C. elegans aging. Metabolite supplementation may prove to be a
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valuable inducer of hormesis and partially compensate for age-related metabolic dysfunction.
The metabolic pathways studied in this proposal are also present in mammals, so the information
gained using C. elegans is likely applicable to human health and disease.
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CHAPTER 2
MATERIALS AND METHODS

2.1 C. elegans strains
All strains used in this study were purchased from the University of Minnesota
Caenorhabditis Elegans Center unless otherwise noted in Table 1. Strains were cultured at 20°C
in either liquid S media or NGM agar media [1] as indicated.
2.2 Chemicals
L-malic acid was purchased from Chem-Impex International. Succinic acid and fumaric
acid were obtained from Fisher Scientific. L-Amino acids were purchased from Acros Organics
and Research Products International Corp.

Glycine was obtained from Fischer Chemical

Company. D-amino acids were purchased from P212121, LLC. When no D or L letter is
present before the name of the amino acid (except for glycine), the L isomer was used. Sodium
DL-3-hydroxybutyric acid (βHB), sodium butyrate, valproic (2-propylpentanoic) acid, ethidium
bromide, and potassium cyanide were purchased from Acros Organics. Sodium D-3hydroxybutyric acid and L-3-hydroxybutyric acid were obtained from Sigma. 5-fluoro-2′deoxyuridine (FUdR) was purchased from Research Products International Corp. and Biotang,
Inc. Sodium hydroxide (Fischer Scientific) was added to metabolite stock solutions to obtain a
pH of 7.0.
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Table 2.1 Caenorhabditis elegans models. C. elegans strains acquired and used for dissertation.

Strain

Genotype

Purchased/Gifted from

N2 Bristol

Wild isolate

University of Minnesota CGC

TJ356

daf-16::GFP zIs356 IV

University of Minnesota CGC

GR1307

daf-16(mgDf50)

University of Minnesota CGC

TG38

aak-2(gt33)

University of Minnesota CGC

DA1116

eat-2(ad1116)

University of Minnesota CGC

TK22

mev-1(kn1)

University of Minnesota CGC

CW152

gas-1(fc21)

University of Minnesota CGC

VC199

sir-2.1(ok434)

University of Minnesota CGC

RB1206

rsks-1(ok1255)

University of Minnesota CGC

RB967

gcn-2(ok871)

University of Minnesota CGC

VC983

hda-2(ok1479)

University of Minnesota CGC

RB1618

hda-3(ok1991)

University of Minnesota CGC

RB758

hda-4(ok518)

University of Minnesota CGC

RB2416

hda-10(ok3311)

University of Minnesota CGC

CL2166

pAF15(gst-4p::GFP::NLS)]

University of Minnesota CGC

SJ4100

hsp-6::gfp(zcIs13)

University of Minnesota CGC

SJ4058

hsp-60::gfp(zcIs9)

University of Minnesota CGC

SJ4005

hsp-4::gfp(zcIs4)

University of Minnesota CGC

ZG449

nhr-57p::GFP + unc-119(+)

University of Minnesota CGC

CL2070

hsp-16-2::gfp(dvIs70)

University of Minnesota CGC

LD1008

skn-1(operon)::GFP + pRF4(rol-6(su1006)

University of Minnesota CGC

PS3551

hsf-1(sy441)

University of Minnesota CGC

SM481

pha-4::GFP::CAAX + (pRF4) rol-6(su1006)

University of Minnesota CGC

CF1874

muIs84 [(pAD76) sod-3p::GFP + rol-6]

University of Minnesota CGC

ZG31

hif-1(ia4)

University of Minnesota CGC

AM140

unc-54p::Q35::YFP

Sandra Westerheide

NL5901

pkIs2386 (unc-54p::alphasynuclein::YFP (+))

University of Minnesota CGC

CL4176

smg-1ts [myo-3::Aβ1–42 long 3′-UTR]

Christopher Link

CL6049

dvls62 (snb-1::hTDP-43 + pCL26 (mtl-2::GFP)

Christopher Link
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2.3 Lifespan measurements
All lifespans were cultured at 20°C unless otherwise specified.
2.3.1 Lifespan measurements in 250 mL liquid culture
The worms were bleach-synchronized as follows: 2 mL of 6% NaOCl were mixed with 1
mL of 5 M NaOH per 7.5 mL of concentrated worm suspension, and shaken for 4–7 minutes
until the carcasses dissolved as monitored by direct observation. The remaining eggs were then
washed 3 times by pelleting at ~1150 g for 2 minutes at room temperature, followed by
aspiration of the supernatant and resuspension in 50 mL of 0.1 M NaCl. A final pellet of eggs
was obtained by centrifugation at ~1150 g for 2 minutes at room temperature, followed by
aspiration of the supernatant. Eggs were then added to a 250 mL liquid culture, as described
above. For experiments without RNAi treatment, bacteria were heat killed at 80°C for 60
minutes. The worms were cultured at 20°C and monitored until they reached adulthood (~72 h),
at which time FUdR was added to a final concentration of 400 uM. Worm viability was scored
every two days by taking ten 10 µL drops (initially ~20 worms per drop) of the culture and
counting the living worms under a microscope. The average number of living worms was then
calculated. S medium or deionized water containing 10 mM malate, succinate, or fumarate was
added back every three days to compensate for metabolism of the compounds and evaporation,
and S medium containing FUdR and bacteria was replaced every 6 days. At least two replicates
of each experiment were performed.
When the worm strains were sickly, limiting body movement, and survival in liquid
medium, lifespans were performed using standard NGM agar media as described in [2] with 400
uM FUdR under standard conditions [3].
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2.3.2 Lifespan measurements in cell culture inserts
Gravid C. elegans adults were bleached synchronized as previously described in 2.3.1 to
yield eggs in S-medium. Most lifespan experiments were performed in liquid media using 0.4
µM or 3 µM transparent cell culture inserts (BD Falcon #353180 and #353181) in 12-well and
24-well microplates as first described in [4] on an orbital shaker at 135 rotations/min at 20°C.
12-well microplates were found preferable due to the easier visualization of the worms through
the suspension of bacteria after swirling the microplate. 3 µM inserts were found preferable due
to the increased E. coli permeability. Initially 1.25 mL of S-medium containing 9×109 HT115
(DE3) E. coli per mL was placed in each well of a 12-well microplate. Then bleach synchronized
worm eggs were suspended at a concentration of 100–200 eggs/mL in S-medium containing
9×109 HT115(DE3) E. coli per mL. Lastly, a cell culture insert was placed in each well followed
by 0.25 mL of the egg/bacterial suspension (25–50 eggs) into each insert (n = 3–6 wells per
condition).
E. coli were grown for 20 hours in 2 L flasks with LB media. The E. coli were then spun
down, the supernatant poured off, and the pellet frozen until use. The E. coli were de-thawed
and heat-killed at 80°C for 1 hour with vibration using a Kendal model HB-S-23DHT ultrasonic
cleaner. The E. coli pellets were then resuspended in an equal volume of S-medium. A 1.3 mL
suspension of S-medium containing 9×109 HT115 (DE3) E. coli per mL was placed in each well
of a 12-well or 24-well microplate. Bleach synchronized worm eggs were suspended at a
concentration of 100-200 eggs/mL in the suspension of E. coli in S-medium. Lastly, a cell
culture insert was placed in each well followed by 0.25 mL of the egg/bacterial suspension (2550 eggs) into each insert (n = 3 wells per condition). Synchronized cultures of worms were
placed on an orbital shaker at 135 rotations per minute at 20°C and monitored until they reached
adulthood (~72 h), at which time FUdR was added to a final concentration of 400 uM. Worm
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viability was scored every two days. Worms that did not respond to repeated stimulus were
scored as dead and those that contained internally hatched larvae were excluded. The culture
media containing E. coli in the 12-well plates below each culture insert (>80% of total culture
media volume) was changed every 3 days.
2.3.3 High glucose lifespan measurements
C. elegans lifespan assays as described above with the addition of 40 mM glucose to the
culture medium. Worms were scored for viability every day. The media containing bacteria in
the wells into which the culture inserts were submerged was changed every two days.
2.4 RNAi feeding experiments
The E. coli skn-, cbp-1, hda-1, hda-2, hda-3, F55E10.6, dhs-2,dhs-16, dhs-20, fum-1,
gei-7, men-1, sdha-2, F48E8.3, qns-1, and W06B3.1RNAi clones from the Ahringer C. elegans
RNAi library (Source BioScience LifeSciences) was grown 16 hours and then 1mM IPTG was
administered to the E. coli for the last 4 hours of growth to induce expression of the double
strand RNA. Lifespan experiments were performed using live instead of heat-killed bacteria.
The culture media containing bacteria in the 12-well plates into which the culture inserts were
submerged was changed daily instead of every 3 days to decrease the chance of E. coli
metabolism depleting the culture level of the supplemented amino acid.
2.5 GFP reporter strains
The GFP fluorescence of C. elegans populations was assayed using a Biotek Synergy 2
microplate reader. Strains were age synchronized and cultured in 12-well microplates as
described above. At the L3 stage of larval development animals were treated with βHB or other
compounds. Following 24 hours of treatment, worms were washed 3 times in S-medium and
approximately 400 worms per 200 μL were added to a clear 96-well microplate and GFP
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fluorescence was measured using 485/20 nm excitation and 528/20 nm emission filters (n=10 per
treatment group).
2.6 Microscopy and quantification
Worms used for microscopy were anesthetized using 1 mM levamisole and transferred to
agar pads with glass coverslips and analyzed using an EVOS fluorescence microscope.
Comparable results were established in the absence of levamisole (data not shown).
Approximately 20 worms per condition were used and all experiments were repeated at least
three times. ImageJ™ software was used to quantify pixel intensities.
2.7 Thermotolerance assays
Thermoterance assays were performed on both liquid and solid media as described
below.
2.7.1 Thermotolerance assays performed in liquid media
A synchronized population of N2 C. elegans eggs was obtained as described in 2.3.1 for
the lifespan measurements. Eggs were placed in an aerated longneck glass bottle filled to 250 mL
with liquid S medium and 4 g of HT115(DE3) E. coli with and without treatment. On day 5 of
the lifespan, the worms were removed and diluted to approximately 10 worms per well in a 96
well microplate. The 96 well microplate containing treated and untreated worms was placed in
an incubator at 38°C. Worms were scored for movement as a marker of survival every 20–30
minutes for 430 minutes.
2.7.2 Thermotolerance assays performed on NGM agar
A synchronized population of N2 C. elegans eggs were placed on treated or non-treated
NGM plates and allowed to hatch at 20°C. At the L4 stage of development animals were
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transferred to a 35°C incubator. Survival was scored as the number of worms responsive to
gentle prodding with a worm pick.
2.8 Alpha-synuclein aggregation assays
Eggs were collected from the NL5901 strain of C. elegans following treatment with
alkaline bleach and placed in 12 well cell culture inserts as described above, with or without
amino acid treatment. Following 2 days of treatment, 400 µM FUdR was added to the inserts to
prevent progeny. On day 8 worms were washed 3 times with M9 media and either placed on 1%
agarose pads to slow movement or immobilized with 10 mM levamisole. Quantification of the
number of inclusions expressing alpha-synuclein-YFP was measured using an EVOS
fluorescence microscope. Foci larger than 2 µm2 were counted for each group (n=30). Image
analysis was performed using ImageJTM software and the assay was completed at least 3 times
[5]. Statistical analysis was completed using GraphPad software and calculation of statistical
significance between groups was carried out using Student’s t-test.
2.9 Aβ-mediated paralysis assays
Paralysis assays were carried out as outlined in [6].Briefly, second generation
synchronized gravid C. elegans strain CL4176 were placed on treated or untreated 6 cm NGM
plates and allowed to lay eggs for 2 hours. After two hours, adults were removed and plates were
placed in a 16°C incubator for 48 hours. Following 48 hours, plates were upshifted to a 25°C
incubator. Scoring for paralyzed worms began 20 hours after upshift. Animals were scored for
movement every two hours. Worms were considered paralyzed if they could not complete a full
body movement after stimulation with a worm pick.
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2.10 Polyglutamine aggregation assays
AM140 [unc-54p::Q35::YFP] worms were synchronized and placed onto NGM plates
supplemented with either 1 mM tryptophan, 10 mM serine, or 5 mM proline. Plates were seeded
with 90% heat-killed OP50 and 10% live OP50. Images were taken at Day 3 of adulthood.
Progeny were avoided by picking daily after day 1. Aggregates were scored for 50 worms per
condition in independent biological duplicates.
2.11 Lifespan assays using transgenic TDP-43 nematodes
CL6049 [snb-1::hTDP-43 + mtl-2::GFP] second generation synchronized gravid animals
were placed on treated or untreated 6 cm NGM plates and allowed to lay eggs for 2 hours. After
two hours, adults were removed and plates were placed in a 16°C incubator. At the L4 larval
stage worms were transferred onto treated or untreated NGM plates with added 5-fluoro-2′deoxyuridine (FUdR, 0.05 mg/mL) to inhibit growth of progeny. Worms were scored everyday
by gentle touching with a platinum wire. Failure to respond to touch or move forward or
backwards was scored as dead.
2.12 Protein assay
Protein was assayed essentially as in [7]. Briefly, one mL of worms suspended in S
medium or M9 medium was snap frozen in liquid nitrogen and stored at −10°C until analysis.
For analysis 500 µL of a worm suspension was sonicated on ice, using a W-380 sonicator (Heat
Systems-Ultrasonics, Inc.) (5-second pulses, 50% duty cycle, max power, 12 pulses). 1.5 mL of
1:1 ethanol/acetone was added and the suspension was vortexed, and incubated for 30 minutes at
4°C. The tube was then centrifuged at 15,000×g for 10 minutes at room temperature. The
supernatant was decanted, and the tube was inverted on a paper towel while the pellet dried. The
pellet was then resuspended in 180 µL of 1 N NaOH, and incubated at 70°C for 25 minutes to
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degrade lipids that could have interfered with analysis. The NaOH was then diluted with 1.26
mL of deionized water and 360 µL of 10% SDS. The sample was then mixed by inversion and
centrifuged at 1,500×g for 2 minutes at room temperature. The protein content of the supernatant
was then analyzed by the BCA assay (Pierce) according to the manufacturer’s protocol.
2.13 NAD, NADH, NAD, and NADPH measurements
The C.elegans MH1317strain having genotype kuIs29[unc-119(+) egl-13::GFP(pWH17)]
V was used. Worms were synchronized and cultured with heat-killed OP50 E. coli as food in the
presence of no treatment, 10 mM malate or 10 mM succinate. On day 4 of the lifespan a 2 mL
aliquot of each culture was snap frozen in liquid nitrogen. The samples were thawed and 50 µL
was added in duplicate to the wells of a 96-well plate. NAD, NADH, NAD, and NADPH
measurements were performed using the Elite Fluorimetric NAD/NADH Ratio Assay and Elite
NADP/NADPH Ratio Assay Kits (eENZYME, LLC), according to the manufacturer’s
instructions. Fluorescence was normalized by the GFP expression of each sample.
2.14 GST-4::GFP fluorescence analysis
C. elegans of strain CL2166 having genotype dvIs19[pAF15(gst-4::GFP::NLS)] as
described in [8] were used. Approximately 300 age-synchronized worms were grown in cell
culture inserts in liquid culture medium containing HT115(DE3) E. coli as food as described
above. Cultures were supplemented with 10 mM succinate, 10 mM malate, or 10 mM fumarate
on day 1 of the lifespan. 10 mM paraquat was added on day 4. 24 hours later on day 5
approximately 20 adult worms from each treatment group were removed and assayed by
fluorescence microscopy. Worms in the images were analyzed for fluorescence intensity
following background subtraction using NIH ImageJ software version 1.44p.
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2.15 DAF-16::GFP and SKN-1::GFP nuclear translocation assays
C. elegans strains N2, TJ356 (DAF-16::GFP), and LD1008 (SKN-1::GFP) were bleach
synchronized and eggs were placed in 3 µM cell culture inserts with heat-killed HT115(DE3) E.
coli in shaken 12-well plates untreated or treated (3 wells per treatment). On day 4 of the
lifespan, worms were chilled on ice to slow movement and 40–50 worms per treatment group
were photographed and analyzed for nuclear translocation.
2.16 Thrashing measurements
For the thrashing assays N2 worms were grown on NGM agar with live HT115(DE3)
control E. coli or HT115(DE3) E. coli expressing RNAi to malic enzyme (men-1) essentially as
in [9]. Some worms were grown in the presence of heat-killed HT115(DE3) E. coli with 10 mM
malate, 10 mM fumarate, or 10 mM succinate, or no addition. Worms were transferred to 50 µL
of S medium. After a one minute recovery period thrashes, defined as changes in the direction of
bending at the mid body, were counted for 30 seconds (n = 8 for the control N2 worms and the
N2 worms feeding on malic enzyme (men-1) RNAi-expressing bacteria and n = 16 for malate,
fumarate, succinate, and control treated N2 worms).
2.17 Pharyngeal pumping measurements
Pharyngeal pumping assays were performed essentially as in [10]. Briefly, agesynchronized eggs from N2 worms were placed on 6 cm agar plates seeded with OP50 E.
coli suspended in S medium with or without treatment. Video of 3 day old worms (n = 16 for
each group) was recorded with a Scopetek 3.2 megapixel microscope eyepiece camera at a
resolution of 1028×764 pixels and quality setting of 50 out of 100 in black and white. Full
pumps were manually counted for 20 seconds during reduced speed video playback using the
VLC media player.
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2.18 Oxygen consumption measurements
Oxygen measurements were performed with live worms using two different methods.
2.18.1 Oxygen measurements using the Clark Oxygen Electrode
N2 worms were grown in 12-well cell culture plates and fed HT115 (DE3) control or
F55E10.6 RNAi knockdown-expressing E. coli as food for 4 days in the absence or presence of
20 mM βHB. Worms were washed 4 times using M9 buffer to free them of the bacteria and then
resuspended in the culture media in which they were grown except without the bacteria. The
average concentration of worms was obtained by taking ten 10 μL drops and counting the
number of living worms in each drop. The volume of the culture was then adjusted to obtain a
final concentration of 2 worms per μL. 300 μL of the worm suspension was then added to the
chamber of a Clark oxygen electrode (MT200A chamber, Strathkelvin Instruments) and the
respiration was monitored for 5 minutes. The respiratory rate was normalized to protein content
by performing a protein assay on the worm suspension.
2.18.2 Oxygen consumption using PreSens OxoPlates
All measurements were acquired using the PreSens OxoPlate protocol supplied with the
OxoPlates. Worms were synchronized with and the eggs were placed in 12-well cell culture
plates in 1mL of S-medium or appropriate amino acid with live HT115 (DE3) bacteria. The pH
and volume of the media were monitored daily. At the L4 stage, worms were washed 3 times
with S-medium or appropriate amino acid. Following rinsing, the worms were concentrated to
approximately 10 worms per microliter and 200uL of each treatment group was placed in the
OxoPlate in replicates of 3-4. Oxygen consumption was measured using 540/650 and 540/590
filters on a Biotek Synergy 2 microplate reader.
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2.19 ATP assays
One mL samples of the N2 C. elegans cultures grown with either heat-killed E. coli or
live RNAi-expressing E. coli were snap frozen on day 4 of the lifespan in liquid nitrogen. The
samples were thawed and then 50 µL was added to a well of a 96-well microplate in a 1:1 ratio
with 50 µL of CellTiter Glo solution (Promega, Madison, WI). The plate was shaken for 2
minutes and then incubated at room temperature for 10 minutes. Luminescence of the samples
was measured in a Biotek Synergy 2 microplate reader. ATP levels were obtained through the
use of a standard curve.
2.20 Mitochondrial membrane potential determination
N2 C. elegans were bleach synchronized and 500 eggs were placed in each well of a 12well shaken microplate along with heat-killed HT115(DE3) E. coli. 24 hours later each well was
treated with 100 nM tetramethylrhodamine ethylester (TMRE). In addition specific wells were
treated with 10 mM malate, 10 mM fumarate, 10 mM succinate, or 10 µM FCCP
(trifluorocarbonylcyanide phenylhydrazone) (3 wells per treatment). 24 hours following
treatment the worms for each treatment group were washed with 10 mL of S-medium and
resuspended in 5 mL of S-medium. 100 µL of worms were added to each well of a 96-well
microplate (n = 6) and fluorescence was measured using a 540/30 nm excitation filter and a
590/35 nm emission filter.
2.21 BHB dehydrogenase assays
D-βHB or L-βHB dehydrogenase activity was assayed as in [11], slightly modified from
the original method published in [12]. The reaction mix contained 100 mM Tris-HCl pH 8.0, 10
mM MgSO4, 5 mm K+ EDTA, 400 mM hydrazine hydrate, 1 μM rotenone, 10 mM NAD, 20 mm
D-βHB or L-βHB, and 10 μL of Halt protease inhibitor cocktail (Thermo Scientific).Worms
were grown with or without D-βHB or L-βHB as indicated. On day 4 of development, worms
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were washed 3 times with M9 buffer to free them of bacteria and condensed to 50 worms per
microliter. 1 mL of concentrated worms was subjected to 3 freeze-thaws cycles in liquid
nitrogen. 50 μL of each sample (~ 2,500 worms) was added to a clear bottomed 96-well
microplate, followed by addition of 100 μL of the reaction mix above. NADH fluorescence was
measured kinetically for 20 minutes using 360/40 nm excitation and 460/40 nm emission filters
(n=5) on a Biotek Synergy 2 microplate reader.
2.22 Statistical analysis
Kaplan-Meier survival analysis and log-rank tests were performed using Sigmaplot
version 11.0. Student’s t-tests and ANOVA were used in other analyses.
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CHAPTER 3
MALATE AND FUMARATE EXTEND LIFESPAN IN CAENORHABDITIS ELEGANS1
3.1 Abstract
Malate, the tricarboxylic acid (TCA) cycle metabolite, increased lifespan and
thermotolerance in the nematode C. elegans. Malate can be synthesized from fumarate by the
enzyme fumarase and further oxidized to oxaloacetate by malate dehydrogenase with the
accompanying reduction of NAD. Addition of fumarate also extended lifespan, but succinate
addition did not, although all three intermediates activated nuclear translocation of the
cytoprotective DAF-16/FOXO transcription factor and protected from paraquat-induced
oxidative stress. The glyoxylate shunt, an anabolic pathway linked to lifespan extension in C.
elegans, reversibly converts isocitrate and acetyl-CoA to succinate, malate, and CoA. The
increased longevity provided by malate addition did not occur in fumarase (fum-1), glyoxylate
shunt (gei-7), succinate dehydrogenase flavoprotein (sdha-2), or soluble fumarate reductase
F48E8.3 RNAi knockdown worms. Therefore, to increase lifespan, malate must be first
converted to fumarate, and then fumarate must be reduced to succinate by soluble fumarate
reductase and the mitochondrial electron transport chain complex II. Reduction of fumarate to
succinate is coupled with the oxidation of FADH2 to FAD. Lifespan extension induced by malate
depended upon the longevity regulators DAF-16 and SIR-2.1. Malate supplementation did not
extend the lifespan of long-lived eat-2 mutant worms, a model of dietary restriction. Malate and
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fumarate addition increased oxygen consumption, but decreased ATP levels and mitochondrial
membrane potential suggesting a mild uncoupling of oxidative phosphorylation. Malate also
increased NADPH, NAD, and the NAD/NADH ratio. Fumarate reduction, glyoxylate shunt
activity, and mild mitochondrial uncoupling likely contribute to the lifespan extension induced
by malate and fumarate by increasing the amount of oxidized NAD and FAD cofactors.
3.2 Introduction
Metabolic control of the aging process is widely accepted, yet little progress has been
made in this field due to the complexity of organismal metabolism. Studies of lifespan in model
organisms have yielded important roles for organelles [1, 2], especially mitochondria, in
regulating the aging process. The mitochondrial electron transport chain (ETC) is the main
producer of damaging reactive oxygen species in the cell and therefore has the potential to
regulate lifespan as postulated by the free radical theory of aging [3]. However, recently data has
accumulated that questions the theory that free radicals are the main regulators of lifespan [4, 5].
Although mitochondrial-derived oxygen radicals have been questioned as the main driving force
for the aging process, changes in mitochondrial metabolism almost certainly play a role. Dietary
restriction (DR), which extends lifespan [6], also delays the aging-induced ETC dysfunction in
rodents [7]. DR increases the NAD/NADH ratio in many tissues [8], which stimulates
mitochondrial tricarboxylic acid (TCA) cycle dehydrogenases that utilize NAD as a cofactor.
The increased TCA cycle function likely necessitates increased anaplerosis, important for
longevity [9].
Alteration of mitochondrial TCA cycle (Fig. 1.1) function influences lifespan in C.
elegans. For example, RNAi knockdown of aconitase or two of the subunits of mitochondrial
NAD+-dependent isocitrate dehydrogenase have been shown to increase lifespan [10, 11].
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Mutations in the thiamine pyrophosphokinase gene, tpk-1, which converts thiamine to the
essential co-factor thiamine pyrophosphate, essential for pyruvate and α-ketoglutarate
dehydrogenases as well as several other enzymes, also extended lifespan [12]. Furthermore,
addition of the TCA cycle intermediate oxaloacetate has been shown to extend lifespan in C.
elegans through an aak-2/AMP kinase and daf-16/FOXO-dependent mechanism [13].
Supplementation with other metabolites that increase flux through the TCA cycle has also shown
beneficial effects on lifespan. Addition of acetate [14] or pyruvate [15] or activation of pyruvate
dehydrogenase with dichloroacetate [16] increased lifespan, while the addition of metabolites
that feed more upstream into glycolysis, such as glucose or glycerol, decreased lifespan [17],
perhaps due to increased methylglyoxal formation [18].
As a soil-dwelling nematode, C. elegans has evolved to be more metabolically flexible
than many other multicellular organisms. C. elegans can survive anaerobically for short periods
of time by utilizing a metabolic process known as malate dismutation (Fig. 1.1) or the
phosphoenolpyruvate carboxykinase (PEPCK)-succinate pathway [19, 20]. Here, a portion of
the intracellular malate is converted to fumarate and then to succinate, which can be excreted
from the cell. This process leads to the oxidation of reducing equivalents providing NAD and
FAD essential for cellular metabolism. C. elegans also has a glyoxylate shunt, not present in
mammals, that converts isocitrate and acetyl-CoA to succinate, malate, and CoA using
glyoxylate as an intermediate (Fig. 1) [21]. This shunt bypasses two NADH and CO2 generating
steps in the TCA cycle, conserving NAD levels and preventing carbon loss, which is
advantageous for biosynthetic reactions in the cell. The glyoxylate shunt is upregulated in many
long-lived C. elegans mutants [22].
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Figure 3.1. The mitochondrial TCA cycle with the glyoxylate shunt and malate dismutation. Numbered
reactions are catalyzed by 1.fumarase, 2a. isocitrate lyase, 2b. malate synthase, 3. mitochondrial succinate
dehydrogenase/fumarate reductase (complex II), 4. soluble fumarate reductase, 5. cytoplasmic malate
dehydrogenase, 6. mitochondrial malate dehydrogenase, and 7. malic enzyme. It is unknown if the
glyoxylate shuntis present in mitochondria, peroxisomes, or glyoxysomes in C. elegans.

In this report, we tested the effect of added succinate, fumarate, and malate on C. elegans
lifespan, and determined the effects on mitochondrial function, redox status, and determined
which metabolic enzymes and longevity pathways were necessary for lifespan extension.
3.3 Results
3.3.1 Malate extends lifespan in WT but not eat-2, daf-16, sir-2.1, or hsf-1 mutant worms
In Fig. 3.2A we show that the addition of 10 mM L-malate and 10 mM fumarate, but not
10 mM succinate, to the growth medium of C. elegans increased lifespan. A summary of all
lifespan experiments is shown in Table 3.1.
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Table 3.1. Summary of lifespan experiments
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Malate increased mean lifespan by 14% and the increase was consistently observed
(p<0.001) in nine total replicates using either live E. coli (n=6) or heat killed E. coli (n=3) as the
food source. The increased lifespan was not due to reduced food intake from diminished
pharyngeal pumping as malate treated (164 pumps per minute ± 4 SEM) showed similar rates as
control (168 ± 3 SEM) worms (p=0.37). Fumarate increased mean lifespan by 16% (p<0.001
n=4). Interestingly, a mass spectrometry-based metabolomics analysis identified 188 total worm
metabolites and indicated that there was a 2-fold reduction in fumarate levels with aging in C.
elegans (data not shown). Therefore, added fumarate or malate may compensate for altered TCA
cycle function in aged worms. Like succinate, the TCA cycle intermediate α-ketoglutarate failed
to extend lifespan. Aspartate, a metabolite of the mitochondrial malate-aspartate NADH shuttle
also failed to induce lifespan extension.
Malate addition was unable to extend the lifespan of sir-2.1(ok434) mutant worms (Fig.
3.2B). SIR-2.1 is a sirtuin family member and is the closest worm homolog of the mammalian
SirT1 NAD-dependent protein deacetylase [23]. In Fig. 3.2C, it is shown that malate did not
extend the lifespan of long-lived eat-2(ad1116) worms that have reduced pharyngeal pumping
rates and are a model of dietary restriction. Treatment with succinate blocked the lifespan
extending effects of dietary restriction (DR) in eat-2 worms, as the maximal lifespan was similar
as the N2 control strain and much shorter than untreated or malate treated eat-2 worms. Fig.3.2D
shows that malate did not extend the lifespan of daf-16(mgDf50) worms. Therefore, DAF-16 is
required for malate-induced lifespan extension. DAF-16 is the worm homolog of mammalian
FOXO transcription factors and is required for lifespan extension in several mutant strains, most
notably in reduced insulin receptor signaling daf-2 mutant worms. Malate also failed to
significantly extend the lifespan of heat shock factor-1 mutant, hsf-1(sy441) worms (log-rank
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p=0.08) (Figure 2E), although a protective effect occurred early in life. HSF-1 is required for
lifespan extension that occurs in daf-2 mutants [24] and in some dietary restriction regiments
[25, 26].
3.3.2 Malate increased lifespan robustly in hif-1 mutant worms and slightly in aak-2 and
skn-1 RNAi worms
Malate and fumarate treatments resulted in increases in the lifespan of hypoxia inducible
factor-1 mutant, hif-1(ia4) worms. HIF-1 functions downstream of Tor kinase and is necessary
for the lifespan extension that occurs in mitochondrial mutants [27, 28]. Malate and succinate
treatments did not significantly increase the mean lifespan of aak-2(ok524) AMP kinase
(AMPK) mutant worms (Fig. 3.2F). But caution should be used when making conclusions from
this data, due to the low number of worms used in these experiments. AMPK has been shown to
be necessary for lifespan extension in worms following oxaloacetate treatment [13], resveratrol
treatment, and under certain DR conditions [25]. SKN-1 is the C. elegans homolog of
mammalian Nrf transcription factors involved in cellular detoxification, stress defense, and
longevity. Malate extended the lifespan of skn-1 RNAi nematodes by 9% (Fig. 3.3A). Consistent
with this, malate, fumarate, and succinate all failed to induce nuclear localization of SKN-1::GFP
(data not shown).
3.3.3 Malic enzyme or malate dehydrogenase knockdown did not block malateinduced lifespan extension
Malic enzyme catalyzes the conversion of malate to pyruvate and carbon dioxide with the
concurrent reduction of NADP to NADPH.To determine if this reaction is essential for the
lifespan extension elicited by malate, we knocked down the sole malic enzyme gene in C.
elegans, men-1 by RNAi and determined the effects of malate addition on lifespan.
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Figure 3.2. Lifespan analysis of C. elegans strains in the presence of TCA cycle intermediates. 10 mM
concentrations of malate, succinate, or fumarate were present where indicated. (A) Malate (log-rank p <
0.001) or fumarate (log-rank p < 0.001), but not succinate (log-rank p = 0.72) extended lifespan of N2
worms. (B) Neither malate (log-rank p = 0.97) nor succinate (log-rank p= 0.88) extended lifespan of sir2.1(ok434) worms. (C) No effect of malate treatment (log-rank p= 0.22) on lifespan and decreased
lifespan with succinate treatment (log-rank p < 0.001) in eat-2(ad1116) worms. (D) Neither malate (logrank p = 0.83) nor succinate (log-rank p = 0.22) extended lifespan of daf-16(mgDf50) worms. (E) 10 mM
malate (log-rank p = 0.08) did not extend the lifespan of HSF-1 mutant hsf-1(sy441) worms. (F) Neither
10 mM malate (log-rank p = 0.18) nor 10 mM succinate (log-rank p = 0.10) extended lifespan of AMPK
mutant aak-2(ok524) worms.

As shown in Fig. 3.3B, the mean lifespan of men-1 RNAi knockdown worms was only 53% of
controls, but malate addition still extended mean lifespan by 30%, suggesting that high malic
enzyme activity is not important for malate-induced lifespan extension. Interestingly, malic
enzyme RNAi knockdown caused an increased rate of body wall muscle contractility (210 body
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bends per minute ± 12 SEM) when compared to control (147 body bends per minute ± 7 SEM)
as measured by a thrashing assay (p < 0.001).
Malate dehydrogenase catalyzes the reversible conversion of malate to oxaloacetate with
the concurrent reduction of NAD to NADH. There are two confirmed malate dehydrogenase
genes in C. elegans. The mdh-1 gene codes for a mitochondrial isoform, while the other gene,
F46E10.10, encodes a cytoplasmic isoform. F46E10.10 is upregulated in long-lived dauer and
daf-2 worms [19] as well as long-lived mitochondrial mutants [29]. Oxaloacetate, the product of
the malate dehydrogenase reaction has been shown to extend lifespan in C. elegans. We first
knocked down the mitochondrial malate dehydrogenase, mdh-1, and determined the effects on
lifespan in the absence and presence of malate (Fig. 3.3C).The mean lifespan of mdh-1
knockdown worms was 66% of controls, but malate addition extended mean lifespan of the
RNAi treatment by 26%, nearly back to that observed in the control worms. We then knocked
down F46E10.10 and performed lifespan analysis with and without malate (Fig.3.3D).
Knockdown worms showed a mean lifespan 85% of controls and malate addition extended mean
lifespan of the F46E10.10 knockdown worms by 8%.
3.3.4 The glyoxylate shunt is required for lifespan extension induced by malate or fumarate
The glyoxylate shunt is composed of two enzymes, isocitrate lyase and malate synthase. In C.
elegans these enzymes are fused into one bifunctional protein named GEI-7 or ICL-1. Isocitrate lyase
reversibly converts isocitrate into succinate and glyoxylate. Malate synthase catalyzes the reversible
synthesis of malate and CoA from glyoxylate and acetyl-CoA (Fig. 3.1).

Since malate can be

metabolized by the glyoxylate shunt we determined the lifespan of gei-7 RNAi worms in the absence and
presence of malate. As shown in Fig. 3.4A, the mean lifespan of gei-7 RNAi knockdown worms was 62%
of controls and the lifespan was not statistically different in the presence of malate (log-rank p=0.24).
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Figure 3.3. Adding malate to the media increased lifespan of C. elegans RNAi knockdown
strains. (A) 10 mM malate increased lifespan of skn-1 RNAi knockdown N2 worms (log-rank p
= 0.03). (B) 10 mM malate increased the lifespan of malic enzyme (men-1) RNAi knockdown
N2 worms (log-rank p < 0.001). (C) 10 mM malate increased the lifespan of mitochondrial
malate dehydrogenase (mdh-1) RNAi knockdown N2 worms (log-rank p < 0.001). (D) 10 mM
malate increased the lifespan of cytoplasmic malate dehydrogenase F46E10.10 RNAi
knockdown N2 worms (log-rank p = 0.006).
Fumarate addition also did not increase lifespan and even decreased the lifespan of the gei-7
RNAi knockdown worms by 9% (Fig. 3.4B). Therefore, the glyoxylate shunt appears to be
essential for the lifespan extension mediated by malate or fumarate treatment.
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Figure 3.4. Malate-induced lifespan extension requires fumarase and the glyoxylate cycle. (A) 10 mM
malate treatment did not alter the lifespan of glyoxylate cycle gei-7 RNAi knockdown N2 worms (logrank p = 0.24). (B) 10 mM fumarate treatment decreased the lifespan of glyoxylate cycle gei-7 RNAi
knockdown N2 worms (log-rank p = 0.02). (C) 10 mM malate treatment did not alter the lifespan of
fumarase (fum-1) RNAi knockdown N2 worms (log-rank p = 0.49). (D) 10 mM fumarate treatment
increased the lifespan of fumarase (fum-1) RNAi knockdown N2 worms (log-rank p < 0.001).
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Interestingly, 10 mM glyoxylate failed to extend lifespan, suggesting a limited conversion of
glyoxylate to malate in the worms under these culture conditions or alternatively, that the acetylCoA consumed during conversion of glyoxylate to malate may prevent lifespan extension.
3.3.5 Fumarase is required for lifespan extension induced by malate but not by
fumarate
Fumarase catalyzes the reversible conversion of fumarate to malate and is dually targeted
to both the cytoplasm and mitochondria [30]. We performed a lifespan assay using fumarase
(fum-1) RNAi knockdown worms in the presence and absence of malate (Fig. 3.4C). The mean
lifespan of fum-1 knockdown worms was 66% of controls.

Strikingly, fum-1 knockdown

prevented malate from increasing lifespan (log-rank, p=0.49). But in contrast to malate addition,
fumarate addition, which is still able to be converted to succinate, did extend lifespan by 18% in
fum-1 RNAi knockdown worms (Fig. 3.4D). Therefore, added malate must be metabolized by
fumarase to form fumarate, running a portion of the TCA cycle backwards, to extend lifespan.
3.3.6 Malate increased lifespan in sdha-1 RNAi knockdown worms, but not in sdha-2 and
F48E8.3 RNAi knockdown worms
There are three separate fumarate reductase isoforms in C. elegans. Two of them, sdha-1
and sdha-2, are exchangeable subunits of the mitochondrial fumarate reductase/succinate
dehydrogenase complex II of the respiratory chain and the other is a soluble cytoplasmic
fumarate reductase F48E8.3. There has been a report of a large decrease in sdha-2 expression in
long-lived dauer larvae [20], but another group found no change [19]. SDHA-2 protein levels
were downregulated in long-lived eat-2 worms [31]. Sdha-1 expression levels were unchanged
[20] or slightly decreased [19] in dauers, while F48E8.3 was strongly upregulated [19, 20].
F48E8.3 protein levels were not changed in eat-2 worms [31]. Proteomics analysis showed an
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increase in sdha-1 levels with aging (data not shown). It was hypothesized that the sdha-1/sdha2 ratio may influence lifespan by regulating the relative fumarate reductase to succinate
dehydrogenase activity of complex II [19]. However, others hypothesized that complex II
flavoprotein phosphorylation may play a role in controlling the relative fumarate reductase to
succinate dehydrogenase activities [32].
To determine if sdha-1 plays a role in lifespan extension mediated by malate, we knocked
it down by RNAi treatment and determined the lifespan in the absence and presence of malate.
As shown in Fig. 5A, sdha-1 knockdown worms had a mean lifespan 78% of controls and malate
treatment increased mean lifespan by 20%. The data indicate that sdha-1 does not likely play a
role in lifespan extension by malate. We next knocked down sdha-2 by RNAi and determined the
effect of malate treatment. Malate addition did not significantly alter the lifespan (log-rank
p=0.95) (Fig.3. 5B). We also knocked down the soluble fumarate reductase F48E8.3 by RNAi.
These worms only lived 79% as long as controls. Once again, malate addition did not extend
lifespan and even caused a 10% decrease in lifespan (Fig. 3.5C). These experiments further
confirm the role of fumarate reduction and the malate dismutation pathway in the lifespan
extending effects of malate.
3.3.7 The effect of malate on lifespan in flavin adenine dinucleotide (FAD) synthase RNAi
knockdown worms
One possible difference between succinate and malate metabolism and their different
effects on lifespan is that following malate conversion to fumarate, fumarate is metabolized to
succinate by fumarate reductase to increase the FAD/FADH2 ratio in the cell, while succinate
conversion to fumarate has the opposite effect on the ratio. To gain insight into a possible role
for FAD levels on lifespan extension by malate, we determined if malate could extend lifespan
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when the flad-1 gene encoding FAD synthase, the terminal step in FAD synthesis, was knocked
down by RNAi. As shown in Fig. 5D, flad-1 RNAi knockdown had a mean lifespan of 71% of
the control, and malate treatment completely restored the lifespan back to that of the control.
Therefore, FAD levels do not appear to be the limiting factor for malate-mediated lifespan
extension. It is possible; however, that a low FAD/FADH2 ratio limits normal C. elegans lifespan
under these growth conditions and malate treatment increases this ratio to increase lifespan.
3.3.8 Malate, fumarate, and succinate treatment increased stress resistance
Since many treatments and mutations that extend lifespan also increase stress resistance,
we determined if malate, fumarate, or succinate could also increase the thermotolerance of the
worms or decrease oxidative stress. As shown in Fig. 3.6A, malate increased the
thermotolerance, the survival time of the worms at 38°C, by 32%, while succinate (log-rank
p=0.03) and fumarate (log-rank p=0.12) were less protective, only increasing thermotolerance by
13% and 10% respectively. The transcription factor SKN-1/Nrf is upregulated in C. elegans in
response to oxidative stress and activates transcription of antioxidant genes such as glutathioneS-transferase-4 (gst-4). By monitoring the fluorescence of a gst-4::gfp oxidative stress reporter
worm strain [33], we found that malate, fumarate, and succinate all decreased endogenous
oxidative stress and the oxidative stress following treatment with paraquat, a stimulator of
mitochondrial reactive oxygen species production (Fig. 6B). Consistent with this protection,
malate, fumarate, and succinate treatment all induced the nuclear translocation of DAF-16::GFP
(Fig. 3.6C).
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Figure 3.5. Malate treatment did not increase the lifespan of sdha-2 and F48E8.3 RNAi knockdown
worms. (A) 10 mM malate increased the lifespan of complex II flavoprotein (sdha-1) RNAi knockdown
N2 worms (log-rank p < 0.001). (B) 10 mM malate did not increase the lifespan of complex II
flavoprotein (sdha-2) RNAi knockdown N2 worms (log-rank p =0.95). (C) 10 mM malate decreased the
lifespan of soluble fumarate reductase F48E8.3 RNAi knockdown N2 worms (log-rank p =0.002). (D) 10
mM malate increased the lifespan of FAD synthase (flad-1) RNAi knockdown N2 worms (log-rank p <
0.001).
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Figure 3.6. Effects of malate, fumarate, and succinate on thermotolerance, oxidative stress, and DAF16::GFP nuclear translocation. (A) 10 mM malate increased thermotolerance (log-rank p < 0.001), while
10 mM succinate (log-rank p = 0.03) and 10 mM fumarate (log-rank p = 0.12) had smaller protective
effects. C. elegans were grown at 20°C and then upshifted to 38°C. (B) 10 mM malate, fumarate, or
succinate treatment decreased GST-4::GFP fluorescence in the absence (* p < 0.05 compared to untreated
N2) and in the presence of 10 mM paraquat (# p < 0.05 compared to paraquat treated N2). (C) 10 mM
malate, fumarate, or succinate treatment increased the nuclear translocation of DAF-16::GFP.
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3.3.9 Malate treatment increased the NAD/NADH ratio and decreased the NADP/NADPH
ratio
An enhanced NAD/NADH ratio occurs in certain tissues during DR in rodents [8], and
this ratio may be important for lifespan extension by activating sirtuins [34]. Therefore we
cultured the worms for 4 days with malate or succinate and then measured NAD and NADH
levels. As shown in Fig. 3.7A, malate addition greatly increased the NAD/NADH ratio.
This result was surprising given that malate metabolism through the enzyme malate
dehydrogenase converts NAD to NADH, which would yield opposite results. Malate addition
also strongly increased total NAD+NADH levels, which also occurs in certain tissues during DR
in mice [8]. Succinate, which did not extend lifespan, showed a smaller increase in NAD levels.
To determine if normal NAD(H) levels are required for malate-induced lifespan
extension we individually knocked down two enzymes in the NAD synthesis pathway by RNAi
and monitored lifespan (Table 3.1). We knocked down the NAD synthetase gene qns-1 and the
nmnat-2 gene (W06B3.1) by RNAi. Knocking down W06B3.1 decreased lifespan by 6% and
fully prevented lifespan extension by malate addition, suggesting normal NAD(H) levels may be
necessary for malate-mediated lifespan extension. However, qns-1 knockdown decreased
lifespan by 24%, but malate addition increased lifespan by 13% (p=0.07). This somewhat
inconclusive data indicates further research is necessary to determine the exact role that NAD(H)
levels play in malate-mediated lifespan extension.
We also measured NADP and NADPH levels following growth of C. elegans for 4 days
with malate or succinate (Fig 3.7B). Malate treatment greatly increased NADPH levels to
decrease the NADP/NADPH ratio, while succinate treatment also increased NADPH levels, but
to a lesser extent than malate. Both treatments also increased total NADP+NADPH levels.
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3.3.10 The effects of malate, fumarate, and succinate on oxygen consumption, ATP levels,
and mitochondrial membrane potential
To determine if malate, fumarate, or succinate treatment had an effect on mitochondrial
function, we measured worm oxygen consumption (Fig. 3.8A), ATP levels (Fig.3.8B), and
mitochondrial membrane potential (Fig 3.8C). Growth in the presence of malate for 4 days led to
an increase in the rate of oxygen consumption. Growth in the presence of fumarate also increased
respiration, while growth in the presence of succinate decreased respiration. Culture of the
worms with malate or succinate greatly decreased ATP levels, while the decrease of ATP
following culture with fumarate was small. To determine if TCA cycle metabolite-treated worms
increased muscle contraction to burn more ATP, we conducted thrashing experiments. Malate
treated worms showed a slightly decreased rate of thrashing (84.8 ± 2.2 SEM body bends

Figure 3.7. Malate treatment increased C. elegans NAD and NADPH levels more than succinate. (A)
Relative NAD and NADH levels in day 4 worms cultured with 10 mM malate, 10 mM succinate, or no
addition (* p < 0.05 compared to control). (B) Relative NADP and NADPH levels in day 4 worms
cultured with 10 mM malate, 10 mM succinate, or no addition (* p < 0.05 compared to control).
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per minute) compared to controls (94.4 ± 4.0 SEM body bends per minute) (p=0.04) while
fumarate and succinate treatment resulted in no significant difference in the rate of thrashing
(87.6 ± 3.3 and 92.8 ± 3.4 SEM body bends per minute, respectively) compared to controls.
Therefore, decreased ATP levels are not a result of increased thrashing.
One possible interpretation of the respiratory and ATP results is that malate and fumarate
are inducing a mild uncoupling of oxidative phosphorylation. Therefore, we monitored the
mitochondrial membrane potential (ΔΨ) with the cationic fluorescent dye TMRE (Fig. 3.8C).
Worms grown in the presence of malate, fumarate, or the uncoupler FCCP showed decreased ΔΨ
compared to control, with malate showing a robust decline, almost to the extent of FCCP. A nontoxic 10 μM concentration of uncoupler, a concentration that was previously shown to extend
lifespan [35] was chosen. Succinate treatment showed a non-significant decrease in ΔΨ.
Therefore, mitochondrial uncoupling is likely the cause for the decreased ΔΨ and ATP levels
occurring following treatment with malate and fumarate, while decreased respiratory activity is
likely responsible for the decreased ATP levels in succinate treated worms.
3.3.11 Prevention of the malate-induced drop in ATP levels in aak-2, sir-2.1, and hif-1
mutants and in gei-7 RNAi knockdown worms
To discern more about the malate-induced drop in ATP levels and to gain insight into
possible important upstream players of malate-induced signaling pathways, we measured ATP
levels of different mutant and RNAi knockdown worms grown in the presence or absence of
malate (Table 3.2). We discovered that malate addition caused a large increase in the ATP levels
in aak-2(ok524) and sir-2.1(ok434) mutants, while a small increase in ATP levels was observed
in the hif-1(ia4) mutant and gei-7 RNAi knockdown worms. Malate treatment decreased ATP to
varying extents in the daf-16(mgDf50) and hsf-1(sy441) mutant strains and the skn-1, sdha-2, and
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fum-1 RNAi knockdown worms. This data suggests that SIR-2.1 and AAK-2 may be important
upstream transducers of malate signaling.

Figure 3.8. The effect of malate, fumarate, and succinate on respiration, ATP, and ΔΨ in C. elegans. (A)
The effect of 10 mM malate, fumarate, or succinate treatment on oxygen consumption in day 4 N2 worms
(p < 0.001). (B) The effect of 10 mM malate, fumarate, or succinate treatment on ATP levels in day 4 N2
worms (p < 0.001). (C) The effect of 10 mM malate, fumarate, or succinate or 10 μM FCCP treatment on
ΔΨ in day 2 N2 worms.

77

Table 3.2 Effect of 10 mM malate on C. elegans ATP levels

3.4 Discussion
Mitochondrial electron transport chain function, which oxidizes NADH and FADH2,
decreases with age across species [36]. This leads to a decreased cellular NAD/NADH ratio in
specific tissues in aged organisms. Anti-aging therapies such as DR increase the NAD/NADH
ratio in many tissues as a possible mechanism to delay aging. We show for the first time that
malate and fumarate addition extend lifespan in C. elegans, while succinate addition did not.
Addition of the TCA cycle intermediates increased the NAD/NADH ratio, which may be
important for the mechanism of lifespan extension. Malate and fumarate treatment also increased
oxygen consumption and decreased ΔΨ, suggesting a mild mitochondrial uncoupling, while
succinate treatment did not. The glyoxylate shunt and malate dismutation/fumarate reduction
metabolic pathways were also necessary for lifespan extension. Activation of these pathways
together with induction of mitochondrial uncoupling likely result in increased cellular NAD
levels. Increased NAD levels have been described to activate the histone deacetylase SIR-2.1
[23] and AMP kinase [37] to increase lifespan.
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3.4.1 Flavin and pyridine nucleotide levels in aging and lifespan extension
Since fumarate conversion to succinate by fumarate reductase also oxidizes FADH2 to
FAD, an increased FAD/FADH2 ratio may play a role in lifespan extension. Malate and fumarate
likely induce large increases in the FAD/FADH2 and NAD/NADH ratios to extend lifespan,
while succinate has a smaller effect on the NAD/NADH ratio and likely an opposite effect on the
FAD/FADH2 levels. In this regard, administration of 5 μM FAD to a short-lived C. elegans
frataxin RNAi knockdown strain extended lifespan to an extent that surpassed the untreated
control worms [38]. We also have obtained data that FAD addition to the medium extends
lifespan (manuscript in preparation). FAD levels have been shown to decrease in many different
tissues with age in rats [39], and levels were restored by exercise [40], which extends mean
lifespan [41, 42].
Fumarate reductase has been shown to be essential for the growth of Sacchromyces
cerevisiae under anaerobic conditions for the re-oxidation of FADH2 [43]. During the dauer state
and other conditions that extend lifespan, C. elegans transitions to a metabolic state very similar
to the one it enters during anaerobic conditions [44]. In dauer larvae, fumarate reductase activity
and the glyoxylate cycle protein GEI-7 are upregulated [20], which decreases the amount of
NAD reduced to NADH in the TCA cycle. However, oxygen is present under these conditions
and electron transport chain complex I function continues to oxidize NADH. This metabolic
transition increases the NAD/NADH ratio and may result in lifespan extension.
3.4.2 Malate and fumarate may increase lifespan through increasing the NAD/NADH ratio
Malate likely increases NADPH levels through the action of malic enzyme, converting
malate to pyruvate with reduction of NADP to NADPH. Malate, as a TCA cycle intermediate,
increases TCA cycle flux and electron transport chain activity to increase oxygen consumption.
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However, the results that malate increased the NAD/NADH ratio and decreased ATP levels were
quite unexpected and may be key to the mechanism of lifespan extension induced by malate.
Since oxygen consumption was increased and ΔΨ was decreased by malate and fumarate, they
likely induce mitochondrial uncoupling. Uncoupling decreases ΔΨ, which often leads to reduced
reactive oxygen species production. Mitochondrial uncouplers have been shown to extend
lifespan in C. elegans [35, 45], consistent with the “uncoupling to survive” hypothesis of
longevity [46].
Malate and fumarate may also increase lifespan by increasing mitochondrial respiration.
Increased electron transport chain function relative to TCA cycle function will increase the
NAD/NADH ratio, which may extend lifespan. In this regard, one research group has found a
positive correlation between C. elegans oxygen consumption and lifespan. By examining
lifespan following RNAi knockdown of the frataxin gene, the authors proposed that 73% of the
lifespan decline following frataxin knockdown was due to decreases in the oxygen consumption
rate [47]. This research group suggests that high rates of respiration are necessary to produce the
normal reactive oxygen species-mediated cell signaling required for a normal lifespan. They
further went on to show that glucose restriction increases lifespan by stimulating mitochondrial
respiration [48] and that daf-2 mutants show reduced glucose uptake, which stimulates
mitochondrial oxidation of L-proline to increase oxygen consumption and increase lifespan [49].
Malate and fumarate could also extend lifespan by decreasing the rate of decline of oxygen
consumption over the lifespan. In this regard, a research group using eight different long and
short-lived mutant strains, found a strong correlation between the inverse of the rate of decline of
oxygen consumption with age and the lifespan [50]. For example, long-lived daf-2 worms
showed a very slow rate of loss of oxygen consumption over their lifespan.
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Another mechanism through which malate may increase the NAD/NADH ratio is through
increasing the activity of the ETC, so more NADH is oxidized by complex I. This may be
possible by activating the NADH-fumarate reductase (malate dismutation) system. Using this
system, following oxidation of NADH by complex I, electrons can be passed to rhodoquinone
instead of ubiquinone. Rhodoquinone passes electrons to membrane bound fumarate reductase
(complex II), which terminally reduces fumarate to succinate. In order for this activity to lead to
oxidation of NADH at a faster rate, complex I activity must be limited by the amount of oxidized
coenzyme Q (ubiquinone). If this is true, increasing the amount of oxidized rhodoquinone by
increasing fumarate levels could increase complex I activity to increase the NAD/NADH ratio.
Using fumarate as a terminal electron acceptor would also result in decreased ATP levels as only
one proton is pumped per NADH oxidized instead of 3 protons being pumped when oxygen is
used as the terminal electron acceptor. Decreased electron flow through complex III of the ETC
could decrease ROS production and be a mechanism of lifespan extension, as complex III is an
important generator of ROS [51]. However, since malate addition increased oxygen consumption
in the worms, fumarate reduction likely only plays a minor role in total ETC function under these
conditions.
Glyoxylate shunt activity also increases the NAD/NADH ratio as the shunt bypasses two
of the three NADH generating reactions of the TCA cycle. We have also shown that glyoxylate
shunt activity is required for the malate or fumarate-mediated increase in lifespan. The
glyoxylate shunt gene gei-7 has been shown to be required for lifespan extension mediated by
daf-16 in daf-2 insulin receptor mutants [52]. So it is not surprising that the glyoxylate shunt is
also required for the lifespan extension mediated by TCA cycle metabolites, which is also daf-16
dependent.
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3.4.3 Does malate increase acetyl-CoA levels to increase lifespan?
The glyoxylate shunt conversion of malate and CoA to glyoxylate and acetyl-CoA may
be important for malate-mediated lifespan extension. Other metabolites that potentially increase
acetyl-CoA levels, such as pyruvate [15] and acetate [14], have also been shown to increase
lifespan. Further support of an important role of increased acetyl-CoA levels in lifespan
extension is that glyoxylate addition did not extend lifespan. Glyoxylate can be converted to
malate, but at the expense of decreasing acetyl-CoA levels. DR induces a metabolic shift from
glucose oxidation to fatty acid oxidation that would also increase acetyl-CoA levels. Histone
acetyltransferases (HATs) utilize acetyl-CoA as a cofactor for acetylation of histone tails. In this
regard the HAT cpb-1/p300 is induced in daf-2 worms and by DR and is essential for full
lifespan extension by these interventions in C. elegans [53]. The histone deacetylase inhibitors
sodium butyrate and trichostatin A also increased lifespan in C. elegans. In yeast it has been
demonstrated that acetyl-CoA levels regulate protein acetylation [54] and that prevention of the
acetylation of the gluconeogenic enzyme PEPCK blocks chronological lifespan extension
induced by water starvation [55].
3.4.4 A proposed mechanism of how malate metabolism results in increased lifespan
We hypothesize that addition of malate or fumarate to C. elegans somehow leads to
activation of the glyoxylate shunt. Regulation of the glyoxylate shunt has not been well studied
in eukaryotes. In Gram-negative bacteria, a dual function kinase/phosphatase AceK responds to
changes in carbon source to control phosphorylation-induced inactivation of isocitrate
dehydrogenase, which induces flux into the glyoxylate shunt [56]. Lysine acetylation of
isocitrate lyase and AceK also regulate shunt activity [57]. Upregulation of shunt activity would
increase NAD levels, which are known to activate AMP kinase [37] and sirtuins [58]. AMP
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kinase activation can further increase NAD levels and sirtuin activity [59]. However, metabolism
under these conditions likely becomes limited by FAD levels, so malate dismutation is activated
to oxidize FADH2 to FAD. SIR-2.1 is known to activate DAF-16 activity [60], which can lead to
lifespan extension [61] and further upregulation of gei-7 expression [52] to amplify the lifespan
extending signaling pathway.
3.4.5 Does mitochondrial uncoupling play a role in malate-mediated lifespan extension?
Malate-mediated mitochondrial uncoupling may be essential for lifespan extension. But 3
experimental results are inconsistent with this suggestion. First, malate addition resulted in
lifespan extension in hif-1 mutant worms, where ATP levels remain high, suggesting uncoupling
is not occurring to a great extent in this strain, yet lifespan was still extended. Second, malate
addition to daf-16 mutants resulted in a large decrease in ATP levels, which may indicate
mitochondrial uncoupling was occurring, when no lifespan extension was induced. However,
one must be careful in ascribing decreases in ATP levels to decreases in oxidative
phosphorylation. Changes in glycolysis and buffering ATP into phosphocreatine can also cause
relatively quick changes in ATP levels without altering oxidative phosphorylation. And third,
lifespan extension mediated by the uncoupler CCCP was described to be daf-16 independent
[35], whereas the lifespan extension mediated by malate requires daf-16. Further research needs
to be performed to determine if activation of mitochondrial uncoupling, or, minimally, a
decreased ΔΨ, is a common pathway of lifespan extension for compounds that extend C. elegans
lifespan. In this regard we have found that a blueberry/green tea extract mixture that extended C.
elegans lifespan also increased oxygen consumption and decreased ATP levels (data not shown).
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3.4.6 Malate-induced lifespan extension compared to oxaloacetate-induced lifespan
extension
Unsurprisingly, the lifespan extension observed following malate addition was similar to
that observed with oxaloacetate treatment [13]. For example, both required daf-16. However,
there were slight differences. Oxaloacetate was reported to extend median lifespan by 25%,
while we report malate only increased mean lifespan by 14%. Under our liquid culture
conditions we found that 10 mM oxaloacetate extended mean lifespan by 49% (data not shown).
This larger effect than malate or fumarate may be due to a higher NAD/NADH ratio in
oxaloacetate fed worms. Also, we found that malate-induced lifespan extension was completely
dependent upon the presence of sir-2.1, while oxaloacetate-induced lifespan was still increased
in the absence of sir-2.1 [13]. This may be due to different growth conditions, either in liquid or
on agar medium.
The worms in most of our experiments were cultured in liquid S medium, which differs
slightly in nutrient composition from nematode growth media (NGM) commonly used for
culturing worms on agar. The liquid S medium contains 10 mM citrate (a TCA cycle metabolite),
in addition to phosphate as a buffer, while the NGM agar lacks citrate, but contains peptone
powder (2.5 g/l) absent in S medium. The added citrate may not be required for malate-mediated
lifespan extension as we found that malate extended the lifespan of worms grown on NGM agar
plates by 10% (see Table 1), but this should be further verified due to the small number of
worms used in the experiment. Also, it has been reported that adding citrate to the culture
medium did not extend lifespan [14]. The worms grown in liquid medium are not dietarily
restricted as eat-2 worms showed a robust increase in lifespan in liquid medium, as they do on
agar plates.
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3.4.7 TCA Cycle function is a key determinant of longevity
Much data implicate TCA cycle function in the control of longevity. Many TCA cycle
genes are upregulated in long-lived Ames dwarf and Little mice [62]. Brown Norway rats, a
long-lived strain, do not shown declines in brain TCA cycle function with age in contrast to
short-lived strains [63]. In yeast, glucose limitation increases chronological lifespan and
upregulates TCA cycle gene expression [64]. Yeast mitochondrial ETC gene knockouts do not
show extended chronological lifespan under DR conditions, but most TCA cycle gene knockouts
showed even greater extension of lifespan than the wild-type yeast undergoing DR [65]. Yeast
mutants with increased lifespan had increased levels of TCA cycle metabolites [66]. A
downregulation of TCA cycle and ETC gene expression occurs in long-lived C. elegans dauer
larvae [19] while long-lived daf-2 insulin receptor mutants show either unchanged [19] or
decreased [67] TCA cycle gene expression with either unchanged [19] or increased [67] ETC
gene expression. Mutations in the Drosophila Indy gene [68], a sodium coupled TCA cycle
dicarboxylate and tricarboxylate carrier in the plasma membrane extend lifespan. Similar results
were found when two of the three C. elegans homologs of Indy were knocked down [69, 70]. But
others failed to replicate these findings [71]. Knockdown of the mouse homolog of Indy resulted
in DR-like phenotypes as well [72]. As a whole, there appears to be little consistency in these
observations in different experimental models. However, proper coordination between ETC
function and TCA function is likely necessary to maintain a normal to slightly high NAD/NADH
ratio conducive to long life. High TCA cycle function with low ETC function is not favorable for
extended lifespan because this would drive down mitochondrial and cellular NAD/NADH
slowing important NAD-driven reactions likely necessary for extended lifespan. As another
example, dietary restriction in mammals likely decreases flux through the TCA cycle while ETC
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function is maintained throughout lifespan, resulting in an increased NAD/NADH ratio in
several important tissues and lifespan extension.
3.4.8 Succinate as a blocker of DR-induced longevity
Since succinate, but not malate addition blocked lifespan extension in eat-2 worms, it is
possible that reduction of fumarate to succinate or maintaining a high FAD/FADH2 ratio is
essential for DR-induced longevity in C. elegans. Increased succinate levels likely decrease
fumarate reductase activity through product inhibition. However, since long-lived eat-2 worms
were shown to have a 21-fold increase in the rate of [2-14C] acetate oxidation as measured by
14

CO2 release [73], perhaps eat-2 worms increase both TCA cycle activity (at least the CO2

generating portion of the cycle) and fumarate reduction to extend lifespan. Interestingly,
proteomic experiments revealed that the glyoxylate cycle protein GEI-7 was down-regulated
slightly in eat-2 worms [73], while GEI-7 is upregulated in long-lived dauer and daf-2 worms
[19]. Therefore distinct metabolic programs may be activated to extend lifespan under these
different conditions.
3.4.9 Malate treatment has beneficial effects in mammals
Although we showed an important role for the glyoxylate shunt and malate dismutation,
metabolic pathways absent in mammals, in malate-mediated lifespan extension in C. elegans,
malate treatment has been shown to be very beneficial in mammals as well. Malate is found at
high concentrations in unripened fruit, most notably in apples, and may contribute to some of the
beneficial effects when these fruit are consumed. In addition, livers excised from aged rats that
had been administered malate for 30 days displayed increased activities of complexes I, III, and
IV of the electron transport chain (ETC) [74]. Malate also improved antioxidant function,
leading to increased superoxide dismutase, glutathione peroxidase, reduced glutathione, and
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decreased lipid peroxidation [75]. Malate supplementation also increased the activity of malateaspartate shuttle components [76]. However, malate had no effect on the decreased
mitochondrial membrane potential measured in aged rat liver [74]. Therefore, many of the
protective effects of malate treatment seem to be conserved from nematodes to mammals.
3.4.10 Conclusion
Malate and fumarate increased the lifespan of C. elegans, while succinate did not. The
glyoxylate shunt and malate dismutation/fumarate reduction pathways and SIR-2.1 were required
for malate-mediated lifespan extension. DAF-16 translocation to the nucleus and transcription of
DAF-16 target genes also plays an essential role in malate-mediated lifespan extension.
However, since succinate addition can also induce DAF-16 nuclear translocation without
lifespan extension, other factors are also involved. In this regard, further research should aim to
elucidate the mechanisms through which addition of malate and fumarate to the culture medium
lead to an uncoupling of mitochondrial oxidative phosphorylation and also determine if the
FAD/FADH2 ratio plays a role in lifespan determination. Since fumarate, malate, and
oxaloacetate extend lifespan in C. elegans through a mechanism similar to dietary restriction, an
anaplerotic cocktail of these compounds may be useful for the treatment of human agingassociated disorders.
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3.5 Supporting information

Figure 3.9. α-ketoglutarate addition did not alter the lifespan of C. elegans. C. elegans N2 worms were
grown in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change every 3 days
in the absence or presence of 10 mM α-ketoglutarate (log-rank p =0.21 vs. untreated control).

Figure 3.10. Aspartate addition did not alter the lifespan of C. elegans. C. elegans N2 worms were grown
in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change every 3 days in the
absence or presence of 10 mM aspartate (log-rank p = 0.57 vs. untreated control).
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Figure 3.11. Malate and fumarate increased the lifespan of hif-1 mutant worms. C. elegans hif-1(ia4)
worms were grown in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change
every 3 days in the absence or presence of 10 mM malate (log-rank p < 0.001 vs. untreated control) or 10
mM fumarate (log-rank p =0.02 vs. untreated control).

Figure 3.12. Glyoxylate addition did not alter the lifespan of C. elegans. C. elegans N2 worms were
grown in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change every 3 days
in the absence or presence of 10 mM glyoxylate (log-rank p =0.35 vs. untreated control).
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CHAPTER 4
MECHANISMS OF AMINO ACID-MEDIATED LIFESPAN EXTENSION IN
CAENORHABDITIS ELEGANS2
4.1 Abstract
Little is known about the role of amino acids in cellular signaling pathways, especially as
it pertains to pathways that regulate the rate of aging. However, it has been shown that
methionine or tryptophan restriction extends lifespan in higher eukaryotes and increased proline
or tryptophan levels increase longevity in C. elegans. In addition, leucine strongly activates the
TOR signaling pathway, which when inhibited increases lifespan.
Therefore each of the 20 proteogenic amino acids was individually supplemented to C.
elegans and the effects on lifespan were determined. All amino acids except phenylalanine and
aspartate extended lifespan at least to a small extent at one or more of the 3 concentrations tested
with serine and proline showing the largest effects. 11 of the amino acids were less potent at
higher doses, while 5 even decreased lifespan. Serine, proline, or histidine-mediated lifespan
extension was greatly inhibited in eat-2 worms, a model of dietary restriction, daf-16/FOXO, sir2.1, rsks-1 (ribosomal S6 kinase), gcn-2, and aak-2 (AMPK) longevity pathway mutants and in
bec-1 autophagy-defective knockdown worms. 8 of 10 longevity-promoting amino acids tested
activated a SKN-1/Nrf2 reporter strain, while serine and histidine were the only amino acids
from those to activate a hypoxia-inducible factor (HIF-1) reporter strain. Thermotolerance was
increased by proline or tryptophan supplementation, while tryptophan-mediated lifespan
2
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extension was independent of DAF-16/FOXO and SKN-1/Nrf2 signaling, but tryptophan and
several related pyridine-containing compounds induced the mitochondrial unfolded protein
response and an ER stress response. High glucose levels or mutations affecting electron transport
chain (ETC) function inhibited amino acid-mediated lifespan extension suggesting that
metabolism plays an important role. Providing many other cellular metabolites to C. elegans
also increased longevity suggesting that anaplerosis of tricarboxylic acid (TCA) cycle substrates
likely plays a role in lifespan extension.
Supplementation of C. elegans with 18 of the 20 individual amino acids extended
lifespan, but lifespan often decreased with increasing concentration suggesting hormesis.
Lifespan extension appears to be caused by altered mitochondrial TCA cycle metabolism and
respiratory substrate utilization resulting in the activation of the DAF-16/FOXO and SKN-1/Nrf2
stress response pathways.
4.2 Background
In C. elegans nematodes free amino acid concentrations change with age [1] and are
altered in long-lived worms [2]. In humans, altered plasma amino acid concentrations are
biomarkers of several diseases [3] such as type 2 diabetes [4]. Calorie restriction has long been
known to delay aging [5] and protein restriction may be responsible for around half of this effect
[6]. Methionine [7, 8] or tryptophan [9, 10] restriction partially mimics protein restriction to
extend lifespan and delay aging-related disease in rodents. But the role that other amino acids
play in longevity and disease has been harder to elucidate. In this regard, experiments with yeast,
worms, and fruit flies are increasingly being used to address this issue.
Using the yeast Saccharomyces cerevisiae, it was first discovered that supplementation
with the branched chain amino acids (leucine, isoleucine, or valine) or threonine extended
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chronological lifespan by downregulating the general amino acid control (GAAC) pathway [11].
Others found that glutamate supplementation extended chronological lifespan [12]. Consistent
with the ability of glutamate to extend lifespan, deletion of genes involved in converting
glutamate to gamma-aminobutyric acid (GABA) increased replicative lifespan [13] and led to
increased conversion of glutamate to alpha-ketoglutarate and other TCA cycle intermediates,
which may be involved in lifespan extension by maintaining mitochondrial respiratory function.
Others using different conditions found that supplementation with serine, threonine, or valine
decreased chronological lifespan [14] while limitation of asparagine [15], methionine, aspartate,
or glutamate [12] extended lifespan. Further research using yeast deletion strains of differing
lifespans found that intracellular levels of many amino acids positively correlated with lifespan
[16].
In Drosophila, dietary restriction (DR) or protein restriction [17] extends lifespan and
supplementing methionine in combination with one or more of the essential amino acids
decreased the lifespan back to the fully fed level [18]. Interestingly, adding methionine by itself
to DR flies increased protein translation [19] and fecundity [18] without decreasing lifespan,
uncoupling these events. Increased levels of amino acids, especially leucine [20, 21], activate the
TOR kinase, which leads to an increased rate of translation. Inhibition of the TOR kinase with
rapamycin [22] or expressing a dominant negative p70-S6 kinase, a kinase downstream of TOR,
extended organismal longevity [23]. Metabolism of sulfur containing amino acids was shown to
be essential for DR-mediated longevity in Drosophila [19], but supplementation of cysteine or
methionine failed to extend lifespan in fully fed Drosophila [24, 25]. However, supplementing
casein and methionine together led to lifespan extension [24].
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In C. elegans, proline supplementation extended lifespan that relied upon its catabolism
and a transient increase in reactive oxygen species (ROS) production from the mitochondrial
electron transport chain [26]. Increased tryptophan levels also increased longevity in C. elegans
as knockdown of an enzyme that catabolizes tryptophan increased lifespan [27]. Unexpectedly,
knockdown of an aromatic amino acid transporter also extended lifespan [28], suggesting that
decreased tryptophan or other aromatic amino acid levels may also boost longevity. Others found
that decreased tyrosine degradation led to increased longevity, but surprisingly supplementation
of tyrosine to the culture medium did not extend lifespan [29]. The majority of amino acid pool
sizes are upregulated in long-lived worms [2]. In daf-2 insulin-receptor deficient worms, for
example, the levels of 8 of the 12 measured amino acids were increased, including the 3
branched chain amino acids. The branched chain amino acids are of special interest for longevity
research, since their levels decreased to wild-type levels in the normal-lived daf-2/daf-16 double
mutants [2].
Feeding mice a diet high in branched chain amino acids led to increased mitochondrial
biogenesis in muscle, decreased ROS production, and increased average lifespan of males [30].
However, branched chain amino acid levels declined in long-lived metformin-treated worms
[31], and increased plasma levels of branched chain amino acids are correlated with the
development of insulin resistance and type 2 diabetes in humans [32]. Furthermore, studies
correlating high levels of free amino acids with longevity must be interpreted with caution as a
decreased rate of translation is frequently associated with or even required for longevity and the
increased amino acid pools may just be a result of that decreased rate of protein synthesis [33,
34].
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Due to the incomplete knowledge of the effects of amino acids on longevity as well as the
widespread use of amino acid and protein supplementation in the human diet we determined the
effects of individual amino acid supplementation on C. elegans lifespan. We found that the vast
majority of amino acids extended lifespan and further determined many of the signaling
pathways required. We then tested the ability of several amino acids or tryptophan catabolites to
induce a heat shock response, the ER stress response, or the mitochondrial unfolded protein
response, which frequently accompany lifespan extension. The amino acids that extended
lifespan to the greatest extent were then tested for effects on stress resistance and proteotoxicity.
4.3 Results
4.3.1 The effects of individual L-amino acids on the lifespan of C. elegans
We determined the effects of individually supplementing the 19 L-amino acids or glycine
on the lifespan of C. elegans at 1 mM (Figure 4.1A), 5 mM (Figure 4.1B), and 10 mM (Figure
4.1 C) concentrations. The percent change of mean lifespan compared to that of untreated
controls performed at the same time is also shown as a table. C. elegans worms were grown in
liquid S medium with heat-killed E. coli as food. Heat killing prevented or at least greatly
reduced bacterial catabolism of the added amino acid. Unlike nematode growth medium (NGM)
which is standardly used, the S medium contains no peptone, so the bacterial food source and the
supplemented amino acid are the only sources of dietary amino acids. The worms feeding on
heat-killed bacteria had a mean lifespan of 17.2 +/- 0.3 days. At a 1 mM concentration, the
amino acids that extended lifespan to the greatest extent (14-17%) were proline, leucine,
glutamine, glutamate, and tryptophan. At a 5 mM concentration, the greatest lifespan extension
was observed with proline, serine, cysteine, and glutamine (16-19%). At this concentration
phenylalanine decreased lifespan (8%). Lastly, at a 10 mM concentration, the greatest increases
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in longevity were observed with serine, proline, arginine, and methionine addition (14-22%).
Asparagine, aspartate, phenylalanine, glutamine, and glutamate decreased lifespan at this
concentration (6-25%). 5 of the amino acids increased lifespan with increasing concentration
from 1 to 10 mM (arginine, histidine, methionine, threonine, and serine), while 7 of the amino
acids decreased lifespan with increasing concentration in this range (aspartate, glutamate,
glycine, phenylalanine, tryptophan, tyrosine, and valine). 3 of the amino acids had the greatest
lifespan extension at the 5 mM concentration (asparagine, cysteine, and glutamine), while the 5
mM concentration yielded the least lifespan extension for alanine. Example lifespan curves for
serine, proline, histidine, and tryptophan at concentrations that yielded the greatest effects on
mean lifespan are shown.
4.3.2 The rate of amino acid uptake may limit the effect on lifespan
To determine if the rate of transport of amino acids into the worms may have limited their
effects on lifespan, we administered the cell-permeable histidine analogs N-acetyl-histidine or
histidine methylester, which get cleaved by intracellular enzymes to form histidine and
monitored lifespan (Table 4.1). These compounds yielded greater lifespan extension than
histidine at the 1 mM dose, suggesting that the rate of transport of the amino acids into the
worms is likely limiting their effect on lifespan. The highest concentration of histidine methyl
ester (10 mM) did not extend lifespan as expected for a hormetic dose response. If the same
observation made for histidine holds for other amino acids, then the rate of amino acid
absorption by the intestine may be an important factor controlling their ability to extend lifespan.
The rate of transport of hydrophilic antioxidant compounds into C. elegans has also been shown
to limit their effect on lifespan [35].
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4.3.3 The effects of D-amino acids on the lifespan of C. elegans
To determine if the effects on lifespan were specific for L-amino acids, we also
determined if there were effects on longevity when supplementing the 4 D-amino acids found
endogenously in C. elegans [36], D-alanine, D-serine, D-aspartate, or D-glutamate (Table 4.1) as
well as D-proline (Table 4.1), which is found naturally at low concentrations in mammals [37].
D-alanine and D-asparatate showed greater lifespan extension then their corresponding Lisomers. D-glutamate addition yielded effects on lifespan somewhat similar to its corresponding
L-isomer. In contrast to the strong pro-longevity effects observed with L-serine, D-serine
supplementation did not lead to lifespan extension at any of the concentrations added and even
slightly decreased lifespan at the higher concentrations. And lastly, D-proline supplementation
did not extend lifespan as well. These lifespan results are consistent with metabolism of the Damino acids being required for lifespan extension as D-alanine, D-aspartate, and D-glutamate are
present in the E. coli food source and have been shown to be catabolized by the products of the
C. elegans genes daao-1, ddo-1, and ddo-3, respectively. D-serine was not found to be present in
the E. coli diet, but was instead found to be synthesized endogenously by C. elegans. However,
no C. elegans enzyme has yet been found to mediate D-serine [36] or D-proline degradation.
4.3.4 Amino acid-mediated lifespan extension, except for tryptophan, is DAF-16 dependent
To determine if lifespan extension induced by amino acids requires specific longevity
pathways, individual amino acids were administered to mutants of known longevity pathways at
the concentration that maximally extended lifespan. First, the amino acids alanine, cysteine,
glutamine, histidine, lysine, proline, serine, tryptophan, and tyrosine were individually
supplemented to short-lived daf-16(mgDf50) mutants (Table 4.2). DAF-16/FOXO is a central
transcription factor that translocates to the nucleus to activate a stress response program in
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insulin-receptor signaling-deficient worms [38]. Tryptophan was the only supplemented amino
acid that extended lifespan in the daf-16 mutant strain indicating tryptophan activates a longevity
pathway independent of daf-16, while the other 8 amino acids require DAF-16 mediated gene
expression for the increased longevity. Cysteine and histidine even decreased lifespan when
supplemented to this strain.
To confirm that amino acids activate DAF-16 transcriptional activity, we measured the
fluorescence of a sod-3p::gfp DAF-16 reporter strain of worms following culture in the presence
of individual amino acids (Figure 4.2A). As expected from the lifespan data, serine and proline
increased fluorescence of these worms. The presence of tryptophan also increased fluorescence,
so tryptophan likely activates both DAF-16-dependent and DAF-16-independent pathways for
lifespan extension. There was also a strong trend for leucine to increase fluorescence.
Unexpectedly, histidine did not increase expression of sod-3p::gfp. The reasons for this finding
are unclear as we found that DAF-16 was required for histidine-mediated lifespan extension.
4.3.5 Most amino acids activate SKN-1 transcriptional activity
The SKN-1/Nrf2 signaling pathway increases cellular antioxidant and detoxification gene
expression to extend lifespan. We determined the effect of serine, tryptophan, histidine, or
proline addition on lifespan of skn-1 knockdown worms. As shown in Table 4, tryptophan or
serine supplementation extended lifespan, but not to the extent as in control worms, while there
were only insignificant trends toward increased lifespan following histidine or proline addition.
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Figure 4.1. Individual supplementation of most amino acids extends mean lifespan in C. elegans. Mean
lifespan of C. elegans supplemented with a (A) 1 mM, (B) 5 mM, or (C) 10 mM concentration of each of
the 20 amino acids (* log rank p < 0.05 vs. control).
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Table 4.1 The effects of D-amino acids and membrane-permeable L-histidine analogs on C.
elegans N2 lifespan.
Treatment

Concentration

D-alanine

1 mM
5 mM
10 mM

D-aspartate

1 mM
5 mM
10 mM

D-glutamate

1 mM
5 mM
10 mM

D-serine

1 mM
5 mM
10 mM

D-proline

5 mM

N-acetyl-L-histidine

0.1 mM
1 mM
10 mM

L-histidine methyl ester

0.1 mM
1 mM
10 mM

% of
untreated
mean lifespan

p-value

# of
worms

Replicates

114

<0.001

219

116

<0.001

273

116

<0.001

240

107

0.024

233

2

118

<0.001

269

108

<0.001

228

2
2

114

<0.001

207

118

<0.001

249

2

97

0.165

232

2

100

0.600

209

2

91

<0.001

198

2

93

<0.001

220

2

101

0.734

113

2

103

0.383

142

2

112

0.002

188

2

110

0.008

196

2

108

<0.001

215

2

109

<0.001

246

2

104

0.11

193

2

2
2
2

2
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Table 4.2. The effects of amino acids on lifespan in daf-16 mutant and skn-1 knockdown C.
elegans
Strain

Treatment

% of N2
mean
lifespan

daf-16(mgDf50)

control

73

N2

(skn-1

% of
untreated
mean
lifespan

p-value

# of
worms

Replicates

<0.001

608

7

5 mM histidine

92

<0.001

286

2

5 mM proline

106

0.0871

133

2

1 mM alanine

102

0.111

107

2

1 mM tryptophan

118

0.008

183

2

10 mM serine

105

0.104

161

2

10 mM glutamine

95

0.107

125

2

5 mM cysteine

95

0.107

115

2

10 mM cysteine

81

<0.001

105

2

5 mM tyrosine

96

0.578

140

2

5 mM lysine

99

0.907

130

2

<0.001

156

3

control

59

RNAi) with live

1 mM tryptophan

107

0.042

125

3

bacteria

10 mM serine

107

0.01

175

3

5 mM histidine

103

0.296

139

3

5 mM proline

105

0.088

111

2

298

5

N2

with

bacteria

live

control

-

1 mM tryptophan

109

<0.001

317

5

10 mM serine

109

<0.001

375

5

5 mM histidine

110

<0.001

277

5

5 mM proline

108

<0.001

268

4

105

Figure 4.2. The effects of amino acid addition on DAF-16, SKN-1, and HIF-1-mediated gene expression.
(A) The effects of amino acid addition on sod-3p::GFP fluorescence as a measure of DAF-16
transcriptional activity. (B) and (C) The effects of amino acid addition on gst-4p::GFP fluorescence as a
measure of SKN-1 transcriptional activity. (D) and (E) The effects of amino acid addition on nhr57p::GFP fluorescence as a measure of HIF-1 transcriptional activity. 20 µM potassium cyanide was
used as a positive control (* p < 0.05).

To further check the ability of amino acids to activate SKN-1, we used a gst-4p::GFP SKN-1
reporter strain of worms (Figure 4.2B and Figure 4.2C). We found that 8 of the 10 amino acids
tested that increased lifespan increased GFP expression of the reporter strain. Amino acids that
activated gst-4p::GFP expression included serine, proline, glutamine, alanine, leucine, lysine,
and tyrosine, while tryptophan and cysteine did not. We also tested the effects of 2 amino acids,
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phenylalanine and asparagine, which decreased lifespan on the fluorescence of this reporter
strain and observed no induction of expression. Overall, there was a small correlation between
the amount of SKN-1 activity and the extent of lifespan extension as serine and proline extended
lifespan to the greatest extent and also increased fluorescence of the SKN-1 reporter strain to the
greatest extent. It has previously been hypothesized that proline catabolism transiently increases
ROS production that leads to SKN-1 activation [26]. Our results are consistent with this
hypothesis. Cysteine is a strong antioxidant and likely quenched ROS required for SKN-1
activation likely explaining the lack of activation by this amino acid.
The RNAi feeding experiments require live bacteria, while heat-killed bacteria were used
in all other lifespan experiments. It is possible that the live bacteria used in the SKN-1 RNAi
lifespan experiments metabolized the added amino acids dampening the degree of lifespan
extension. Therefore, we performed control experiments supplementing amino acids to C.
elegans feeding on live control HT115(DE3) E. coli. C. elegans fed live control bacteria had a
mean lifespan of 16.1 +/- 0.2 days, slightly less than worms fed heat-killed bacteria (mean
lifespan of 17.2 +/- 0.3 days). Histidine extended lifespan to a similar extent in the presence of
live or heat-killed bacteria as shown (Table 4.2). However, tryptophan-induced lifespan
extension was slightly blunted by the use of live bacteria, and serine or proline-induced lifespan
extension was blunted by roughly 50% by the use of live bacteria. A faster rate of E. coli
catabolism of serine and proline than tryptophan and histidine likely explain these observations.
4.3.6 Histidine and serine increase HIF-1 target gene expression
The hypoxia-inducible factor-1 (HIF-1) protein is degraded quickly during standard
conditions, but is stabilized during hypoxia or by other specific stresses to increase lifespan in C.
elegans [39]. Therefore, we tested the HIF-1 reporter strain nhr-57p::GFP [39] for amino acid-
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induced changes in GFP fluorescence (Figure 4.2D and Figure 4.2E). Cyanide was used as a
positive control as it inhibits cytochrome c oxidase, the protein complex which binds molecular
oxygen, the terminal electron acceptor in the electron transport chain, to mimic the effects of
hypoxia on mitochondria. We found that histidine or serine increased fluorescence, while
tryptophan, proline, tyrosine, alanine, cysteine, glutamine, lysine, or leucine did not. These data
indicate that stabilization of HIF-1 may be one of the mechanisms through which histidine and
serine extend lifespan, although lifespan experiments with HIF-1 mutant worms are needed to
confirm this hypothesis.
4.3.7 Amino acid-mediated lifespan extension is AAK-2 (AMPK) dependent
Next we individually administered C. elegans our test set of 10 amino acids except
leucine to aak-2(gt33) worms, which are depleted of one of the two catalytic subunit of AMPactivated protein kinase (AMPK) and performed lifespan analysis (Table 4.3). AMPK signaling
inhibits target of rapamycin (TOR) kinase signaling to stimulate autophagy to recycle cellular
components. AMPK also stimulates the sirtuin deacetylase SIR-2.1, SKN-1/Nrf2, and DAF16/FOXO pro-longevity pathways [40]. None of the amino acids extended lifespan in this mutant
strain. Tyrosine decreased lifespan while the other 8 amino acids tested had no significant effect.
Therefore, AAK-2 is required for the longevity benefits provided by the amino acids.
4.3.8 Many amino acids require SIR-2.1 for lifespan extension
Next the effects of individual supplementation of these same 9 amino acids as well as
phenylalanine on lifespan of the sir-2.1(ok434) NAD-dependent sirtuin deacetylase mutant were
determined (Table 4.3). Small to moderate lifespan increases occurred with cysteine, glutamine,
lysine, and low dose phenylalanine supplementation, but there were no significant effects of 6
other amino acids tested on the lifespan of this strain. Therefore SIR-2.1 was required for
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lifespan extension mediated by slightly more than half of the amino acids tested. Surprisingly,
high dose (10 mM) phenylalanine supplementation did not lead to a decreased lifespan in this
strain as it did in the N2 control worms.
4.3.9 Amino acids do not significantly extend lifespan in long-lived DR worms
Restricting a specific amino acid such as methionine from the diet can be utilized to
extend lifespan and gain some of the benefits of dietary restriction (DR) [8], but there is not
much evidence that specific amino acid supplementation can yield enhanced longevity effects.
Therefore, we administered individual amino acids to eat-2(ad1116) mutants that are dietarily
restricted and long-lived because of reduced pharyngeal pumping. The non-treated control eat-2
mutants had a mean lifespan 44% longer than N2 controls indicating that our control worms
were not dietarily restricted under our growth conditions. None of the 5 amino acids tested
yielded statistically significant lifespan extension (Table 4.3). However, 4 of the amino acids
yielded strong trends toward lifespan extension (p-values between 0.08 and 0.10). Therefore the
individual amino acids are likely utilizing some portion of the DR signaling pathway for lifespan
extension.
4.3.10 Autophagy is required for the lifespan extension induced by serine, proline, or
histidine supplementation, but not by tryptophan
Since autophagy has been shown to be required for DR-mediated lifespan extension [41],
we determined if autophagy was also required for amino acid-mediated longevity. To block
autophagy we knocked down bec-1, the C. elegans Beclin-1 homolog and monitored lifespan
following supplementation with serine, proline, histidine, or tryptophan.
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Table 4.3. The effects of amino acids on lifespan in aak-2, sir-2.1 and eat-2 mutant and bec1 knockdown worms

% of N2
% of
control
Strain

# of

Treatment

untreated

p-value

mean

Replicates
worms

mean lifespan
lifespan
aak-

control

2(gt33)

5 mM histidine

80

<0.001

786

8

100

0.877

189

2

5 mM proline

100

0.919

187

2

1 mM alanine

100

0.943

209

2

1 mM tryptophan

102

0.060

220

2

10 mM serine

101

0.137

204

2

5 mM lysine

87

0.373

180

2

5 mM cysteine

85

0.952

140

2

10 mM cysteine

90

0.122

145

2

5 mM tyrosine

80

<0.001

200

2

5 mM glutamine

94

0.436

180

2

10 mM glutamine

103

0.126

200

2

<0.001

299

4

sir-

control

86

2.1(ok434)

5 mM histidine

100

<0.830

154

2

5 mM proline

104

0.211

114

2

1 mM alanine

98

0.225

165

2

1 mM tryptophan

102

0.673

121

2

10 mM serine

101

0.482

136

2

10 mM glutamine

110

<0.001

180

2

5 mM cysteine

105

0.244

192

2

10 mM cysteine

110

<0.001

190

2

5 mM tyrosine

93

0.231

131

2

5 mM lysine

107

0.017

146

2

1 mM phenylalanine

105

0.049

155

2

110

Table 4.3 (Continued)
% of N2
% of
control
Strain

# of

Treatment

untreated

p-value

mean

Replicates
worms

mean lifespan
lifespan
10 mM phenylalanine

101
142

0.402

176

2

<0.001

135

2

eat-

control

2(ad1116)

10 mM serine

108

0.078

161

2

1 mM tryptophan

105

0.099

138

2

5 mM glutamine

100

0.841

134

2

5 mM histidine

106

0.091

153

2

5 mM proline

107

0.076

176

2

<0.001

184

2

N2 (bec-1

control

RNAi)

1 mM tryptophan

107

<0.001

162

2

10 mM serine

101

0.316

152

2

5 mM histidine

99

0.274

117

2

5 mM proline

98

0.09

102

2

with

live

bacteria
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Knockdown of bec-1 by RNAi feeding increased lifespan as has previously been shown
in [42] and prevented lifespan extension induced by supplementation with serine, proline or
histidine, but not by tryptophan (Table 4.3).Therefore, the majority of amino acids, but not
tryptophan, require autophagy for lifespan extension, once again suggesting that tryptophan
extends lifespan through a mechanism distinct from other amino acids.
The PHA-4/FOXA transcription factor is required for induction of autophagy and
lifespan extension in response to DR. In addition, expression of the PHA-4 transcription factor
has been shown to be upregulated by roughly 50% by DR [43]. Therefore, we determined if
individual amino acid administration could increase PHA-4 protein levels by using a strain of
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worms engineered to express PHA-4:GFP:3xFLAG using the endogenous pha-4 promoter [44].
Surprisingly, we found that serine, histidine, or tryptophan addition did not alter the GFP
fluorescence of this strain. However, leucine addition resulted in a strong trend toward increased
fluorescence (p=0.08). On the whole, individual amino acid supplementation did not appear to
have much of an effect on fluorescence in this strain. However, we cannot yet rule out the
possibility that changes in PHA-4 localization or post-translational modification play a role in
individual amino acid-induced longevity. It is also possible that the added GFP and FLAG tags
affect the stability of the protein. Lifespan studies using pha-4 RNAi are needed to determine a
role, if any, for PHA-4 in amino acid-mediated lifespan extension.
4.3.11 Inhibition of TOR signaling plays a role in amino acid-mediated lifespan extension
Specific amino acids, most notably leucine, but also to a lesser extent arginine and glutamine can
be activators of the TOR signaling pathway that limits lifespan [45]. Administering rapamycin, a TOR
inhibitor, or feeding TOR RNAi to C. elegans induces autophagy and extends lifespan [46, 47]. More
recently it was found that alpha-ketoglutarate supplementation can lead to TOR inhibition to extend
lifespan [48]. Knockout or knockdown of the ribosomal S6 kinase, which is downstream of TOR kinase
in the signaling pathway, also extends lifespan [49]. Part of this effect may rely on a decreased rate of
protein translation as inhibitors of protein translation can also extend lifespan [49]. Therefore, we
determined the effects of specific amino acids on lifespan in long-lived rsks-1(ok1255) ribosomal S6
kinase mutants, where this arm of the TOR signaling pathway is inhibited (Table 4). Unlike the results

with N2 control worms, addition of serine or tryptophan did not alter the lifespan of this strain,
while proline or histidine addition slightly decreased lifespan, and tryptophan addition decreased
lifespan by 20%. Therefore, these amino acids appear to use inhibition of TOR signaling to
mediate lifespan extension, as the amino acids did not extend lifespan in long-lived mutant
worms where TOR signaling was already disrupted.
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4.3.12 A decreased rate of translation is required for the full lifespan extending effects of
amino acids
GCN-2 (general control nonderepressible-2) kinase can slow the rate of translation
initiation by phosphorylating eukaryotic translation initiation factor-2 alpha (eIF-2α) when
tRNAs become uncharged due to low amino acid levels [34] or in times of mitochondrial
metabolic stress [33]. We hypothesized that amino-acid supplementation causing amino acid
imbalance could result in inefficient tRNA charging or cause metabolic stress signaling through
GCN-2 to extend lifespan. Therefore, we determined the lifespan of gcn-2(ok871) mutants
supplemented with individual amino acids (Table 4.4). We found that histidine or tryptophan
supplementation did not lead to increased longevity when using this strain, while only a 4% or
7% lifespan extension occurred when serine or proline, respectively, were supplemented. To
further determine a role for decreased translation in amino acid imbalance-mediated longevity,
we performed lifespan analysis using the ife-2(ok306) strain [50], which is deficient in an
isoform of the translation initiation factor eIF4E and shown to be long-lived. Surprisingly, under
our liquid culture conditions using heat-killed bacteria as food, the lifespan of this strain was not
significantly different than the control. However, supplementation of serine, proline, histidine, or
tryptophan to this strain did not lead to extended lifespan, while tryptophan addition even
slightly decreased lifespan. Therefore signaling to slow the rate of translation is likely a general
mechanism involved in individual amino acid-mediated increased longevity.
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4.3.13 The effect of individual amino acids on the lifespan of mitochondrial ETC complex I
and II mutants
To test the hypothesis that mitochondrial ETC activity is important for amino-acid
induced lifespan extension we supplemented serine, histidine, or proline to either short-lived
mitochondrial ETC complex I defective gas-1(fc21) mutant worms or to short-lived
mitochondrial ETC complex II defective mev-1(kn1) mutant worms (Table 4.4). We found that
proline supplementation extended the lifespan of gas-1 mutants, but that serine or histidine were
unable to extend lifespan, although there was a strong trend with histidine (p=0.09). When we
supplemented each of these 3 amino acids to mev-1 mutants, we found opposite effects. Proline
did not extend lifespan, although a strong trend was observed (p=0.10), while serine and
histidine extended lifespan. Therefore normal complex I (NADH dehydrogenase) activity is
required for the full serine and histidine-mediated lifespan extension, while normal complex II
activity is required for proline-mediated lifespan extension. This data may be explained in that
proline dehydrogenase generates FADH2 which feeds electrons into the ETC at complex II and
histidine and serine catabolism generates NADH that feeds electrons into the ETC at complex I.
4.3.14 Most supplemented metabolites extended lifespan at an optimal concentration
Since supplementation with an optimal concentration of most amino acids extended the
lifespan of the worms, it is possible that their breakdown to TCA cycle intermediates may play a
role in lifespan extension. It has previously been shown that supplementation with pyruvate [51],
acetate (that can be readily metabolized to the TCA cycle substrate acetyl-CoA) [52], or the TCA
cycle intermediates malate, fumarate [53], oxaloacetate [54], and alpha-ketoglutarate [48]
extended lifespan in C. elegans. We therefore determined the lifespan of the worms individually
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supplemented with 1, 5, or 10 mM concentrations of the TCA cycle intermediates citrate,
isocitrate, alpha-ketoglutarate, or succinate (Table 4.1).
We previously found that 10 mM succinate did not extend lifespan, but did induce
translocation of the pro-longevity factor DAF-16 to the nucleus [53]. But here we find that
lowering the concentration of succinate to 5 mM or 1 mM resulted in lifespan extension (Figure
4.3A), consistent with a recent report of a longevity benefit [48]. Citrate is present at 10 mM in
all of our experiments as a standard buffer component of the S-medium.

We found that

removing it did not affect the lifespan (Figure 4.3B). Previous findings also failed to find an
extension of lifespan with citrate supplementation [48, 52]. We found that alpha-ketoglutarate at
any of the 4 concentrations tested from 0.1 to 10 mM extended lifespan (Figure 3C), as recently
reported for an 8 mM dose [48]. Adding DL-isocitrate to the medium led to an increase in
lifespan at the 5 mM concentration, but a decrease in lifespan at the 10 mM concentration
(Figure 4.3D). It is unknown if the non-naturally occurring L-isomer contributed to this effect,
but since we found the non-naturally occurring isomer D-malate to decrease lifespan at all 3
concentrations tested (Table 4.1), it is a strong possibility. Another group observed no effect of 8
mM isocitrate on lifespan [48]. Therefore, of the 7 TCA cycle intermediates that we have tested,
6 were able to extend lifespan at an optimal dose.
We hypothesized that catabolism of the amino acids for anaplerosis or energy production
was likely playing a role in the lifespan extension. If this is true supplementing other common
cellular metabolites should also extend lifespan. Therefore, we performed lifespan analysis of
worms supplemented with sugars or other metabolites lacking nitrogen atoms.
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Table 4.4 The effects of amino acids on lifespan of rsks-1, gcn-2, ife-2, gas-1, and mev-1
strain

treatment

% of
N2
control
mean
lifespan

rsks1(ok1255)

control

109

gcn-2(ok871)

Ife-2(ok306)

gas-1(fc21)

mev-1(kn1)

% of
untreated
mean
lifespan

p-value

# of
worms

replicates

<0.001

362

4

1 mM tryptophan

71

<0.001

130

2

5 mM histidine

93

0.031

135

2

5 mM proline

94

0.042

140

2

10 mM serine

101

0.236

162

2

<0.001

479

4

control

90

1 mM tryptophan

99

0.489

160

2

5 mM histidine

100

0.335

163

2

5 mM proline

107

0.001

205

2

10 mM serine

104

0.006

183

2

0.245

112

2

control

97

1 mM tryptophan

94

0.029

138

2

5 mM histidine

98

0.597

110

2

5 mM proline

102

0.352

117

2

10 mM serine

99

0.791

96

2

<0.001

119

2

control

69

5 mM histidine

104

0.092

110

2

10 mM serine

98

0.327

106

2

5 mM proline

109

0.003

115

2

<0.001

273

2

control

69

5 mM histidine

104

0.021

215

2

10 mM serine

109

<0.001

258

2

5m

102

0.102

256

2
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Table 4.5 The effects of TCA cycle intermediates on C. elegans lifespan
treatment

concentration

succinate

1 mM
5 mM
10 mM

citrate1

10 mM

α-ketoglutarate

0.1 mM
1 mM
5 mM
10 mM

DL-isocitrate

1 mM
5 mM
10 mM

D-malate

1 mM
5 mM
10 mM

% of
untreated
mean lifespan

p-value

# of
worms

replicates

111

<0.001

590

4

110

<0.001

570

4

104

0.098

607

4

98

0.414

229

2

110

<0.001

261

3

115

<0.001

345

3

111

<0.001

337

3

107

0.042

333

3

103

0.202

452

4

113

<0.001

523

4

72

<0.001

217

4

85

<0.001

106

1

76

<0.001

77

1

79

<0.001

142

1

1

compared to a medium lacking citrate. All other experiments contain 10 mM citrate as part of the
standard culture media.

Glucuronolactone, glyceraldehyde, fructose, propionate, or dihydroxyacetone did not
extend lifespan and the last 4 of these compounds even decreased lifespan by 13-25% at the 10
mM dose. Glyceraldehyde, fructose, and dihydroxyacetone are readily converted into glycolytic
intermediates leading to the formation of toxic methylglyoxyl from glyceraldehyde phosphate or
dihydroxyacetone phosphate, which could contribute to their toxicity, while propionic acid is
known to be neurotoxic at high levels [28]. Since many amino acids activated SKN-1, while
TCA cycle intermediates did not, we hypothesized that nitrogen-containing metabolites might be
slightly more potent inducers of lifespan extension. The effects of many nitrogen-containing
metabolites on lifespan are shown in 4.13. At an optimal dose carnosine, beta-alanine, betaine,
homocysteine, ornithine, agmatine, putrescine, taurine, and theanine extended lifespan.
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Figure 4.3. Individual supplementation of many TCA cycle metabolites extends mean lifespan in C.
elegans. (A) Succinate extends lifespan, (B) citrate does not extend lifespan, (C) alpha-ketoglutarate
extends lifespan, and (D) isocitrate extends lifespan at one or more of the concentrations tested. 10 mM
citrate is a standard component of the S-medium. It was removed to determine the effect of citrate on
lifespan.
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For the majority of these compounds, the lowest concentration, such as 1 mM, yielded
greater lifespan extension than the highest 10 mM concentration suggesting a hormetic dose
response. Supplementation with creatine, or the histidine catabolites histamine or urocanic acid
did not extend lifespan at any of the 3 concentrations tested. Although most of the nitrogencontaining compounds extended lifespan at an optimal dose, the extent of lifespan extension was
not noticeably different than when supplementing with compounds lacking nitrogen.
4.3.15 C. elegans lifespan was not limited by nitrogen availability
We used heat-killed E. coli as a food source to prevent the bacteria from metabolizing the
added metabolites, but we have found that heat-killing E. coli causes the loss of one or more
essential growth-limiting nutrients during heating. So lowering the concentration of heat-killed
bacteria in the growth media by just a factor of 2 did not allow completion of larval growth into
adulthood, but instead led to dauer formation. The concentration of live bacteria could be
reduced by 30-40 fold before dauer formation during larval development. To test if the worms
may have been nitrogen limited under our culture conditions, we supplemented the worms with
peptone or other nitrogen containing compounds and measured the lifespan. Interestingly,
peptone at 1.25 g/L, half the concentration present in nematode growth media (NGM) decreased
lifespan by 22% (Additional file 6: Table S3). This concentration contains roughly 10 mM total
amino acids. These results support published findings where 5 g/L (2x NGM) and 10 g/L (4x
NGM) peptone also decreased C. elegans lifespan in liquid S medium [55]. Lowering the
peptone concentration to 0.125 g/L (0.1x NGM) yielded a similar lifespan as untreated controls.
We next added ammonium chloride as a nitrogen source. Concentrations of ammonium
chloride from 1 to 10 mM did not extend lifespan. So amino acids do not increase lifespan solely
by providing nitrogen to the worms.
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4.3.16 Phenylalanine and alpha-ketoglutarate activate a HSF-1 reporter strain
Since supplementation of many of the amino acids and other metabolites showed less
lifespan extension at higher concentrations, we hypothesized that C. elegans mounted a stress
response that resulted in lifespan extension at lower amino acid levels, but at higher levels the
stress response was overwhelmed leading to decreased lifespan. Therefore, we determined if
amino acid supplementation activates a Phsp-16.2::GFP heat shock reporter strain of worms.
HSP-16.2 is a small cytoplasmic heat shock protein and target of the HSF-1 transcription factor
[56]. We first tested the effects of glutamine, histidine, methionine, serine, tryptophan, or
tyrosine, amino acids that extended lifespan, or phenylalanine, an amino acid that decreased
lifespan on GFP fluorescence in the Phsp-16.2::GFP reporter strain using heat shock as a
positive control (Figure 4.4 A). Of these amino acids, only phenylalanine activated GFP reporter
gene expression.
We next tested the effects of TCA cycle intermediate or pyruvate supplementation on the
Phsp-16.2::GFP reporter strain, as amino acids are broken down into TCA cycle intermediates
when they are present in excess. When administered to the Phsp-16.2::GFP reporter strain
alpha-ketoglutarate, but none of the other TCA cycle intermediates supplemented increased GFP
fluorescence (Figure 4.5A). Many of the amino acids showing the largest stimulatory effects on
lifespan (proline, arginine, histidine, glutamine, and glutamate) are catabolized through
glutamate into alpha-ketoglutarate in the TCA cycle.
4.3.17 Histidine, tryptophan, and citrate induce an ER stress response
We next determined if amino acids activated the endoplasmic reticulum (ER) stress
response by using a reporter strain of worms engineered to contain a heat shock protein-4 (hsp-4)
promoter driving expression of green fluorescent protein (GFP) [57]. We tested the effect of
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glutamine, histidine, methionine, serine, tryptophan, or tyrosine supplementation on expression
of GFP in the Phsp-4::GFP reporter strain of worms using heat shock as a positive control
(Figure 4.4B). Histidine and tryptophan induced GFP expression, methionine and glutamine
reduced GFP expression, while the other amino acids had no effect.
Subsequently we determined the effects of supplemented TCA cycle intermediates and
pyruvate on the Phsp-4::GFP ER stress response reporter strains of worms (Figure 4.5B).
Citrate activated Phsp-4::GFP reporter gene expression, and there was also a strong trend
(p=0.08) for increased expression with alpha-ketoglutarate, while the other TCA cycle
intermediates had no effect. Chelation of calcium or other metal ions is a possible mechanism as
to how some of these compounds or their metabolites activate ER stress.
4.3.18 Tryptophan induces the mitochondrial unfolded protein response
We further tested for activation of the mitochondrial unfolded protein response using
Phsp-6 and Phsp-60 reporter strains and ethidium bromide treatment as the positive control.
HSP-6 is the worm homolog of mammalian mitochondrial hsp-70, while HSP-60 is also
localized to the mitochondrion. Both mitochondrial heat shock proteins play a role in the
mitochondrial unfolded protein response, but this response is not always associated with
longevity [58]. For the Phsp-6::GFP reporter strain we tested glutamine, histidine, serine,
phenylalanine, and tryptophan (Figure 4.4C). We found phenylalanine and tryptophan to robustly
increase expression, while the other amino acids did not increase expression. We further tested
the effects of glutamine, histidine, phenylalanine, proline, serine, tryptophan, and tyrosine on
GFP expression in the Phsp-60::GFP reporter strain (Figure 4.4D). We found only tryptophan to
increase expression. There was also a strong trend for proline to increase expression (p=0.06),
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while serine slightly decreased expression. Overall, most amino acids do not rely upon the
mitochondrial unfolded protein response pathway for lifespan extension.
Next, we determined the effects of the TCA cycle intermediates and pyruvate on the
mitochondrial unfolded protein response reporter strains. None of the metabolites affected
expression of the Phsp-6::GFP reporter (Figure 4.5C), while pyruvate, succinate, and malate
slightly decreased expression of the Phsp-60::GFP reporter strain (Figure 4.5D). Overall, the
data suggest that TCA cycle intermediate supplementation does not require the mitochondrial
unfolded protein response pathway for lifespan extension.
4.3.19 Tryptophan metabolites nicotinic acid, nicotinamide, and picolinic acid induce both
ER stress and mitochondrial unfolded protein responses
Since tryptophan activated expression of the ER stress response and 2 mitochondrial
unfolded protein response reporter strains, we determined if one or more of its breakdown
products or structurally related metabolites could also induce these responses or activate
expression in the HSF-1 reporter strain. Therefore we added many of the tryptophan degradation
products or tryptophan-related cellular metabolites including serotonin, anthranilic acid, nicotinic
acid, nicotinamide, NAD, glutaric acid, kynurenic acid, quinolinic acid, and picolinic acid to the
HSF-1 reporter strain, the ER stress reporter strain, and the 2 mitochondrial unfolded protein
response reporter strains (Figure 6A-D). Strikingly, nicotinic acid activated expression of the
same ER stress response and mitochondrial unfolded protein response reporters as tryptophan,
while picolinic acid and nicotinamide activated expression of all 4 GFP reporter strains, although
activation of hsp-60::GFP by nicotinamide was low (p=0.07). Picolinic acid is an isomer of
nicotinic acid and an important endogenous metal chelator [59]. Quinolinic acid induced
expression of the 2 non-mitochondrial heat shock protein reporters. Therefore, we performed
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lifespan experiments adding 1 mM picolinic acid or 1 mM quinolinic acid to the culture medium
(Additional file 6: Table S3). Picolinic acid addition showed a trend (p=0.13) toward increased
lifespan. In contrast, quinolinic acid addition decreased worm lifespan by 26%, as might be
expected from its known neurotoxicity [60]. NAD precursors have previously been shown to
induce the mitochondrial unfolded protein response [61]. Here, we added a 0.1 mM dose of NAD
and found it to only activate expression of hsp-4, the marker of ER stress. Although tryptophan
metabolic byproducts could contribute to the protective effects of supplemental tryptophan,
others have shown data suggesting that tryptophan itself may be the protective metabolite in a C.
elegans model of alpha-synuclein toxicity [27].
4.3.20 Proline and tryptophan increase C. elegans thermotolerance
Amino acids could have induced expression of other heat shock or stress-inducible genes
to extend lifespan not assayed in our reporter experiments described above. Therefore, we
determined the effect of individual amino acid supplementation on the thermotolerance of C.
elegans. We supplemented the growth medium with glutamine, histidine, proline, serine, or
tryptophan and monitored the viability of the worms following transfer from 20°C to 35°C.
Proline provided a 30% increase in thermotolerance and tryptophan provided a 10% increase in
thermotolerance, while there was no significant effect of the other amino acids. The effect of
proline is not too surprising given that proline stabilizes proteins and membranes and is
overproduced to protect plants and some microorganisms from osmotic, salinity, and temperature
stresses [62].
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We next monitored the resistance to oxidative stress by monitoring the viability of worms
following administration of paraquat. Paraquat is an inducer of superoxide production through
redox cycling. None of the tested amino acids including proline, serine, histidine, tryptophan, or
leucine significantly protected the worm viability against this stress, although there was a strong
trend for protection with histidine (p=0.08).
4.3.21 Little effect of amino acid supplementation on Alzheimer’s amyloid-beta toxicity
Since many of the amino acids extended lifespan when they were supplemented to the
culture medium, we also determined if individual amino acid supplementation could delay
toxicity in C. elegans models of human neurodegenerative disorders. We first determined the
effects of serine, histidine, proline, tryptophan, or methionine supplementation on the rate of
paralysis development when the amyloid-beta peptide, which builds up in Alzheimer’s disease
brain, is expressed in worm body wall muscle from a temperature-inducible promoter [63].
Overall, amino acid supplementation only had a minimal effect on the rate of paralysis. We
found that serine (p=0.07) (Figure 4.7A) or histidine (p=0.05) (Figure 4.7B) supplementation
gave strong trends to delay muscle paralysis, while no significant effects were found with
proline, methionine, or tryptophan (Additional file 4.8).
4.3.22 Tryptophan protects from alpha-synuclein and polyglutamine toxicity
We next determined the effects of supplementation with histidine, proline, serine, or tryptophan
on alpha-synuclein aggregation in worms expressing an alpha-synuclein-green fluorescent
protein fusion (Figure 4.7C). Tryptophan was highly protective giving a 17% reduction in
aggregate fluorescence, while the other amino acids were without effect. We also tested the
effects of tryptophan, serine, and proline on aggregates formed from the expression of a
polyglutamine (Q35)–GFP fusion protein [64] (Additional file 4.9).
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Figure 4.4. The effects of amino acids on heat shock, mitochondrial unfolded protein response, and ER
stress response. Amino acids were added at the concentration tested that yielded maximal lifespan
extension except phenylalanine, which did not extend lifespan. (A) Phsp-16.2::GFP (B) Phsp-4::GFP
(C) Phsp-6::GFP (D) Phsp-60::GFP. For panels A and B heat shock at 35°C for 2 hours was used as a
positive control. For panels C and D 50 µg/ml ethidium bromide treatment for 2 days was used as a
positive control (* p < 0.05 vs. control).
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Figure 4.5. The effects of TCA cycle metabolites and pyruvate on heat shock, mitochondrial unfolded
protein response, and ER stress response. (A) Phsp-16.2::GFP (B) Phsp-4::GFP (C) Phsp-6::GFP (D)
Phsp-60::GFP (* p < 0.05 vs. control). For panels A and B heat shock at 35°C for 2 hours was used as a
positive control. For panels C and D 50 µg/ml ethidium bromide treatment for 2 days was used as a
positive control (* p < 0.05 vs. control).
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Figure 4.6. The effects of tryptophan metabolites on heat shock, mitochondrial unfolded protein
response, and ER stress response. (A) Phsp-16.2::GFP (B) Phsp-4::GFP (C) Phsp-6::GFP (D) Phsp60::GFP (* p < 0.05 vs. control). For panels A and B heat shock at 35°C for 2 hours was used as a
positive control. For panels C and D 50 µg/ml ethidium bromide treatment for 2 days was used as a
positive control (* p < 0.05 vs. control).
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Figure 4.7. Amino acids do not provide much protection in models of proteotoxicity. (A) Serine and (B)
histidine supplementation yield slight protection against muscle amyloid-beta toxicity. (C) Tryptophan
supplementation decreases alpha-synuclein aggregate fluorescence. (D) Amino acid supplementation
does not protect against TDP-43 toxicity.
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We found a strong trend toward a decreased number of aggregates with the addition of
tryptophan (p = 0.07), but no significant effect of the other two amino acids tested. It is not
surprising that tryptophan supplementation was protective in these C. elegans proteotoxicity
models as depletion of the TDO-2 enzyme that degrades tryptophan has been shown to increase
worm tryptophan levels and be protective in several worm models of proteotoxicity [27]. It was
also shown that tryptophan supplementation was able to increase the motility of Q40
polyglutamine expressing worms.
4.3.23 Alpha-ketoglutarate, but not amino acids, protects C. elegans expressing TDP-43
Tar DNA-binding protein-43 (TDP-43) is mostly a nuclear protein under normal
conditions, but cytoplasmic accumulation is associated with ALS and other neurodegenerative
diseases. Overexpression of TDP-43 leads to toxicity in C. elegans and is used as an ALS model.
We therefore tested if several amino acids including histidine, methionine, proline, serine, and
tryptophan could alter the reduced lifespan of TDP-43 overexpressing worms (Figure 4.7D and
Additional file 4.10). However, none of these amino acids protected against the reduced lifespan,
while histidine addition even further reduced the lifespan. But, we did find a protective effect of
alpha-ketoglutarate supplementation in this model, supporting data from a study in which alphaketoglutarate in combination with other metabolites was protective in the SOD1-G93A mouse
model of ALS [65].
4.3.24 Serine and tryptophan partially block lifespan reduction in high glucose culture
media
High glucose in the bloodstream is a marker of insulin resistance and diabetes and high
levels of glucose in C. elegans culture medium is known to reduce lifespan [66, 67]. Therefore
high glucose supplementation has been used as a model of diabetes in C. elegans. Since
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alterations of amino acid levels also accompany diabetes, we determined if select amino acids
could alter the decreased lifespan resulting from the addition of 50 mM glucose to the culture
medium. We found glucose addition decreased lifespan by 30 percent and that serine (Figure
4.8A) or tryptophan (Figure 4.8B) supplementation partially blocked lifespan reduction.
Histidine, proline, or tyrosine addition had no significant effect, while glutamine addition
decreased lifespan to a greater extent than glucose by itself.
4.3.25 Amino acid supplementation does not significantly alter C. elegans oxygen
consumption and ATP levels
Since amino acid supplementation may transiently increase ROS production for the
activation of SKN-1, we hypothesized that the added amino acids may be catabolized to increase
mitochondrial ETC function. Therefore we measured worm oxygen consumption and ATP
levels.However, we did not find significantly altered oxygen consumption or ATP levels
following addition of the individual amino acids serine, proline, histidine, tryptophan, leucine,
asparagine, or phenylalanine to the worms. Therefore, the supplemented amino acids are either
not being metabolized at a substantial rate or are being metabolized in replacement of respiratory
substrates present in the E. coli food source preventing an overall increase in metabolic rate.
4.4 Discussion
Individual supplementation with 18 of the 20 proteogenic amino acids at an optimal
concentration increased the lifespan of C. elegans. This metabolite-induced lifespan extension
was not specific for only amino acids as supplementation with TCA cycle intermediates and
many different classes of cellular metabolites also led to significant lifespan extension,
suggesting altered cellular metabolism or TCA cycle anaplerosis plays a prominent role.
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Figure4. 8. Serine or tryptophan partially prevent high glucose from reducing C. elegans lifespan. (A)
Serine extends C. elegans lifespan in the presence of high glucose (p < 0.001). (B) Tryptophan extends C.
elegans lifespan in the presence of high glucose (p < 0.001).

Of the 20 amino acids, serine and proline extended lifespan to the largest extent.
Strikingly, these and other top amino acids did not significantly extend the lifespan of long-lived
dietary restricted eat-2 mutants. If similar effects occurred in humans, imbalanced amino acid
diets could be developed as a dietary restriction mimetic to delay aging and aging-related
disease. In this regard a methionine restricted diet has been used clinically to treat metabolic
syndrome [68]. However, whether or not amino acid supplementation strategies will apply to
higher eukaryotes remains to be determined as individual supplementation of methionine failed
to extend the lifespan of fruit flies [24], while supplementation of methionine decreased the
lifespan of mice [69].

131

4.4.1 Individual amino acid supplementation may decrease the rate of translation to extend
lifespan
Most of the well-studied longevity pathways in C. elegans such as DAF-16, SKN-1,
AAK-2, SIR-2.1, and HIF-1 appear to be involved in the lifespan extension mediated by
histidine, serine, and proline, with the exception of the HIF-1 pathway for proline. However,
tryptophan extends lifespan in a SKN-1 and DAF-16 independent manner, although tryptophan
did increase fluorescence of a DAF-16 reporter strain of worms. These different longevity
pathways may converge to decrease the rate of translation by the ribosome for lifespan
extension. A small to moderate amount of amino acid imbalance could hinder correct aminoacyltRNA synthetase charging of tRNAs slowing the rate of translation in a GCN-2 dependent
manner to increase lifespan, while a higher amount of amino acid imbalance may lead to a toxic
reduction in translation rates decreasing lifespan. Previously, a decreased rate of translation has
been shown to be essential for lifespan extension in mitochondrial mutants [33], during TOR
inhibition, or during dietary restriction [34]. Furthermore, long-lived daf-2 mutants were also
shown to have a reduced rate of translation [70]. Reduced mitochondrial translation causing
mitonuclear protein imbalance has also been shown to lead to increased lifespan [71]. High rates
of translation during aging may overwhelm protein chaperone systems resulting in
proteotoxicity. Slowing translation or increasing heat shock protein activity may delay this
proteotoxicity to increase longevity.
The branched chain amino acid leucine most strongly activates TOR kinase, which can
increase the rate of translation and lead to decreased lifespan. Therefore, we were surprised to
find that supplementation with 1 mM leucine greatly increased lifespan. In fact, leucine was the
second most potent amino acid at this concentration for promoting longevity. Under our standard
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growth conditions TOR signaling may already be highly activated by amino acids present in the
bacterial food source and so may not be able to be further activated. Instead, we hypothesize that
leucine metabolism or the amino acid imbalance caused by excess leucine may have activated
other signaling pathways leading to TOR inhibition. In this regard, the lack of lifespan extension
by amino acids in rsks-1 mutants suggests that individual amino acid supplementation inhibits
TOR signaling to extend lifespan. Of the other two branched chain amino acids, valine
supplementation showed similar lifespan trends as leucine, even though it is not a potent inducer
of TOR activity, and isoleucine supplementation showed little effect on lifespan. At higher
concentrations, branched chain amino acids did not affect lifespan as much as at the lower
concentrations. Therefore, high levels of branched chain amino acids do not always directly
correlate with lifespan extension. Consistent with this hypothesis, decreased levels of branched
chain amino acids were found in long-lived Ames dwarf mice [72]. However, amino acid
imbalance cannot explain the increased longevity conferred upon supplementation with many
other diverse cellular metabolites. Therefore, TCA cycle anaplerosis leading to a reprogramming
of mitochondrial metabolism may be the molecular mechanism responsible for lifespan
extension.
4.4.2 NAD precursors and tryptophan induce the ER stress response and the mitochondrial
unfolded protein response
Another significant finding in this report is that supplementation with tryptophan,
nicotinamide, nicotinic acid, or its isomer picolinic acid resulted in the activation of both the
mitochondrial unfolded protein and the ER stress response pathways, while NAD addition
induced only the ER stress response. In mouse muscle and heart, decreased nuclear NAD levels
with aging cause a hypoxia inducible factor-1α (HIF-1α)-induced decrease in mitochondrial
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transcription leading to mitochondrial dysfunction that was reversed by supplementation with an
NAD precursor [73]. In addition to reversing this aging-induced mitochondrial dysfunction,
supplementing NAD precursors (or tryptophan) can further protect cells by inducing an ER stress
response and a mitochondrial unfolded protein response, although it has already been shown that
NAD precursors induce a mitochondrial unfolded protein response [61]. Picolinic acid is a strong
metal chelator that is frequently taken with chromium as a possible treatment for metabolic
syndrome, although the efficacy of this treatment has been questioned [74]. But picolinic acid
itself has been shown to be neuroprotective [59]. It will be important to determine if the
protective effects of picolinic acid are due to metal chelation and if picolinic acid, nicotinic acid,
and nicotinamide also induce the ER stress response or mitochondrial unfolded protein response
in mammalian cells.
4.4.3 Is catabolism of amino acids important for their longevity effects?
The catabolism of supplemented amino acids likely mediates their effects on longevity,
but there are likely exceptions to this rule. We were surprised to find no increase in oxygen
consumption or ATP levels as markers of increased metabolism when amino acids were added to
the culture medium. It was previously shown that proline catabolism and the resulting transient
increase in ROS production by the electron transport chain were essential for its pro-longevity
effects [26]. Most other amino acids may also be metabolized to emit a transient ROS signal
leading to SKN-1 dependent lifespan extension. Possible evidence for this includes that enzymes
for proline, tryptophan, phenylalanine, glutamine, and D-alanine degradation are upregulated in
long-lived daf-2 insulin receptor mutant worms [26], where SKN-1 is also activated [75].
However, alpha-ketoglutarate-mediated lifespan extension was shown to be independent of ROS
production [48]. Therefore more downstream TCA cycle catabolites such as alpha-ketoglutarate,
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succinate, malate, and fumarate extend lifespan through SKN-1independent, but DAF-16
dependent mechanisms [53]. In addition, cysteine and tryptophan-induced lifespan extension
were independent of SKN-1, so supplementation with these amino acids did not likely alter
mitochondrial metabolism to increase ROS production. Consistent with this, knockdown of the
tryptophan 2,3-dioxygenase (TDO-2) enzyme that degrades tryptophan led to increased lifespan
and increased tryptophan levels, but no changes in the levels of many of the downstream
metabolites of tryptophan degradation suggesting that increased tryptophan levels and not altered
levels of the catabolic byproducts were responsible for the increased lifespan and protection from
proteotoxicity [27].
Future studies will aim to determine the metabolic mechanisms through which amino
acids activate SKN-1 activity and through which serine and histidine activate HIF-1. For
example, enzyme knockdown studies using RNAi may be used to determine whether serine
catabolism is required for serine-mediated lifespan extension, as serine can be directly
deaminated to pyruvate, which extends lifespan [51]. However, serine can also be used as a onecarbon donor for methylation events such as histone methylation, which can alter gene
expression patterns leading to increased longevity as well [76].
4.4.4 TCA cycle metabolism and longevity
Different amino acids are catabolized and enter the TCA cycle through different
intermediates of the cycle. We did not find that the amino acids yielding the greatest effects on
lifespan were degraded through one common catabolic pathway. Additional file 13: Figure S7,
Additional file 14 Figure S8, and Additional file 15: Figure S9 show the specific TCA cycle
intermediate into which each of the amino acids is catabolized and how lifespan was affected by
1 mM, 5 mM, and 10 mM amino acid concentrations, respectively. As mentioned previously, the
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only trend in the data set is that amino acids broken down into alpha-ketoglutarate yielded larger
than average lifespan extensions. However, this cannot explain the large lifespan extension
induced by serine addition, which is catabolized to pyruvate. Surprisingly, we previously
discovered that malate or fumarate supplementation increased total pyridine (NAD + NADH)
nucleotide levels and also induced mild mitochondrial uncoupling increasing the NAD/NADH
ratio, both of which may have been involved in the lifespan extension induced by these TCA
cycle intermediates [53]. Catabolism of other metabolites may result in similar effects.
Knockdown of mitochondrial aconitase or a subunit of mitochondrial NAD-dependent
isocitrate dehydrogenase increased lifespan in C. elegans [77]. The increased longevity of these
mutants is likely due in part to decreased flux through this portion of the TCA cycle leading to
increased NAD levels, which has been shown to extend lifespan [78]. The isocitrate
dehydrogenase and alpha-ketoglutarate dehydrogenase enzymes reduce mitochondrial NAD to
NADH. Citrate supplementation may not increase lifespan due to the increased flux through this
portion of the TCA cycle leading to a decrease in NAD levels, although in the cytoplasm citrate
is metabolized to acetyl-CoA that has been shown to inhibit autophagy, which can also prevent
lifespan extension [79]. However, isocitrate supplementation would also not be expected to
increase longevity as its normal metabolism is predicted to lower NAD levels. However, there is
also an NADP-dependent isocitrate dehydrogenase isoform present that may help prevent
declines in NAD levels and allow for isocitrate-mediated lifespan extension at least in a narrow
range of concentrations.
It is possible that supplementation with amino acids broken down into alphaketoglutarate may extend lifespan by running isocitrate dehydrogenase in the opposite direction
of its normal mode to oxidize NADH to NAD while alpha-ketoglutarate and carbon dioxide are
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metabolized into isocitrate. Some cancer cells have been shown to use this metabolism when
oxidizing glutamine as a primary energy substrate [80]. The citrate produced from isocitrate is
then exported to the cytoplasm where acetyl-CoA and oxaloacetate are formed by ATP citrate
lyase. This metabolic flexibility in TCA cycle metabolism may be required for specific amino
acid and TCA cycle metabolite-mediated longevity and is a hypothesis for future testing, as
running the TCA cycle in the reverse of its normal direction was shown to be needed for malate
and fumarate-mediated lifespan extension [53].
4.4.5 Glycolysis as a lifespan shortening metabolic pathway in C. elegans
Since supplementation with glucose and other glycolytic precursors decrease lifespan in
C. elegans as shown here and in [66, 67], there are likely specific metabolic pathways such as
glycolysis that decrease lifespan. We propose that many of the supplemented metabolites that
increased lifespan are catabolized by mitochondria to increase TCA cycle metabolite levels. The
DAF-16/FOXO longevity pathway has been shown to be activated by increased TCA cycle
metabolite levels [53]. So the TCA cycle appears to be lifespan-extending metabolic pathway in
C. elegans. In addition increased TCA cycle flux could also transiently increase mitochondrial
ETC ROS production to activate the SKN-1 longevity pathway as previously suggested [26].
This metabolite oxidation for energy production would also decrease reliance on lifespanshortening glycolysis as a source of mitochondrial respiratory substrates.
4.4.6 Refinements in C. elegans culture media for lifespan experiments by limiting peptone
levels and using heat-killed bacteria during adulthood
When performing lifespan experiments, sources of stress should be removed from the
environment, so control animal lifespan is not limited. Unfortunately when working with C.
elegans, this has proven difficult due to the slight toxicity of their live E. coli food source. We
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and others [55] have also found that the peptone present in nematode growth media (NGM) also
induces a type of stress that decreases lifespan. It is unclear which component of peptone
decreases lifespan as it contains not only proteolyzed proteins (amino acids and oligopeptides),
but also fats, metals, salts, vitamins, and other compounds. Because of the slight toxicity
associated with the use of peptone and live E. coli, we chose to perform C. elegans lifespan
experiments using heat-killed E. coli in liquid S-medium, which lacks peptone. Due to partial
degradation of one or more nutrients in the E. coli food source needed for larval development
during the heat-killing treatment, it may be advantageous, especially in certain mutant
backgrounds, to treat the worms with live E. coli during larval development to ensure adequate
nutrition, and then switch them to heat-killed E. coli during adulthood to prevent the bacteria
from metabolizing added nutrients. Further refinements in experimental methods will allow C.
elegans to become an even more valuable model for investigating the effects of altered
metabolism on lifespan.
4.5 Conclusions
Individual amino acid supplementation increased the lifespan of C. elegans and increased
stress resistance with serine, proline, and tryptophan showing the greatest effects. Many
longevity pathways including DAF-16, SKN-1, AAK-2, SIR-2.1, GCN-2, heat shock, autophagy,
DR, and inhibition of TOR signaling are involved in these protective effects. Anaplerosis and
altered mitochondrial metabolism transiently increasing ROS production to activate SKN-1
appear to be involved in the longevity signaling. The exact pathways involved vary slightly from
one amino acid to the next. For example, serine and histidine stimulated transcriptional activity
of HIF-1, while 6 other amino acids did not. Likewise 8 lifespan-extending amino acids
increased the transcriptional activity of SKN-1, but not tryptophan, cysteine, or the lifespan-
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decreasing amino acids phenylalanine and asparagine. Uniquely, tryptophan activated the ER
stress response and mitochondrial unfolded protein response pathways and lifespan extension
was independent of SKN-1 and DAF-16. Future experiments will aim to develop an improved
axenic medium that can be used to determine the effects of amino acid restriction on the lifespan
of C. elegans. Through the use of both amino acid supplementation and restriction, a diet may
one day be developed that can substantially increase stress resistance and slow aging and the
onset of aging-associated disorders.
4.6 Supporting information
Table 4.6 The effect of amino acid supplementation on C. elegans lifespan

Amino acid

% of
control
mean
lifespan

n

# of
worms

p-value

108

3

264

0.015

104

3

277

0.305

Strain

Concentration

N2

1 mM

N2

5 mM

N2

10 mM

111

3

274

0.003

N2

1 mM

108

4

428

0.007

N2

5 mM

111

4

412

<0.001

N2

10 mM

115

4

438

<0.001

N2

1 mM

101

3

350

0.331

N2

5 mM

105

3

319

0.032

N2

10 mM

75

3

297

<0.001

N2

1 mM

103

3

477

0.15

N2

5 mM

100

3

495

0.052

N2

10 mM

94

3

544

0.001

N2

1 mM

109

2

200

0.029

N2

5 mM

116

2

190

<0.001

N2

10 mM

102

2

195

0.513

N2

1 mM

114

2

156

0.005

N2

5 mM

111

2

191

0.034

N2

10 mM

92

2

172

0.005

N2

1 mM

115

2

184

0.002

alanine

arginine

asparagine

aspartate

cysteine

glutamate

glutamine
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Table 4.6 (Continued)

Amino acid

% of
control
mean
lifespan

n

# of
worms

p-value

Strain

Concentration

N2

5 mM

116

2

196

0.002

N2

10 mM

94

2

214

0.001

N2

1 mM

110

3

321

0.008

N2

5 mM

103

3

298

0.538

N2

10 mM

96

3

327

0.09

N2

1 mM

104

3

338

0.155

N2

5 mM

109

3

269

<0.001

N2

10 mM

112

3

282

<0.001

N2

1 mM

103

3

344

0.079

N2

5 mM

103

3

290

0.066

N2

10 mM

103

3

360

0.033

N2

1 mM

116

2

265

<0.001

N2

5 mM

106

2

238

0.042

N2

10 mM

107

2

240

0.032

N2

1 mM

107

4

562

<0.001

N2

5 mM

108

4

583

<0.001

N2

10 mM

106

4

547

<0.001

N2

1 mM

104

2

160

0.094

N2

5 mM

108

2

162

0.002

N2

10 mM

114

2

148

<0.001

N2

1 mM

97

2

167

0.491

N2

5 mM

92

2

165

<0.001

N2

10 mM

88

2

164

<0.001

N2

1 mM

117

3

369

<0.001

N2

5 mM

119

3

322

<0.001

N2

10 mM

118

3

329

<0.001

N2

1 mM

108

5

495

<0.001

N2

5 mM

118

5

501

<0.001

N2

10 mM

122

5

607

<0.001

N2

1 mM

100

3

317

0.901

N2

5 mM

103

3

326

0.179

N2

10 mM

108

3

279

<0.001

N2

1 mM

114

3

289

<0.001

106

3

234

0.003

glycine

histidine

isoleucine

leucine

lysine

methionine

phenylalanine

proline

serine

threonine

tryptophan
N2

5 mM
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Table 4.6 (Continued)

Amino acid

% of
control
mean
lifespan

n

# of
worms

p-value

Strain

Concentration

N2

10 mM

101

3

203

0.643

N2

1 mM

110

2

198

<0.001

N2

5 mM

105

2

186

0.001

N2

10 mM

102

2

168

0.014

N2

1 mM

113

3

338

0.155

N2

5 mM

108

3

269

<0.001

N2

10 mM

99

3

282

<0.001

tyrosine

valine

Figure 4.9. Example lifespan curves for several amino acids that strongly extended lifespan in C.
elegans. (A) serine, (B) proline, (C) tryptophan, and (D) histidine. Concentrations chosen for display were
those that stimulated lifespan extension to the greatest extent (log rank p < 0.001).

141

Figure 4.10. Supplementation of several D-amino acids found endogenously in C. elegans extends
lifespan. (A) D-alanine, B) D-aspartate, or C) D-glutamate extended lifespan at one or more of the
concentrations tested (log rank p < 0.05), while (D) D-serine supplementation did not extend lifespan at
any of the concentrations tested.

Figure 4.11. The effect of amino acids on the fluorescence of a pha-4p::gfp:pha-4 reporter strain of C.
elegans. ( * p < 0.05)
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Table 4.7 The effect of sugars and other metabolites lacking nitrogen on C. elegans lifespan
Treatment

p‐value

# of worms

Replicates

1 mM ribose
5 mM ribose
10 mM ribose

% of N2
control
mean
lifespan
109
109
101

<0.001
<0.001
0.726

333
345
377

3
3
3

10 mM glycerol

121

<0.001

134

1

1 mM dihydroxyacetone
10 mM dihydroxyacetone

77
75

<0.001
<0.001

275
269

2
2

1 mM glyceraldehyde
10 mM glyceraldehyde

74
87

<0.001
<0.001

113
186

1
1

1 mM inositol
10 mM inositol

103
117

0.0397
<0.001

220
235

1
1

10 mM xylose

106

0.038

133

1

1 mM galactose
10 mM galactose

101
106

0.887
0.0349

296
250

2
2

1 mM gluconate
5 mM gluconate
10 mM gluconate

108
117
116

0.0263
<0.001
<0.001

127
124
120

1
1
1

1 mM glucuronolactone
5 mM glucuronolactone
10 mM glucuronolactone

102
103
103

0.717
0.829
0.831

290
300
310

1
1
1

1 mM propionate
5 mM propionate
10 mM propionate

85
87
82

<0.001
<0.001
<0.001

104
106
110

1
1
1

1 mM fructose
10 mM fructose

96
86

0.010
<0.001

251
233

2
2

1 mM phosphoenolpyruvate
5 mM phosphoenolpyruvate
10 mM phosphoenolpyruvate

112
112
108

<0.001
<0.001
0.002

180
170
149

1
1
1

0.01 mM caprylate
0.1 mM caprylate
1 mM caprylate
5 mM caprylate

101
107
95
82

0.356
0.019
0.001
0.001

192
165
186
165

2
2
2
2

1 mM DL‐lactate
5 mM DL‐lactate
10 mM DL‐lactate

103
106
102

0.35
0.03
0.62

213
220
189

1
1
1
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Table 4.8 The effects of nitrogen containing metabolites on C. elegans lifespan
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Figure 4.12. Thermotolerance and paraquat-induced toxicity. (A) Proline or tryptophan supplementation
increases thermotolerance in C. elegans. (log rank p < 0.001) Serine, histidine, or glutamine
supplementation did not significantly affect thermotolerance. (B) Amino acid supplementation did not
significantly delay paraquat-induced toxicity. However, there was a strong trend toward protection with
histidine (p=0.08), but no effect with serine, proline, tryptophan, or leucine.

145

Table 4.9 The effects of amino acids on amyloid-beta-induced muscle paralysis

Figure 4.13. Tryptophan slightly decreased polyglutamine aggregates in C. elegans. The GFP
fluorescence of five worms placed side by side are shown in each photo. There were on average 7 less
aggregates in tryptophan treated worms than in controls (p = 0.07).
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Table 4.10 The effects of amino acids on lifespan in human TDP-43 transgenic C. elegans

Table 4.11 The effects of amino acids on C. elegans lifespan in the presence of 50 mM
glucose.
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Figure 4.14. Amino acid supplementation did not significantly alter C. elegans oxygen consumption or
ATP levels. A) The amount of oxygen in the medium following a 30 minute incubation in the well of an
Oxoplate. B) ATP levels.
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Figure 4.15. Metabolism and effects on lifespan of a 1 mM dose of amino acids. A diagram of the TCA
cycle metabolites to which the 20 amino acids are catabolized is shown. It is also shown how
supplementation of a 1 mM concentration of the amino acids or some of the TCA cycle metabolites
affected C. elegans lifespan.

Figure 4.16. Metabolism and effects on lifespan of a 5 mM dose of amino acids. A diagram of the TCA
cycle metabolites to which the 20 amino acids are catabolized is shown.
It is also shown how
supplementation of a 5 mM concentration of the amino acids or some of the TCA cycle metabolites
affected C. elegans lifespan.
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Figure 4.17. Metabolism and effects on lifespan of a 10 mM dose of amino acids. A diagram of the TCA
cycle metabolites to which the 20 amino acids are catabolized is shown. It is also shown how
supplementation of a 10 mM concentration of the amino acids or some of the TCA cycle metabolites
affected C. elegans lifespan.
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CHAPTER 5
D-BETA-HYDROXYBUTYRATE EXTENDS LIFESPAN IN C. ELEGANS3
5.1 Abstract
The ketone body beta-hydroxybutyrate (βHB) is a histone deacetylase (HDAC) inhibitor
and has been shown to be protective in many disease models, but its effects on aging are not well
studied. Therefore we determined the effect of βHB supplementation on the lifespan of C.
elegans nematodes. βHB supplementation extended mean lifespan by approximately 20%.
RNAi knockdown of HDACs hda-2 or hda-3 also increased lifespan and further prevented βHBmediated lifespan extension. βHB-mediated lifespan extension required the DAF-16/FOXO and
SKN-1/Nrf longevity pathways, the sirtuin SIR-2.1, and the AMP kinase subunit AAK-2. βHB
did not extend lifespan in a genetic model of dietary restriction indicating that βHB is likely
functioning through a similar mechanism. βHB addition also upregulated ΒHB dehydrogenase
activity and increased oxygen consumption in the worms. RNAi knockdown of F55E10.6, a
short chain dehydrogenase and SKN-1 target gene, prevented the increased lifespan and βHB
dehydrogenase activity induced by βHB addition, suggesting that F55E10.6 functions as an
inducible

βHB

dehydrogenase.

Furthermore,

βHB

supplementation

increased

worm

thermotolerance and partially prevented glucose toxicity. It also delayed Alzheimer’s amyloidbeta toxicity and decreased Parkinson’s alpha-synuclein aggregation. The results indicate that DβHB extends lifespan through inhibiting HDACs and through the activation of conserved stress
response pathways.
3

This chapter have been previously published in Aging, 2014, 6(8): 621–644 and have been
reproduced with permission from Aging
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5.2 Introduction
Aging leads to a progressive decline of cell and tissue function and is the primary risk
factor for many ailments, including the prevalent neurodegenerative disorders Alzheimer’s
disease (AD) and Parkinson’s disease (PD). Mitochondria are the central hub of cellular
metabolism and mitochondrial dysfunction, especially in stem cells [1], has been shown to cause
the development of premature aging phenotypes in mice [2]. Paradoxically, slight inhibition of
mitochondrial respiration can also lead to small increases in reactive oxygen species (ROS)
production and extend the lifespan of yeast, C. elegans, Drosophila, and mice [3-6]. Even in
young animals, roughly 0.15% of electrons passing through the mitochondrial electron transport
chain (ETC) combine with molecular oxygen to form superoxide [7, 8]. Mitochondrial ROS
production increases with age and leads to progressive damage of cellular macromolecules as
outlined in the mitochondrial free radical theory of aging [9].
Dietary restriction (DR) increases the lifespan of many organisms including C. elegans
[10]. As interest in the molecular mechanisms responsible for the effect of DR on lifespan have
expanded, so has the discovery of the pathways involved and the search for DR mimetic
compounds that promote survival and stress resistance [11, 12]. The ketone body betahydroxybutyrate (βHB) has been described as a DR mimetic compound [13], in part because it
increases in the plasma during DR and when administered exogenously leads to decreased levels
of oxidative stress [14]. In mammals, βHB is produced in the liver, primarily from the catabolic
breakdown of fatty acids, and is used as an alternative energy source when blood glucose is low.
This is especially important in the brain where only a very limited amount of fatty acid betaoxidation takes place [15]. In mitochondria βHB is catabolized to acetoacetate by βHB
dehydrogenase 1 (BDH1). The reaction is linked to the reduction of NAD to NADH, which fuels
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mitochondrial ETC complex I. The resulting acetoacetate is catabolized to acetoacetyl-CoA and
then to acetyl-CoA, which is metabolized as part of the TCA cycle. The βHB dehydrogenase 2
(BDH2) enzyme localizes to the cytoplasm, but no changes in ketone body metabolism were
found in BDH2 knockout mice suggesting BDH2 plays a limited role, if any, in ketone body
metabolism [16].
Researchers are investigating DR mimetics not only for their possible lifespan extending
capabilities, but also for their potential ability to delay the onset and progression of ageassociated diseases such as AD. [17, 18]. Phenotypes of AD brain include extracellular senile
plaques containing Aß peptide as well as intracellular neurofibrillary tangles consisting of
hyperphosphorylated tau protein [19]. Intracellular Aß can inhibit mitochondrial ETC complex
IV and increase ROS production [20]. βHB has shown some efficacy in the protection against
AD-mediated neurodegeneration in animal models and human trials. βHB protected cultured
hippocampal neurons from Aß

1–42

toxicity [21]. βHB or a ketogenic diet has shown mixed

effects on disease phenotypes in mouse models of AD. For example in one study, a ketogenic
diet lowered Aß levels, but did not affect cognitive impairment [22]. In another study a ketogenic
diet improved motor function, but did not affect cognition or tau or Aß pathology [23]. However,
a further study found that supplementation of βHB methyl ester to AD mice was able to restore
cognitive function and decrease Aß levels, likely due to the fact that the methyl ester is
transported through the blood-brain barrier more efficiently than the free acid [24]. There is also
evidence for the clinical use of ketone bodies to treat neurodegenerative disorders as oral
ingestion of medium chain triglycerides, which are catabolized in part to ketone bodies,
increased plasma levels of βHB and led to improved cognitive function in human patients with
AD [25].

159

PD, another aging-associated disorder, is characterized by an accumulation of Lewy
bodies in the substantia nigra region of the brain. The alpha-synuclein protein is a major
component of Lewy bodies and can also localize to mitochondrial membranes [26] causing
decreased ETC complex I activity with an accompanying increase in ROS production [27]. This
may be partly responsible for the increased mitochondrial oxidative damage that has been
observed in brains from autopsied PD patients [28, 29]. βHB has also been shown to be
efficacious in several animal models of PD. Mice treated with βHB showed partial protection
against neurodegeneration and motor deficiency induced by the neurotoxin 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP), which induces PD-like symptoms [30]. Additionally, βHB
protected cultured neurons from toxicity induced by the structurally related ETC complex I
inhibitor 1-methyl-4-phenylpyridinium (MPP(+)) [21]. In human clinical trials, PD patients
treated with a ketogenic diet for one month improved their Unified Parkinson’s Disease Rating
Scale scores by a mean of 43% [31].
Although much is known about the effects of βHB on neurodegenerative and other agingassociated diseases, not much is known about its effects on aging. Moreover, the mechanisms
through which βHB are protective are not entirely clear. However, recent evidence suggests that
βHB protects against oxidative stress through its action as a class I and class IIa histone
deacetylase inhibitor to increase expression of stress response genes such as FoxO3A and MT2
[14]. In this report we determined the effect of βHB on lifespan in C. elegans and determined the
cytoprotective signaling pathways required for this effect. We then determined the effects of
βHB on proteotoxicity in nematode models of AD, PD, and amyotrophic lateral sclerosis (ALS).
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5.3 Results
5.3.1 D-beta-hydroxybutyrate extends the lifespan of C. elegans
Addition of 2, 10, or 20 mM DL-beta-hydroxybutyrate (βHB) to the culture medium of
C. elegans feeding on heat-killed E. coli increased lifespan with 20 mM having the greatest
effect, increasing mean lifespan by 26%, from 17.2 to 21.7 days (Figure 5.1A). 50 mM and 100
mM concentrations decreased lifespan. Therefore a 20 mM concentration was used in further
experiments. When C. elegans were fed live E. coli, 20 mM βHB only extended mean lifespan
by 14%, from 16.0 to 18.3 days. This is likely due to catabolism of a portion of the βHB by the
bacteria. To determine if the lifespan extension was due to D-βHB or L-βHB, we performed
lifespan experiments with each isomer separately and found that only D-βHB addition resulted in
lifespan extension (Figure 5.1B).

Figure 5.1. D-βHB extends the lifespan of N2 C. elegans worms. (A) Concentration dependency of βHBmediated extension of lifespan. (B) D-βHB, but not L-βHB addition led to lifespan extension. When no D
or L prefix is present, βHB refers to DL-βHB.
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5.3.2 βHB or butyrate individually, but not when combined, extend the lifespan of C.
elegans
The histone deacetylase (HDAC) inhibitors sodium butyrate and valproic acid have been
shown to extend lifespan in C. elegans [32, 33]. Since βHB has a similar chemical structure as
butyrate and since βHB has been shown to inhibit class I and IIa histone deacetylases (HDACs 1,
3, and 4) in mammals with a Ki of 2-5 mM [13], we determined if βHB could further extend the
lifespan of sodium butyrate treated worms. As shown in Figure 2A, and as previously found by
others [33], sodium butyrate extended lifespan, but strikingly the combination of sodium butyrate
and βHB led to a slightly decreased lifespan. This data is consistent with the possibility that βHB
is functioning as an HDAC inhibitor as HDAC inhibitors such as valproic acid are known to
cause decreased lifespan at higher concentrations in C. elegans ([32]. The combination of
sodium butyrate and βHB likely has an additive inhibitory effect on HDAC activity, thereby
decreasing lifespan. βHB addition also decreased the lifespan of worms treated with valproic
acid (Supplementary Table 5.1), likely through a similar mechanism.
5.3.3 Inhibition of HDA-2 and HDA-3 play a role in βHB-mediated lifespan extension
Many general HDAC inhibitors inhibit both class I and class II HDAC enzymes [13, 34].
The C. elegans genome has 3 class I HDACs, hda-1, hda-2, and hda-3. In addition there are 5
class II HDACs, hda-4, hda-5, hda-6, hda-10, and hda-11, with hda-4 being the only member of
class IIa [35]. To determine if HDAC inhibition plays a role in βHB-mediated lifespan extension,
we knocked down the 3 class I HDACs in C. elegans by RNAi in the presence or absence of
βHB and determined the effect on lifespan. RNAi knockdown of hda-1 had no effect on lifespan
and βHB addition extended lifespan, but to a lesser extent than in the absence of knockdown
(Fig. 5.2B). However, RNAi knockdown of either hda-2 (Fig. 5.2C) or hda-3 (Fig. 5.2D)
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extended C. elegans lifespan, by 13% and 16% respectively, and prevented βHB from further
extending lifespan. Therefore βHB likely extends lifespan in part through inhibition of hda-2 and
hda-3. We also performed lifespan analysis using hda-2(ok1479), hda-3(ok1991), hda-4(ok518),
and hda-10(ok3311) mutant worms (Supplementary Figure 5.9 A-D). All of the HDAC mutant
strains had roughly 30% decreased mean lifespans indicating that a partial knockdown, but not
full knockout of HDA-2 or HDA-3 activity promotes lifespan extension. Consistent with the
RNAi knockdown results, βHB addition did not extend the lifespan of the hda-2 or hda-3 mutant
animals. However, βHB addition did lead to lifespan extension in the hda-4 and hda-10 mutants,
suggesting βHB primarily extends lifespan through inhibiting the class I HDACs in C. elegans.
5.3.4 F55E10.6 is likely a D-βHB inducible βHB dehydrogenase gene
There is no strong homolog of human mitochondrial BDH1 in C. elegans. However, a
BLASTP search identified 4 candidate genes with 38-41% protein sequence identity with BDH1
(dhs-2, dhs-20, dhs-16 (a 3-hydroxysteroid dehydrogenase [36]), and F55E10.6 (similar to
human microsomal retinol dehydrogenase [37] and hydroxysteroid dehydrogenases [38]). DHS2, DHS-16, and DHS-20 have been predicted to have a mitochondrial localization [39] like
BDH1, however DHS-20 has also been predicted to have an ER localization [40] as has
F55E10.6 [41]. Therefore, we knocked down each of the 4 candidates individually in the worms
grown in the absence or presence of D-βHB and measured D-βHB dehydrogenase activity in the
worm extracts. None of the knockdowns showed decreased basal D-βHB dehydrogenase activity.
However, we found that adding D-βHB to the growth medium resulted in a 2-fold increase in DβHB dehydrogenase activity and knockdown of F55E10.6 largely prevented this increased DβHB dehydrogenase activity (Fig. 5.3A), suggesting that F55E10.6 likely encodes the D-βHB
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inducible D-βHB dehydrogenase activity. Knockdown of either dhs-2 or dhs-16 increased the
ability of D-βHB to upregulate D-βHB dehydrogenase activity.

Figure 5.2. βHB-mediated HDAC inhibition plays a role in lifespan extension. (A) Survival of N2
worms in the presence of βHB, butyrate, or both compounds together. (B) Effects of hda-1, (C) hda-2, or
(D) hda-3 RNAi knockdown on C. elegans lifespan in the presence or absence of 20 mM βHB.
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We also found that adding L-βHB to the culture medium resulted in a roughly 3-fold
increase in D-βHB dehydrogenase activity in the worm extracts that was independent of the
expression of F55E10.6, dhs-2, dhs-16, or dhs-20 (Figure 5.3B), suggesting L-βHB induces a
separate D-βHB dehydrogenase enzyme. Consistent with this data, when worms were cultured
with a racemic mixture of 20 mM βHB (DL-βHB) we found an almost additive 4.5-fold increase
in D-βHB dehydrogenase activity (data not shown).
We also measured L-βHB dehydrogenase activity in the worm extracts (Supplementary
Figure 2). There was roughly 5-fold lower basal L-βHB dehydrogenase activity than D-βHB
dehydrogenase activity in the worm extracts (data not shown). Adding D-βHB to the culture
medium yielded a roughly 50% increase in L-βHB dehydrogenase activity in control worm
extracts that was almost completely blocked by RNAi knockdown of F55E10.6. Therefore, the
F55E10.6 βHB dehydrogenase activity can likely utilize either D-βHB or L-βHB as substrates,
but the activity with D-βHB appears roughly 10-fold higher than with L-βHB. Interestingly,
knockdown of dhs-2, dhs-16, or dhs-20 decreased basal L-βHB dehydrogenase activity in the
extracts (Supplementary Figure 5.10). Determining whether any of these genes play a direct role
in L-βHB metabolism, or if a gene encoding an enzyme with L-βHB dehydrogenase activity is
down-regulated by knockdown of these genes awaits further investigation.
5.3.5 F55E10.6 is required for βHB-mediated longevity
To determine if βHB-mediated upregulation of F55E10.6 was essential for the effect of
βHB on longevity, lifespan was monitored in worms in which expression of F55E10.6 was
knocked down by RNAi feeding. RNAi knockdown of F55E10.6 increased lifespan by 7% and
unexpectedly completely prevented lifespan extension induced by βHB supplementation (Figure
5.4A). F55E10.6 is a SKN-1 transcriptional target [42].
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Figure 5.3. D-βHB dehydrogenase activity in worm extracts following RNAi-mediated gene knockdown.
(A) D-βHB dehydrogenase activity following worm culture in the absence or presence of 10 mM DβHB. Conditions in the legend refer to the culture conditions. The genes F55E10.6, dhs-2, dhs-16, or dhs20 were knocked down by RNAi feeding (* p < 0.05 compared to Control + 10 mM D-βHB; # p < 0.05
compared to Control). (B) D-βHB dehydrogenase activity following worm culture in the absence or
presence of 10 mM L-βHB. The assay conditions were the same as panel A (# p < 0.05 compared to
Control).
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SKN-1 is a homolog of mammalian Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)
and a transcriptional regulator that induces the expression of genes involved in antioxidant
defense and xenobiotic metabolism to promote longevity. Therefore, addition of βHB to the
culture media activates SKN-1, which induces expression of F55E10.6. F55E10.6 could either
metabolize βHB or metabolize another endogenous substrate leading to lifespan extension.
It is possible that metabolism of βHB, either dependent or independent of F55E10.6, is
required for lifespan extension. This increased βHB metabolism may increase TCA cycle and
electron transport chain (ETC) activity increasing ROS production, which has been shown to
lead to lifespan extension in C. elegans [43]. Therefore we determined if administration of the
antioxidant and glutathione precursor N-acetylcysteine (NAC) prevented the lifespan extension
induced by βHB. As shown in Figure 5.4B, NAC by itself moderately increased lifespan, but
NAC supplementation did not prevent lifespan extension mediated by βHB. Therefore, βHB is
likely extending lifespan through a mechanism that does not require increased ROS production.
5.3.6 Knockdown of F55E10.6 does not prevent the βHB-mediated increase in oxygen
consumption
Since F55E10.6 expression was essential for βHB-mediated lifespan extension, we
wished to determine if supplemented βHB was being utilized as a respiratory substrate by the
worms and whether knocking down F55E10.6 would decrease βHB-induced respiratory
metabolism. Therefore, we determined the effect of βHB supplementation on worm oxygen
consumption (Figure 5.4C). βHB supplementation increased oxygen consumption by 2.3 fold
indicating that βHB is being metabolized by the worms. Unexpectedly, we found that RNAi
knockdown of F55E10.6 in the absence of βHB also increased oxygen consumption by around
2.3 fold, suggesting that F55E10.6 represses mitochondrial biogenesis or respiratory function.
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Figure 5.4. F55E10.6 is required for βHB-mediated lifespan extension, but not for βHB-induced oxygen
consumption. (A) Treatment with βHB did not increase the lifespan of N2 worms fed RNAi to F55E10.6.
(B) The addition of N-acetyl-L-cysteine (NAC) did not decrease the lifespan of βHB treated worms. (C)
The effect of 20 mM βHB and RNAi knockdown of F55E10.6 on oxygen consumption (* p < 0.05 vs.
untreated; # p < 0.05 vs. Control). (D) The effect of 20 mM βHB treatment on ATP levels in day 4 N2
worms (p = 0.202). Data are represented as mean +/- SEM.

168

But RNAi knockdown of F55E10.6 did not decrease the βHB-mediated increase in
oxygen consumption. The results suggest that the metabolism of βHB by F55E10.6 does not play
a significant role in the use of βHB as an energy substrate for respiration, and so other
mechanisms likely explain the requirement of F55E10.6 for lifespan extension.
We also determined the effect of βHB addition on worm ATP levels (Figure 5.4D). ATP
levels were not significantly altered by βHB addition, although oxygen consumption rates
increased suggesting that βHB either stimulates energy utilization pathways or decreases the
coupling efficiency of oxidative phosphorylation. In this regard, we have previously shown that
growth of C. elegans in the presence of the TCA cycle metabolites malate or fumarate resulted in
a partial uncoupling of mitochondria [44].
5.3.7 SKN-1 and DAF-16 are required for βHB-mediated longevity
To determine other molecular pathways through which βHB functions to extend lifespan,
we performed lifespan experiments using worms deficient in common longevity pathways. In C.
elegans the SKN-1 transcriptional activator is normally sequestered in the cytoplasm by WDR23 and the DDB1/CUL4 ubiquitin ligase complex until the presence of specific xenobiotics or
reactive oxygen species leads to a disruption of the interaction. This allows nuclear translocation
of SKN-1 leading to the activation of a phase II detoxification transcriptional response and
lifespan extension [45, 46]. We next determined if βHB extended the lifespan of worms in which
SKN-1 levels were knocked down by RNAi feeding. Consistent with a role for SKN-1 and SKN1 transcriptional targets such as F55E10.6 in βHB-mediated longevity, βHB did not extend the
lifespan in these SKN-1 RNAi worms (Figure 5.5A). Additionally βHB was able to increase
GFP fluorescence in the gst-4::gfp SKN-1 reporter strain of worms (Figure 5.5B) supporting this
assertion. βHB was also able to induce expression of this reporter strain following knockdown of
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the F55E10.6 gene suggesting that F55E10.6 functions downstream of SKN-1 in the longevity
pathway, as is expected for a SKN-1 transcriptional target.
Disruption of the DAF-2 insulin receptor signaling pathway is known to extend lifespan
through activation of the DAF-16 transcriptional activator. DAF-16 is homologous to
mammalian FOXO genes. βHB supplementation to worms homozygous for the daf-16(mgDf50)
null allele did not lead to lifespan extension (Figure 5.5C). Furthermore, βHB supplementation
slightly increased fluorescence of the sod-3::gfp DAF-16 reporter strain of worms (Figure 5.5D),
supporting the ability of βHB treatment to activate DAF-16 activity for lifespan extension.
Butyrate treatment also led to a similar small increase in GFP fluorescence of the sod-3::gfp
worms suggesting a similar mechanism through which βHB and butyrate extend lifespan.
Another transcriptional regulator linked to longevity is hypoxia inducible factor-1 (HIF1) [47]. We hypothesized that βHB catabolism would increase the concentration of TCA cycle
metabolites that inhibit the alpha-ketoglutarate-dependent degradation of HIF-1 by the
proteasome [48, 49] initiated by the EGL-9 prolyl hydroxylase [50]. However, we found that
βHB supplementation did not increase fluorescence in the nhr-57::gfp reporter strain [47] for
HIF-1 transcriptional activity (Supplementary Figure 3A). In addition supplementation with 10
mM pyruvate, or the TCA cycle metabolites citrate, succinate, fumarate, malate, or oxaloacetate
also failed to induce GFP expression (Supplementary Figure 5.12B) suggesting that C. elegans
HIF-1 may be regulated slightly differently than mammalian HIF-1.
5.3.8 βHB increases thermotolerance
Since lifespan extension, and DAF-16 and SKN-1 activation in particular, has been
linked to stress resistance, we determined the effect of βHB supplementation on thermotolerance
in C. elegans.
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Figure 5.5. SKN-1 and DAF-16 are required for βHB-mediated lifespan extension. (A) βHB addition did
not increase the lifespan of N2 worms fed RNAi to knockdown expression of skn-1. (B) βHB addition
increased fluorescence of the gst-4::gfp SKN-1 reporter strain. Data are represented as mean +/- SEM (*
p < 0.05). (C) βHB addition did not increase lifespan in daf-16(mgDf50) mutant worms. (D) βHB or
butyrate increased fluorescence when administered to the sod-3::gfp DAF-16 reporter strain. Data are
represented as mean +/- SEM (* p < 0.05).
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Figure 6. Treatment with βHB increases thermotolerance (log-rank p < 0.001) in N2 worms when
upshifted from 20°C to 35°C. βHB mean survival time = 5.7 hours. Control mean survival time = 4.5
hours.

As shown in Figure 5.6, βHB administration extended the mean survival time of the
worms after they were shifted to an elevated temperature by 22%. Due to the increased
thermotolerance we hypothesized that heat shock proteins were induced by βHB
supplementation. Therefore we monitored GFP fluorescence in 4 heat shock reporter strains of
worms following βHB treatment.
We used the strains hsp-6::gfp and hsp-60::gfp to monitor the mitochondrial unfolded
protein response [51], hsp-4::gfp to monitor ER stress, and hsp-16.2::gfp to monitor heat shock
factor-1 (HSF-1)-mediated gene expression [52]. βHB supplementation did not induce
expression of any of these four reporter strains. Therefore βHB supplementation does not induce
a broad heat shock response, even though thermotolerance was increased.
172

5.3.9 Decreased protein synthesis rates likely contribute to βHB-mediated lifespan
extension
Recently it has been recognized that several of the common longevity pathways converge
to decrease the rate of translation initiation to extend lifespan [53, 54]. This can occur through
several mechanisms including preventing phosphorylation of ribosomal protein S6 by S6 kinases
of the TOR signaling pathway, blocking phosphorylation of eukaryotic initiation factor 4E
(eIF4E) binding proteins (4E-BPs) by the TOR kinase, or by activation of general control
nonderepressible 2 (GCN2) kinase. GCN2 activation can occur in the presence of uncharged
tRNAs due to amino acid restriction [55] or during times when mitochondria produce high levels
of reactive oxygen species [56]. C. elegans appears to lack close functional homologs of
mammalian 4E-BPs [57] (although one distant homolog has been reported [58]), so they likely
control the rate of translation initiation mainly through the p70 S6 kinase homolog RSKS-1 and
the worm GCN2 homolog GCN-2. Therefore, we obtained the mutant strains rsks-1(ok1255) and
gcn-2(ok871) and performed lifespan analysis in the absence or presence of βHB. The untreated
lifespan of the rsks-1 mutant was greater than that of the N2 control (Fig. 5.7A) as expected,
while the untreated lifespan of the gcn-2 mutant was less than the N2 control (Fig. 5.7B). With
either strain, we found that βHB-mediated lifespan extension was greatly blunted compared to
the effect on the N2 control strain. There was a 5% mean lifespan extension in the βHB-treated
rsks-1 mutant and a 8% mean lifespan extension in the βHB-treated gcn-2 mutant compared to
the 26% lifespan extension in the βHB-treated N2 control. Therefore, the ability to decrease
translation rates through both the TOR/RSKS-1 and GCN-2 pathways likely allows for full βHBmediated lifespan extension in the wild-type N2 animals.
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Figure 5.7. A decreased rate of protein synthesis contributes to βHB-mediated longevity. (A) βHBmediated lifespan extension was blunted in rsks-1(ok1255) mutant worms. (B) βHB-mediated lifespan
extension was also blunted in gcn-2(ok871) mutant worms.

5.3.10 ETC Complex I function is needed for full βHB-mediated lifespan extension
Following mitochondrial βHB dehydrogenase function, acetoacetate is converted to
acetoacetyl-CoA with the concurrent conversion of succinyl-CoA to succinate as a byproduct of
the succinyl-CoA: 3-ketoacid CoA transferase reaction. Because of this succinate production, it
has been suggested that βHB protected a PD cell model by increasing mitochondrial ETC
complex II (succinate dehydrogenase) activity, bypassing the ETC complex I deficits present in
the disease [30]. To determine if normal mitochondrial ETC complex I or complex II activity is
required for βHB-mediated lifespan extension, we determined the effect of βHB supplementation
on the lifespan of short-lived complex I-defective gas-1(fc-21) mutants [59] (Figure 5.8A) and
short-lived complex II defective mev-1(kn1) mutants [60] (Figure 5.8B). βHB extended the
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lifespan of the gas-1 mutant by 11%, but not to the full 26% extent observed in wild-type worms.
Therefore, normal ETC complex I function is necessary for the full effect of βHB on longevity.
βHB supplementation fully extended the lifespan of mev-1 mutants indicating that βHB does not
require normal ETC complex II function to extend lifespan.
5.3.11 βHB-mediated longevity requires AAK-2, SIR-2.1, CBP-1, and may occur in a
similar manner as in DR
To identify if other important longevity regulators are required for βHB-mediated
longevity, βHB was supplemented to AMP kinase (AMPK) aak-2(TG38) mutant worms (Figure
5.9A) and sir-2.1(ok434) NAD-dependent protein deacetylase mutant worms (Figure 5.9B) and
lifespan was monitored. βHB addition did not extend the lifespan of either strain suggesting that
both proteins play a role in βHB-mediated longevity. Since ketone body levels rise during caloric
restriction (CR) in mammals and increased βHB levels may be responsible for some portion of
the increased stress and disease resistance conferred by CR, we determined the effect of βHB
supplementation on lifespan in the nematode eat-2(ad1116) model of dietary restriction (DR) in
which pharyngeal pumping is slowed (Figure 5.9C). We found that treatment with βHB had no
significant effect on the longevity of eat-2 worms suggesting that βHB extended lifespan using
some of the same downstream effectors activated in DR. The CREB binding protein-1 (CBP-1)
transcriptional co-activator and protein acetyltransferase has been shown to be essential for DRmediated longevity in C. elegans [33]. Therefore we determined the effect of βHB on lifespan in
worms where cbp-1 expression was knocked down by RNAi (Fig. 5.9D). Consistent with βHB
extending lifespan in a manner similar to DR, knocking down cbp-1 prevented lifespan extension
induced by βHB treatment.
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Many of the same compounds that extend lifespan in C. elegans in a CBP-1 dependent
manner also protect against glucose toxicity [61]. It’s been shown that C. elegans shows a
reduced lifespan when grown in a high glucose containing media [62-64]. When we grew worms
in 50 mM glucose, lifespan was decreased by roughly 30% (Figure 5.10A). βHB
supplementation to the glucose-containing media partially restored the lifespan, resulting in a
lifespan reduction of only 21% compared to the non-glucose treated controls.

Figure 5.8. βHB extends the lifespan of short-lived mitochondrial ETC complex I and complex II
mutants. (A) gas-1(fc21) survival in the absence and presence of βHB. (B) mev-1(kn1) survival in the
absence and presence of βHB.
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Figure 5.9. βHB extends lifespan in a similar manner as DR and requires AAK-2, SIR-2.1, and CBP-1.
(A) βHB does not extend lifespan of AMPK mutant aak-2(TG38) worms, (B) sir-2.1(ok434) worms, or
(C) eat-2(ad1116) worms. (D) Additionally, βHB does not extend the lifespan cbp-1 RNAi knockdown
N2 worms.
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5.2.12 βHB delays Aß-induced paralysis and decreases alpha-synuclein aggregation
We next performed experiments using a strain of worms engineered to express human
AD-associated Aß peptide within body wall muscle upon temperature upshift from 16° to 25°C,
which leads to paralysis of all worms by 32 hours after upshift [65]. Figure 10B shows the
paralysis over time in these worms in the presence and absence of βHB treatment. βHB increased
the mean paralysis time following Aß induction by 15%, from approximately 26 to 30 hours.
Since βHB supplementation was beneficial in this model of proteotoxicity, we next determined
the effects of βHB administration on a PD-model worm strain expressing human α-synuclein
fused to yellow fluorescent protein (YFP) in the body wall muscle [66]. Alpha-synuclein protein
is prone to aggregation and is the major protein constituent of Lewy bodies in PD brain [67].
YFP aggregation and fluorescence was decreased by 35% in worms treated with βHB for 8 days,
indicating a protective decrease in the levels of alpha-synuclein aggregates (Figure 5.10C).
A ketogenic diet has been shown to delay loss of motor performance and loss of spinal
cord motor neurons in the SOD1-G93A mouse model of amyotrophic lateral sclerosis (ALS)
[68]. So lastly, we performed experiments using worms overexpressing human TDP-43 [69],
which forms insoluble aggregates in the nervous system of patients with ALS and other
neurodegenerative disorders [70] and when expressed in the nervous system of worms [69].
TDP-43 expression caused a greatly reduced lifespan in C. elegans both when grown at 20°C
and when grown at 16°C (Supplementary Table 1). 20 mM βHB supplementation was unable to
prevent the reduction in lifespan (Figure 10D). Concentrations of βHB from 2 mM to 200 mM
were also tested. Only 30 mM βHB was found to be effective at delaying toxicity and the
increase in longevity at this concentration was only 5%.
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Figure 5.10. βHB protects against glucose toxicity and proteotoxicity. (A) Treatment with βHB partially
protects against 50 mM glucose-induced reduction of lifespan in N2 worms. (B) Survival of the CL4176
strain of C. elegans expressing Aβ in muscle following temperature upshift. Treatment with βHB
increases the time to paralysis (log-rank p < 0.001). βHB-treated mean lifespan = 29 hours, untreated
control mean lifespan = 26 hours. The curves are generated from the results of six assays (n > 500 for
both groups). (C) Treatment with βHB decreases α-synuclein-GFP aggregation in the NL5901 strain
GFP fluorescence readings were taken on day 8 of worm lifespan. Data are represented as mean +/- SEM.
(log-rank p < 0.001) (D) 20 mM βHB did not protect against the shortened lifespan induced by human
TDP-43 overexpression when the worms were grown at 16°C.
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5.4 Discussion
Administering βHB to C. elegans extended lifespan and delayed proteotoxicity and
glucose toxicity. βHB extended C. elegans lifespan in a SIR-2.1 and AMPK-dependent manner
that also required the stress-responsive transcription factors DAF-16 and SKN-1. Since βHB did
not extend lifespan in eat-2 pharyngeal pumping mutants, βHB likely acts as a dietary restriction
mimetic, as previously hypothesized for its effects in mammals [71]. Even though protective
effects of D-βHB on rodent disease models are known, this is the first report to identify D-βHB
as a positive modulator of organismal longevity in wild-type animals. We also identified many of
the signaling pathways and genes required for this effect. A key finding is that D-βHB-mediated
lifespan extension requires SKN-1 and its transcriptional target F55E10.6, a short-chain
dehydrogenase/reductase with βHB dehydrogenase activity, although inhibition of HDACS
HDA-2 and HDA-3 are also required for the increased longevity.
5.4.1 The role of F55E10.6 in βHB-mediated lifespan extension
The βHB dehydrogenase enzyme assay data suggest that F55E10.6 is a D-βHB-inducible
βHB-dehydrogenase enzyme. However, D-βHB may not be the preferred physiological substrate
for the enzyme or the substrate required for lifespan extension. Since knockdown of F55E10.6
did not affect the increased oxygen consumption following βHB supplementation, the enzyme
does not likely possess a mitochondrial localization producing NADH for ETC complex I
function. In this regard in addition to sharing homology with mitochondrial BDH1, F55E10.6
shares homology with microsomal retinol dehydrogenases [37] and microsomal hydroxysteroid
dehydrogenases [38]. Due to these homologies and the role that SKN-1 plays in controlling the
ER stress response [41], F55E10.6 has been putatively assigned an ER localization [41],
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although no signal peptide was found [40]. Key to its localization, F55E10.6 is predicted to have
a transmembrane domain [40].
It is of interest that knockdown of F55E10.6, a SKN-1 target gene increased C. elegans
oxygen consumption, suggesting that SKN-1 signaling may decrease mitochondrial biogenesis or
function. Expression of F55E10.6 has been shown to decline with aging [72], likely due to the
aging-related decline in activity of SKN-1 [42]. The mammalian SKN-1 homolog Nrf2 is also
known to play a role in mitochondrial biogenesis. When overexpressed Nrf2 was shown to be a
negative modulator of mitochondrial mass and membrane potential in a high throughput screen
using C2C12 myoblast cells [73]. However, when upregulated under physiological conditions
Nrf2 was found to be a positive regulator of mitochondrial biogenesis by inducing nuclear
respiratory factor-1 (NRF-1) and peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC-

[74], liver [75], and lung [76].

5.4.2 Full βHB-mediated lifespan extension requires mitochondrial ETC complex I function
βHB-induced lifespan extension was partially blocked in ETC complex I mutant worms
and was unaffected in mitochondrial ETC complex II mutant worms. This likely suggests that
the lifespan extension is driven partly by βHB metabolism-independent effects and partly by
metabolism-dependent effects. Normal complex I activity may be needed to maintain a high
NAD/NADH ratio beneficial for maximal lifespan extension [77]. In this regard, it has been
shown that rotenone can induce a roughly 10-fold reduction in C. elegans respiration, but only a
2-fold reduction occurred in the presence of 10 mM βHB [78]. Therefore, βHB either stabilized
complex I function in the presence of rotenone or stimulated complex II-dependent respiration to
bypass this block of complex I function. In mammals βHB has been shown to stabilize and
increase the efficiency of ETC complex I [68, 79]. The increased rate of NADH oxidation in the
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presence of βHB led to decreased ROS levels in mouse neocortical neurons following glutamate
excitotoxicity [79]. βHB may also enhance complex I activity in worms, but it may not be able to
fully do so in the gas-1 mutants preventing full lifespan extension.
5.4.3 Proposed mechanism for βHB-mediated lifespan extension
We propose 2 possible mechanisms for lifespan extension mediated by βHB
supplementation. In the first mechanism (see Supplementary Figure 5), we propose that βHB
directly inhibits HDACs to increase histone acetylation [14] causing gene expression changes
ndependent of βHB catabolism. The metabolism-independent
activation of SKN-1 is consistent with our previous data showing that stimulation of metabolism
by supplementation of several TCA cycle metabolites did not activate SKN-1 transcriptional
activity [44]. Next, SKN-1 activity induces expression of F55E10.6 [42, 45], required for proper
execution of the SKN-1 longevity program. SKN-1 activation has been shown to repress
expression of the insulin-like peptides DAF-28 and INS-39, decreasing DAF-2 insulin receptor
signaling to activate DAF-16 [80]. βHB catabolism also likely increases the level of specific
TCA cycle intermediates, which may contribute to the DAF-16-mediated lifespan extension. We
and others have shown that supplementation of the TCA cycle metabolites fumarate, malate, and
oxaloacetate activated nuclear translocation of DAF-16 to extend lifespan in an AMPK and SIR2.1-dependent manner [44, 81]. Others have also found that the TCA cycle metabolite alphaketoglutarate extends lifespan through a TOR kinase-dependent mechanism [82]. Although this
model is consistent with our data, is also possible that βHB-mediated HDAC inhibition causes a
direct transcriptional upregulation of DAF-16, as βHB-mediated HDAC inhibition directly
upregulates expression of the DAF-16 homolog FOXO3A in mammals [14].
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In addition, βHB metabolism may increase acetyl-CoA levels that serve as a substrate for
histone acetyltransferases to increase histone acetylation [83], which could strengthen the effects
of HDAC inhibition to extend lifespan. However, increased cytoplasmic acetyl-CoA levels have
also been shown to inhibit autophagy [84], which could potentially dampen lifespan extension.
However, the acetyl group from mitochondrial acetyl-CoA can be transferred to carnitine to form
acetylcarnitine and exported from mitochondria to the nucleus, where acetyl-CoA is reformed
and used for nuclear histone acetylation [85]. This mechanism may allow for increased histone
acetylation without decreased rates of autophagy.
The second proposed model of how βHB may extend lifespan is through inhibition of the
insulin signaling pathway. In mammals, it has been shown, contrary to expectations, that βHB
administration or a ketogenic diet blocks the insulin signaling pathway in muscle leading to
insulin resistance [86]. This adaptation likely evolved to allow the brain preferential use of the
bloodstream glucose during starvation. However, a ketogenic diet has also been shown to be
effective at lowering blood glucose in patients with type II diabetes due to the decreased
carbohydrate intake [87]. In mouse studies, βHB administration yielded a 50% reduced
phosphorylation and activity of Akt/protein kinase B downstream of the insulin receptor
decreasing insulin signaling [86]. The mechanism for this βHB-mediated inhibition of Akt and
the insulin signaling pathway was not fully elucidated, but it relied upon administration of DβHB and not L-βHB, suggesting that mitochondrial metabolism of D-βHB may be involved. In
C. elegans, inhibition or decreased expression of Akt or other proteins of the insulin signaling
pathway have been shown to activate both DAF-16 and SKN-1 leading to lifespan extension
[88], thereby providing a potential mechanism for the effect of βHB on longevity.
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5.4.4 βHB does not induce a broad heat shock response, but still increases thermotolerance
Although βHB did not induce expression of four specific heat shock proteins monitored
(Supplementary Fig. 3), it did activate the DAF-16 and SKN-1 signaling pathways, which are
both likely responsible for the increased thermotolerance observed following βHB treatment.
Previous research has shown that RNAi knockdown of either skn-1 or daf-16 decreased
thermotolerance [89]. DAF-16 is known to induce expression of several heat shock proteins
including hsp-12.6, sip-1, and hsp-16.1, which may play a role in the increased thermotolerance.
The factors that SKN-1 induce to confer thermotolerance are less clear, although SKN-1 function
has been implicated in the induction of hsp-4 expression and activation of the ER stress response
[41]. However, we did not find βHB to induce hsp-4::GFP expression, but a positive trend was
observed (p = 0.18).
5.4.5 Neuroprotective effects of ketone bodies
In an AD cell model, βHB has been shown to protect hippocampal neurons from Aß
toxicity [90]. The protection may have occurred through decreasing ROS levels as decreased
ROS production is known to lower expression levels of beta-secretase (BACE1), a protease that
contributes to toxic Aß generation [91]. This mechanism may be responsible for the ketogenic
diet-induced reduction of Aß levels in a mouse model of AD [22]. The brain’s ability to utilize
glucose decreases in AD. To prevent deficits in brain ATP levels, βHB has been used as an
alternative metabolic energy source for patients with AD [25]. Increased inflammation
accompanies brain aging and may contribute to the development of AD. Increased levels of
ketone bodies have been shown to reduce inﬂammation [71, 92] and this may result from
increased mitochondrial efficiency and decreased ROS production [93].
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PD is associated with aggregation of alpha-synuclein and death of dopaminergic neurons
leading to motor decline. Mice treated with βHB showed partial protection against
neurodegeneration and motor deficiency induced by MPTP [30]. Surprisingly, this was not due
to increased NADH generation fueling complex I, but was described to be due to an increased
supply of succinate, a substrate for ETC complex II [94]. As mentioned previously, the
stimulation of complex II activity by βHB metabolism depends on the increased succinate
produced as a byproduct of the mitochondrial succinyl-CoA: 3-ketoacid CoA transferase
reaction. However, since βHB fully extended lifespan in complex II-defective mev-1 mutants, it
is unlikely that this mechanism plays a substantial role in βHB-mediated lifespan extension. The
mechanism of βHB-mediated protection in PD models may be similar to the mechanism by
which βHB supplementation increases lifespan in the complex I-defective gas-1 worms.
5.4.6 Study limitations and future directions
Although we were able to dissect many of the pathways through which βHB extends
lifespan in C. elegans, many questions remain. For example, is the reason that D-βHB but not LβHB extended lifespan due to the increased ability of D- βHB to be metabolized or due to the
higher efficiency of D-βHB as an HDAC inhibitor? Is HDAC inhibition required for βHBmediated upregulation of SKN-1 or DAF-16 activity? In addition to extending lifespan as shown
here, RNAi knockdown of the class I HDAC hda-3 was shown to protect against polyglutaminemediated toxicity in a C. elegans Huntington’s disease, while knockdown of most other HDACs
increased toxicity [95]. Is HDAC inhibition or SKN-1 activity required for DAF-16 activation by
βHB? Also is βHB catabolism required for βHB-mediated SKN-1 or DAF-16 activation?
Furthermore, is the transcription factor PHA-4/FoxA, which is required for DR-mediated
longevity [96], also required for βHB-mediated longevity? In this regard mammalian Foxa2 is
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known to induce expression of BDH1 [97]. Do βHB levels increase in DR worms and if so does
this play a role in DR-mediated longevity? Lastly, are the same signaling pathways required for
longevity also required for βHB-mediated protection in the C. elegans models of Aß and alphasynuclein toxicity? Future experiments will provide answers to these questions and elucidate the
molecular mechanisms responsible for the protective effects of βHB. This knowledge will allow
for a broader use of βHB as a therapy for aging-related disorders.
5.5 Conclusions
βHB treatment extended lifespan and protected against metabolic, proteotoxic and
thermal stress in C. elegans. βHB-mediated lifespan extension occurred through induction of the
DAF-16 and SKN-1 signaling pathways and was dependent upon βHB-mediated inhibition of
HDACs HDA-2 and HDA-3. Our data support the hypothesis that βHB is a DR mimetic and that
βHB treatment will likely be useful in the treatment of many human aging-associated disorders.
5.6 Supporting information

Figure 5.11. L-βHB dehydrogenase activity in worm extracts grown in the absence or presence of 10 mM
D-βHB. Knockdown of F55E10.6 almost completely prevented the increased L-βHB dehydrogenase
activity induced by culturing with D-βHB (* p < 0.05 vs. (Control + 10mM D-βHB)). Knockdown of dhs2, dhs-16, or dhs-20 decreased endogenous L-βHB dehydrogenase activity in the extracts (# p < 0.05 vs.
Control).
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Figure 5.12. The effect of βHB on lifespan in histone deacetylase mutants. βHB addition
did not extend the lifespan of (A) hda-2(ok1479) mutant worms or (B) hda-3(ok1991) mutant worms.
βHB addition extended the lifespan of (C) hda-4(ok518) mutant worms (log-rank p =0.001) and (D) hda10(ok3311) mutant worms (log-rank p =0.002).
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Figure 5.13. βHB addition does not induce expression of several heat shock proteins. The
effect of βHB addition on the fluorescence of (A) hsp-6::gfp, (B) hsp-60::gfp, (C) hsp-16.2p::GFP, or
(D)hsp-4::GFP worms. For (A) and (B) 50 _g/ml ethidium bromide treatment for 2 days was used as a
positive control. For (C) and (D) heat shock at 35°C for 2 hours was used as a positive control. (* p <
0.05).
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Figure 5.14. βHB, pyruvate, or TCA cycle metabolites do not activate HIF-1 transcriptional
activity. The effect of (A) βHB, (B) pyruvate, or TCA cycle metabolites on GFP fluorescence in nhr57::gfp worms. 20 _M potassium cyanide was used as a positive control. (* p < 0.05).

Figure 5.15. One possible mechanism through which βHB may extend lifespan in C. elegans.
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Table 5.1 Lifespan data

190

Table 5.1 (Continued)
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CHAPTER 6
SIGNIFICANCE OF FINDING COMPOUNDS THAT INFLUENCE AGING
6.1 Summary
Our studies focus on discovering supplemented metabolites that attenuate aging and age-related
decline and elucidating the genetic pathways involved. In Chapter 3 we show that the TCA cycle
metabolites malate and fumarate increased the lifespan of C. elegans via the non-mammalian glyoxylate
shunt and malate dismutation/fumarate reduction pathways. Further, we identified that the SIR-2.1 and
DAF-16 proteins were necessary for malate-mediated lifespan extension. The next step was to examine
(in Chapter 4) the effects on the rate of aging of amino acids that catabolize into TCA metabolites. We
show that individual amino acid supplementation increased the lifespan of C. elegans and the pathways
involved vary from one amino acid to the next. Various longevity pathways including DAF-16, SKN-1,
AAK-2, SIR-2.1, GCN-2, heat shock, autophagy, CR, and inhibition of TOR signaling were involved in
protective effects. Finally, we looked at alternative mitochondrial energy sources and found that βHB
treatment extended lifespan and protected against metabolic, proteotoxic, and thermal stress in C. elegans.
βHB-mediated lifespan extension occurred through induction of the DAF-16 and SKN-1 signaling
pathways and relied upon βHB-mediated inhibition of HDACs. Our data support the hypothesis that

βHB is a CR mimetic and that treatment with βHB will likely be beneficial in the management of
many human aging-related disorders.
Although TCA cycle metabolites, most amino acids, and βHB are produced naturally
within cells, this does not denote that the metabolites, when administered through feeding, will
act in the same manner. One can assume that CR induced ketosis, when compared to βHB
supplementation, activates alternate signaling pathways and ketones are catabolized for energy in
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various tissues to different extents. The same rationale applies to TCA cycle metabolites and
amino acids.
6.2 TCA Cycle metabolites and aging
As described in Chapter 3, changes in energy metabolism influence epigenetic
mechanisms and can alter the aging process. The TCA cycle is a central pathway for metabolism
and much data implicate its function in the control of longevity [1]. Proper coordination between
the electron transport chain and the TCA cycle is necessary to maintain a normal NAD+/NADH
ratio beneficial to long life. The function of the mitochondrial electron transport chain, which
oxidizes NADH and FADH2, decreases with age across species [2], which leads to a reduced
cellular NAD+/NADH ratio during aging. Anti-aging therapies such as CR increase the
NAD+/NADH ratio in many tissues as a possible mechanism to delay aging.

Figure 6.1. The TCA Cycle

199

In an effort to understand if TCA cycle intermediates could rescue mitochondrial
dysfunction during the aging process in C. elegans, we performed lifespan assays supplementing
TCA cycle metabolites into the worm’s diet. Yeast mutants with increased lifespan have been
shown to have increased levels of TCA cycle metabolites [3]. In Chapter 3, we showed that
malate and fumarate addition extend lifespan in C. elegans and the addition of TCA cycle
intermediates increased the NAD+/NADH ratio, likely contributing to lifespan extension.
Increased NAD+ levels activate the histone deacetylase SIR-2.1 [4] and AMP kinase [5], both
known to interact with DAF-16 to increase lifespan. Through knockdown models we showed
that malate-mediated lifespan extension is dependent upon SIR-2.1 and AMP kinase. Malate
supplementation resulted in DAF-16 translocation to the nucleus and transcription of DAF-16
target genes, which likewise plays an essential role in lifespan extension. In Chapter 4 we show
that a lower concentration of succinate (when compared to malate) results in lifespan extension,
which supported data from Chapter 3 indicating that succinate addition induces DAF-16 nuclear
translocation.
We also hypothesized that addition of malate or fumarate to C. elegans leads to activation
of the glyoxylate shunt. Glyoxylate shunt activity increases the NAD+/NADH ratio as the shunt
bypasses two of the three NADH generating reactions of the TCA cycle resulting in a
conservation of NAD+. Isocitrate is reversibly converted into succinate and glyoxylate by the
isocitrate lyase activity. The glyoxylate shunt malate synthase enzymatic activity catalyzes the
reversible conversion of malate and CoA to glyoxylate and acetyl-CoA that may also be
important for malate-mediated lifespan extension. Upregulation of shunt activity would increase
NAD+ levels, though metabolism under these conditions likely becomes limited by FAD levels,
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so malate dismutation is activated to oxidize FADH2 to FAD. Further research should target the
role of the FAD/FADH2 ratio in lifespan determination. We did find that addition of FAD to
worm media increased lifespan (data not shown).
6.3 NAD+ metabolism and aging
Mammals convert tryptophan to NAD+ through quinolinic acid in the de novo NAD+
synthesis pathway [6]. When looking at the C. elegans genome, the first gene in the pathway for
quinolinic acid conversion to NAD+ appears to be absent. Therefore it was first assumed that
worms must utilize the NAD+ salvage pathway rather than direct de novo synthesis. The first
enzyme in the NAD+ salvage pathway is nicotinamidase that catalyzes the conversion of
nicotinamide to nicotinic acid. There are three nicotinamidases found in C. elegans, two PNC-1
isoforms and PNC-2. Male worms with mutations in PNC-1 are infertile while hermaphrodites
with the same mutation display muscle impairment [7]. Knockdown of the NAD+ salvage
pathway in worms decreases lifespan, but since it is not lethal there may be additional genes that
play a role in quinolinic acid conversion to NAD+. So therefore, there is likely a mechanism
present in worms to convert tryptophan to NAD+ (see Fig. 2), which I hypothesize to play a role
in tryptophan-mediated longevity.

During CR in yeast, PNC-1 activity and expression is

upregulated to convert the Sir2 inhibitor NAM to nicotinic acid, resulting in increased Sir2
activity [8]. Given that malate supplementation increased lifespan through SIR-2.1, it is plausible
that PNC-1 is upregulated through the addition of TCA cycle metabolites (Fig 2). This is
supported by our data that malate supplementation greatly increased NAD(H) levels in C.
elegans (see Chapter 3).Therefore further investigation of TCA cycle metabolite supplementation
in conjunction with RNAi knockdown of PNC-1 would further elucidate the mechanism by
which malate, fumarate, oxaloacetate, and alpha-ketoglutarate extend lifespan.
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Figure 6.2. The C. elegans NAD salvage pathway. Malate may be increasing NAD through the indirect
upregulation of pnc-1.

Although increased NAD+ levels are important for lifespan extension, the assays used for
NAD+ quantification in C. elegans are difficult. Moreover, when assays optimized for
mammalian cell culture or tissues are changed and utilized with C. elegans, the possibility of
errors in the results are increased. The main reason for this is that C. elegans possess a hard
cuticle that may be incompletely disrupted when performing assays to release small molecule
metabolites such as NAD+. Therefore, the results may be difficult to replicate. Being that C.
elegans have become a popular model for aging, the need for nematode specific protocols is
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necessary for accurate and reproducible results. A recent study provided evidence that altered
NAD+ homeostasis and mitochondrial dysfunction accompany age-related decline using a novel,
non-invasive, resonance-based, in vivo NAD+ assay to monitor NAD+ concentrations in the
human brain [9]. This non-invasive method could be adapted for use on C. elegans to follow
NAD+ homeostasis throughout their lifespan. Further, this method could more accurately verify
if addition of metabolites, such as malate, are increasing NAD+ levels in long-lived worms.
6.4 Mitochondrial membrane potential and aging
The pumping of protons by the electron transport chain together with phosphate-proton
symporters in the inner mitochondrial membrane creates a mitochondrial membrane potential
(MMP) across the inner membrane. Decreased MMP has been shown to increase lifespan in C.
elegans [10] and yeast [11]. This is not completely intuitive as the magnitude of the MMP is
directly proportional to the amount of ATP that can be made by ATP synthase. However, a high
MMP also increases ROS production and this ROS production, not ATP levels, may limit
lifespan. Many long-lived mutants and RNAi knockdown of genes that are associated with
lifespan extension exhibit a lower MMP when compared to wild-type nematodes. Diminished
MMP of DAF-2 mutants is reliant on DAF-16, suggesting that DAF-16 is essential for lifespan
regulation and mitochondrial energy homeostasis. Additionally, studies show that protection by
mitochondrial uncoupling against neuronal excitotoxicity is dependent on the increased
phosphorylation state of AMPK [10]. We showed in Chapter 3 that C. elegans longevity by
malate supplementation is dependent upon AMPK and DAF-16 activation. Malate also increased
oxygen consumption, decreased ATP, and was associated with a decline in MMP. Therefore,
malate may act as a mild mitochondrial uncoupler, leading to the activation of DAF-16 by
AMPK stimulating increased longevity. Although the use of TMRE and TMRM are common
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assays used to quantify MMP in C. elegans, results are challenging to reproduce since conditions
of animal culture vary considerably in the literature. One way to follow up and verify the effects
of metabolites on MMP is to use multiple types of assays that are developed specifically for
worms, such as the recently developed assay that incorporates the fluorescent cationic, lipophilic
carbocyanine dye, DiSC3(3) [12]. DiSC3(3) is a membrane potential sensitive dye used for
examining in vivo changes in MMP and exhibits fluorescence fluctuations upon membrane
hyperpolarization (when the matrix space of the mitochondrion becomes more negative).
Multiple techniques and C. elegans specific assays will improve reproducibility of the results.
6.5 Mitohormesis and alternate mechanisms of metabolite-mediated longevity
Small deviations in cellular metabolism such as through metabolite supplementation can
activate multiple stress response pathways and upregulate genes associated with longevity such
as HSF-1, SKN-1, and heat shock proteins. In Chapters 4 we investigate the role of amino acids
in lifespan extension and identify that many amino acids are acting as hormetics and a few as
mitohormetics, such as tryptophan and proline. To answer some questions left from Chapter 1,
we also found that alpha-ketoglutarate supplementation upregulates HSF-1 and the ER stress
response in GFP reporter strains of worms. Most of the amino acids that extended lifespan the
greatest: proline, arginine, histidine, glutamine, and glutamate, are catabolized through glutamate
into alpha-ketoglutarate in the TCA cycle. It was recently shown that alpha-ketoglutarate greatly
extends lifespan of C. elegans by inhibiting ATP synthase and TOR [13]. Citrate also activates
an ER stress reporter, however, no lifespan extension was seen when citrate was added to worm
medium. GFP reporter strains can be dim and heat shock proteins are only one part of the
hormesis story. Understanding the effect of these metabolites on the ROS defense enzymes
(SOD, catalase) is necessary and can be achieved by western blot analysis or enzymatic assays
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specific for catalase and SOD. Monitoring ROS levels in TCA cycle treated young and old
worms would allow for a better understanding of how the mitochondria is affected and if
homeostasis is being influenced.
Although we showed an important role for the glyoxylate shunt and malate dismutation
in malate-mediated lifespan extension in C. elegans, malate treatment has been shown to be
beneficial in mammals as well. Therefore, many of the protective effects of malate treatment
seem to be conserved from nematodes to mammals. Since fumarate, malate, succinate, alphaketoglutarate, isocitrate, and oxaloacetate extend lifespan in C. elegans through a mechanism
similar to calorie restriction, an anaplerotic cocktail of these compounds may be useful for the
treatment of human aging-associated disorders.
6.6 Amino acids function through diverse mechanisms to extend lifespan
Amino acids can be deaminated into keto acids and then directly or indirectly fed into
the TCA cycle. In C. elegans, the mitohormetic effect of proline supplementation extended
lifespan [14] and knockdown of the enzyme that catabolizes tryptophan also led to lifespan
extension [15]. Feeding mice a diet high in branched chain amino acids led to increased
mitochondrial biogenesis in muscle, decreased ROS production, and increased average lifespan
of males [16]. Due to the incomplete knowledge of the effects of amino acids on longevity as
well as the widespread use of amino acid and protein supplementation in the human diet we
determined the effects of individual amino acid supplementation on C. elegans lifespan. In
Chapter 4, we establish that individual amino acid supplementation increased the lifespan of C.
elegans and increased stress resistance with serine, proline, and tryptophan showing the greatest
effects. Perhaps these amino acids are transported into the gut at a faster rate and therefore act as
quick anaplerotics for the TCA cycle intermediates. Because so little is known about many of the

205

amino acids, especially serine, future work should aim at investigating how these metabolites
contribute to longevity in more complex models.
Of the 20 amino acids, serine and proline extended lifespan to the largest extent. Proline
was recently found to be mitohormetic in C. elegans and our data confirms this finding. In
Chapter 4, we show that the well-studied longevity pathways including DAF-16, SKN-1, AAK2, SIR-2.1, GCN-2, heat shock, autophagy, calorie restriction, and inhibition of TOR signaling
are involved in these protective effects. These different longevity pathways may converge to
decrease the rate of translation by the ribosome for lifespan extension. In addition, cysteine and
tryptophan-induced lifespan extension were independent of SKN-1, so supplementation with
these amino acids did not likely alter mitochondrial metabolism to increase ROS production.

Figure 6.3. Entry of amino acids into the TCA cycle.
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As discussed in Chapter 4, the pathways involved with lifespan extension vary from one
amino acid to the next, but the DAF-16 and AMP kinase longevity pathways appeared to be
activated by supplementation most, if not all, lifespan extending amino acids. Examples of other
longevity pathways activated include, serine and histidine stimulating transcriptional activity of
HIF-1, while other amino acids did not. Eight lifespan-extending amino acids increased the
transcriptional activity of SKN-1, but not tryptophan, cysteine, or the lifespan-decreasing amino
acids phenylalanine and asparagine. Proline has been previously shown to extend the lifespan of
worms through mitohormesis and it showed the greatest lifespan extension of all the amino
acids. Another mechanism of lifespan extension observed with proline supplementation may be
FOXO activation of glutamine synthetase, which inhibits TOR signaling by blocking its
lysosomal translocation and stimulates autophagy to recycle cellular components [17]. Inhibition
of TOR activity through upregulation of glutamine synthetase expression may also explain how
alpha-ketoglutarate, glutamine, arginine, and histidine influence lifespan. Proline can be
catabolized to glutamate through proline dehydrogenase and 1-pyrroline-s-carboxylate
dehydrogenase. Prior studies show that an increase in proline dehydrogenase increases
mitochondrial ROS production, which activates stress signaling genes to extend lifespan.
Perhaps, the impressive lifespan extending ability of proline is due to a combination of
mitohormesis and inhibition of TOR signaling. Interesting, plants exposed to various stressful
conditions accumulate abundant proline reserves. Proline acts as a metal chelator and
overproduction of proline supports osmotic balance and prevents oxidative damage in plant cells
[18]. Similarly, this same trend of proline accumulation is seen in E. coli when undergoing
hypertonic stress [19]. Therefore, additional proline may protect C. elegans from protein
misfolding during normal aging and during times of stress. Future research should aim to
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identify a role for proline in protecting nematodes from osmotic imbalance. Additionally, proline
precursors have been shown to sustain collagen synthesis in mammals [20]. Proline is
hydroxylated into collagen, which is necessary for the development and maintenance of the
exoskeleton (cuticle) in C. elegans [21] and collagen remodeling is required for longevity in C.
elegans [22]. Therefore, proline may not only be protecting through mitohormesis, chelation, and
osmotic regulation, but it may also contribute to collagen sparing and synthesis in aged worms,
reducing the rate of cuticle breakdown.
Of the top lifespan extending amino acids, perhaps the least is known about how serine
levels affect signaling pathways in mammals. In Chapter 4 we found serine among the top
amino acids to extend lifespan and the lifespan extension required HIF-1, DAF-16, SKN-1, and
inhibition of TOR signaling, which, like proline, may converge to decrease the rate of translation
by the ribosome for lifespan extension. In human endothelial cells serine acts as an antioxidant
and cytoprotectant through upregulation of Nrf2 and heme oxygenase-1 [23]. Serine is a
precursor for tryptophan, glycine, cysteine, and pyruvate, which all demonstrate lifespan
extending capabilities in C. elegans. In tumors, HIF-1 activation increases glycolysis, including
an increase in pyruvate production [24]. Perhaps serine addition acts on HIF-1 to increase
pyruvate levels resulting in TCA cycle anaplerosis in aging worms. Serine is also an essential
building block of phospholipids, such as phosphatidylserine, and therefore necessary for cellular
membrane composition. The phospholipid cardiolipin accounts for 20% of mitochondrial
phospholipids and deterioration of cardiolipin is associated with age-related disease and decline.
Serine supplementation may increase phosphatidylserine synthesis and participate in cardiolipin
sparing. Quantifying phosphatidylserine and cardiolipin in serine treated worms and isolated
mitochondria would elucidate any role for serine supplementation in phospholipid metabolism.
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Interestingly, in human endothelial cells, serine acts as an antioxidant and cytoprotectant by
increasing expression of Nrf2, its transcriptional target HO-1, and NO. Being that both histidine
and serine were tested at 10 mM concentrations (while others were tested at 1 or 5 mM
concentrations), homeostatic dysregulation could also explain why these two metabolites, but not
the others, induced HIF-1 activity. Careful consideration should be taken when using GFP
reporter gene fusion animals. Multiple assays should be utilized to verify findings to make
certain that results are reproducible under all growth conditions. Amino acid supplementation in
liquid culture is susceptible to bacterial and fungal contamination, which is only sometimes
readily detectable. Therefore, any results should be explored with uncertainty and verified by
multiple techniques and labs.
As mentioned in Chapter 1, histidine is a zinc and nickel chelator that protects against
metal toxicity in C. elegans [25] and human astrocytes [26]. Cobalt-induced HIF-1 expression is
inhibited by histidine in cultured mammalian cells [27], yet HIF-1 activation has been shown to
be regulated by the conversion of histidine to histamine through histidine decarboxylase
expression under hypoxic conditions [28]. Future research should identify if histamine, histidine
analogs, or histidine breakdown products, such as urocanic acid, increase HIF-1 expression.
Unlike histidine, N-acetyl-histidine and histidine methylester are cell permeable and both were
slightly more effective than histidine at increasing lifespan when supplemented at a low
concentration. These results suggest that the rate of amino acid absorption by the intestine may
be a limiting factor in lifespan extension.
Another significant finding from my research is that supplementation with tryptophan,
nicotinamide, quinolinic acid, nicotinic acid, or its isomer picolinic acid resulted in the activation
of both the mitochondrial unfolded protein and the ER stress response pathways, while NAD+
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addition induced only the ER stress response. Although there is no obvious homolog for the first
gene in the pathway for quinolinic acid conversion to NAD+ in C. elegans, knockdown of the
NAD+ salvage pathway is not lethal to worms indicating that other genes may be involved in
tryptophan catabolism. As mentioned above, in vivo quantification of NAD+ in tryptophan
treated worms could directly answer if tryptophan alone or its breakdown products are
responsible for increasing NAD+ levels. NAD+ precursors and tryptophan can also protect cells
by inducing an ER stress response and a mitochondrial unfolded protein response. Picolinic acid
is a strong metal chelator and it will be important to determine if the protective effects of
picolinic acid are due to metal chelation or increased NAD+ levels.
Different amino acids are catabolized and enter the TCA cycle through separate
intermediates. We did not find that the amino acids yielding the greatest effects on lifespan were
degraded through one common catabolic pathway.

We suggest that through anaplerosis,

supplemented metabolites that increased lifespan may be catabolized by mitochondria to increase
TCA cycle metabolite levels. The DAF-16/FOXO longevity pathway has been shown to be
activated by increased TCA cycle metabolite levels [29]. As shown in Chapter 3, the TCA cycle
appears to be a lifespan-extending metabolic pathway in C. elegans.
Future experiments will aim to develop an axenic medium that can be used to determine
the effects of amino acid restriction on the lifespan of C. elegans. Currently used axenic medium
appears to induce dietary restriction yielding long-lived worms. Future studies will also aim to
determine the metabolic mechanisms through which amino acids activate SKN-1 activity and
through which serine and histidine activate HIF-1. It should also be identified whether serine
catabolism is required for serine-mediated lifespan extension, as serine can be converted to
pyruvate, which extends lifespan. Since lifespan extension by serine is so robust, further research
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is warranted to identify the exact mechanistic details. Research should continue to focus on the
individual signaling pathways by which amino acids affect health and lifespan. In our studies we
focused on 1, 5, and 10 mM concentrations, but further research should examine concentrations
below and above these parameters to identify a proper dose for amino acids that had little to no
effect on lifespan. It is hoped that an optimal dose will be identified for each amino acid.
Through the use of both amino acid supplementation and restriction, a diet may one day be
developed that can significantly increase stress resistance and slow aging and the onset of agingassociated disorders.
6.7 Beta-hydroxybutyrate as an alternative energy source
Under standard dietary conditions, the human body uses glucose to fuel glycolysis, which
is used as energy or stored as glycogen when present in excess. Glucose oxidation is used
together with fatty acid and amino acid oxidation for energy production. During times of
starvation or restricted carbohydrate consumption when glycogen stores are reduced,
triglycerides in adipose tissue are broken down into fatty acids and transported to peripheral
tissues to be broken down by mitochondrial beta-oxidation into acetyl-CoA for energy
production through the TCA cycle. In the liver, fatty acids experience a different fate. There
acetyl-CoA is converted into the ketone bodies acetoacetate and βHB, which are exported from
the liver to other tissues as an alternative energy source. This is especially important for neurons,
which are unable to catabolize fatty acids at an appreciable rate. The ketogenic diet is a high fat,
low protein and low carbohydrate diet that mimics calorie restriction to provide the body with
energy when glucose is not freely available. Many of the benefits produced by CR, especially at
the mitochondrial level, can be attributed to the ketones generated by a low calorie state [29].
Like CR, βHB has shown some effectiveness in the protection against Alzheimer’s and
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Parkinson’s disease-mediated neurodegeneration in animal models and human trials, but until
now little was known about its effects on lifespan. Because βHB can feed into the TCA cycle, in
Chapter 5 we determined if it can also extend lifespan in C. elegans.
We were the first to identify D-βHB as a positive modulator of organismal longevity. We
showed that administering βHB to C. elegans extended lifespan and delayed proteotoxicity and
glucose toxicity in a SIR-2.1 and AMPK-dependent manner that also required the stressresponsive transcription factors DAF-16 and SKN-1. The mammalian SKN-1 homolog Nrf2 has
been shown to play a limited role in mitochondrial biogenesis in some tissues. We also found
that βHB did not extend lifespan in eat-2 pharyngeal pumping mutants and therefore acts as a
dietary restriction mimetic. An important finding in Chapter 5 is that D-βHB-mediated lifespan
extension

required

SKN-1

and

its

transcriptional

target

F55E10.6,

a

short-chain

dehydrogenase/reductase with βHB dehydrogenase activity, although inhibition of HDACS
HDA-2 and HDA-3 were also required for the increased longevity. βHB-induced lifespan
extension was partially blocked in ETC complex I mutant worms and was unaffected in
mitochondrial ETC complex II mutant worms. This suggests that the lifespan extension is driven
partly by mitochondrial metabolism-dependent effects, specifically though NAD(H) metabolism.
Multiple physiological conditions are associated with a reduction in the cellular
NADH/NAD+ ratio. As discussed in Chapter 1, CR decreases the NADH/NAD+ in yeast, which
activates Sir2 (NADH is a competitive inhibitor of Sir2), resulting in an increase in lifespan [30].
Another situation where a decline in NADH is seen is during the use of metformin, a drug
prescribed for the treatment of Type II diabetes, which accompanies increased SIRT1 activity
[31]. Activation of SIRT1 by metformin was associated with lowered blood glucose and
recovered insulin sensitivity.
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Figure 6.4. Ketone bodies entry in to the TCA cycle.

Like CR, the ketogenic diet reduces the NADH/NAD+ ratio by boosting mitochondrial
respiration through increased NADH oxidation [32]. So similar are the affects seen during CR
and the administration of βHB (or the ketogenic diet) that some researchers speculate that CR
may be beneficial at least in part through increasing ketone levels, which act as HDAC inhibitors
and increase expression of stress response genes. Not only do both CR and the ketogenic diet
extend lifespan, reduce the NADH/NAD+ ratio, and activate SIRT1 [33], they are associated with
a reduction in ROS production [29]. Both CR and the ketogenic induce mitochondrial
biogenesis, which partially compensates for the decline in ATP observed during aging and
dysfunction [34]. Prior to the irreversible conversion of acetoacetate to acetone, acetoacetate and
βHB exist in a reversible equilibrium. So, in theory, administration of acetoacetate to C. elegans
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would increase that NAD+/NADH ratio and extend lifespan. Unfortunately, acetoacetate is
quickly decarboxylated and is very unstable, making its use as a supplement difficult.
In Chapter 5 we propose two overlapping pathways for lifespan extension mediated by
βHB supplementation as shown in Figure 4. In the first, βHB directly inhibits HDACs to increase
histone acetylation leading to DAF-16/FOXO transcription and activation. The second proposed
protective pathway involves mitochondrial metabolism of βHB, leading to increased citric acid
cycle metabolites and electron transport chain (ETC) activity, increased reactive oxygen species
production, and activation of the SKN-1 antioxidant response pathway.

Figure 6.5. Proposed mechanisms of D- βHB mediated lifespan extension in C. elegans.
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In Chapter 5 we also showed that βHB increased thermotolerance and delayed Aβinduced paralysis and decreased alpha-synuclein aggregation in C. elegans models of human
disease. Although we show compelling evidence for the use of D-βHB as a prophylactic for
disease in nematode models, questions remain. For example, are the same signaling pathways
required for longevity also required for βHB-mediated protection in the C. elegans models of
amyloid beta and alpha-synuclein toxicity? Future experiments will elucidate the molecular
mechanisms responsible for the protective effects of βHB and this knowledge will allow for a
broader use of D-βHB as a therapy for aging-related disorders.
6.8 Metabolites that delay aging
In order to discover metabolic pathways that delay aging, the effects of large sets of
metabolites on lifespan were investigated. C. elegans share almost all metabolic pathways with
humans. We hypothesized that changes in mitochondrial metabolite levels could result in an
increased lifespan and protection from proteotoxic stress. We have determined that the TCA
cycle metabolites fumarate, malate, succinate, alpha-ketoglutarate, isocitrate, and oxaloacetate
extended lifespan in C. elegans, while all of the amino acids except phenylalanine and aspartate
extended lifespan at least to a small extent at one or more of the 3 concentrations tested with
serine and proline showing the largest effects. We also found that the ketone body, βHB, extends
lifespan in C. elegans and we determined the cytoprotective signaling pathways required for this
effect. Figure 5 highlights the many pathways associated with longevity.
The major aim of this study was to understand the mechanisms by which natural
metabolites influence the lifespan of C. elegans. From our studies we have identified many
metabolites that can increase lifespan and prevent age-related decline.
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Figure 6.6. The availability of nutrients and external stress roles in longevity.
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